# EDGAR Filing Document

**Accession Number:** 0000930420
**File Stem:** 0000930420-26-000013
**Filing Date:** 2026-3
**Character Count:** 382496
**Document Hash:** 112b8c0a64a4c4a4e2e4945baeaae209
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000930420-26-000013.hdr.sgml**: 20260313

**ACCESSION NUMBER**: 0000930420-26-000013

**CONFORMED SUBMISSION TYPE**: DEF 14A

**PUBLIC DOCUMENT COUNT**: 83

**CONFORMED PERIOD OF REPORT**: 20260422

**FILED AS OF DATE**: 20260313

**DATE AS OF CHANGE**: 20260313

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** KFORCE INC
- **CENTRAL INDEX KEY:** 0000930420
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-HELP SUPPLY SERVICES [7363]
- **ORGANIZATION NAME:** 07 Trade & Services
- **EIN:** 593264661
- **STATE OF INCORPORATION:** FL
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** DEF 14A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-42104
- **FILM NUMBER:** 26752719

**BUSINESS ADDRESS:**
- **STREET 1:** 1150 ASSEMBLY DRIVE
- **STREET 2:** SUITE 500
- **CITY:** TAMPA
- **STATE:** FL
- **ZIP:** 33607
- **BUSINESS PHONE:** 8135525000

**MAIL ADDRESS:**
- **STREET 1:** 8405 BENJAMIN ROAD
- **STREET 2:** SUITE G
- **CITY:** TAMPA
- **STATE:** FL
- **ZIP:** 33634

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** KFORCE  INC
- **DATE OF NAME CHANGE:** 20000517

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** ROMAC INTERNATIONAL INC
- **DATE OF NAME CHANGE:** 19950502

?xml version='1.0' encoding='ASCII'? kfrc-20260313

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, D.C. 20549**

**SCHEDULE 14A**

**Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934**

Filed by the Registrant 🗷&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Filed by a party other than the Registrant ◻

---

| | |
|:---|:---|
| Check the appropriate box | Check the appropriate box |
| ◻ | Preliminary Proxy Statement |
| ◻ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
| 🗷 | Definitive Proxy Statement |
| ◻ | Definitive Additional Materials |
| ◻ | Soliciting Material Pursuant to Rule 14a-12 |

---

![Kforce_Trademark_FullColor_500.jpg](kfrc-20260313_g1.jpg)

**KFORCE INC.**

**(Name of Registrant as Specified In Its Charter)**

Payment of Filing Fee (Check the appropriate box):

---

| |
|:---|
| No fee required |
| Fee paid previously with preliminary materials |
| Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 |

---

------

![Kforce_Trademark_FullColor_500.jpg](kfrc-20260313_g1.jpg)

---

| | |
|:---|:---|
| **2026** | **Proxy<br>Statement** |

---

**NOTICE OF ANNUAL MEETING OF SHAREHOLDERS**

You are cordially invited to attend the 2026 Annual Meeting of Kforce Inc. Shareholders (the Annual Meeting).

---

| | | | |
|:---|:---|:---|:---|
| ![Calendar.jpg](kfrc-20260313_g2.jpg)<br>**DATE** | **Wednesday, April 22, 2026** | ![Clock.jpg](kfrc-20260313_g3.jpg)<br>**TIME** | **8:00 a.m. Eastern Time** |
| ![Location.jpg](kfrc-20260313_g4.jpg)<br>**LOCATION** | **1150 Assembly Drive, Suite 500, Tampa, Florida 33607** | ![Clipboard.jpg](kfrc-20260313_g5.jpg)<br>**RECORD DATE** | **February 20, 2026** |

---

**Proposals and Voting Recommendations**

---

| | | | |
|:---|:---|:---|:---|
| **Proposal** | **Description** | **Board Recommendation** | **Page Reference** |
| 1 | Elect three Class II directors nominated by the Board of Directors of Kforce Inc. to serve until 2029 | **FOR** | **<u>[12](#ibde21b2946834ef1acfb04b1aa73fd7c_43)</u>** |
| 2 | Ratify the appointment of Deloitte & Touche LLP as Kforce's independent registered public accountants for 2026 | **FOR** | **<u>[19](#ibde21b2946834ef1acfb04b1aa73fd7c_64)</u>** |
| 3 | Conduct an advisory vote on executive compensation | **FOR** | **<u>[48](#ibde21b2946834ef1acfb04b1aa73fd7c_145)</u>** |
| 4 | Approve the Kforce Inc. 2026 Stock Incentive Plan | **FOR** | **<u>[49](#ibde21b2946834ef1acfb04b1aa73fd7c_148)</u>** |
| 5 | Attend to other business properly presented at the meeting |  |  |

---

The proxy statement, proxy card and Kforce's 2025 Annual Report to Shareholders are being mailed on or about March 13, 2026. Regardless of whether or not you plan to attend the annual meeting, we encourage you to vote your shares online, by phone, or by signing, dating and mailing the enclosed proxy card.

If you need further assistance, please contact Kforce Investor Relations at (813) 552-5000. Thank you for your continuing support.

**By the Order of the Board of Directors,**![davekellysignaturea03.jpg](kfrc-20260313_g6.jpg)

David M. Kelly

Corporate Secretary

Tampa, Florida

March 13, 2026

**Important Notice Regarding the Availability of Proxy Materials for the Shareholder Meeting to be Held on April 22, 2026.**<br>**This proxy statement and our 2025 Annual Report to Shareholders are available at** <br>**<u>https://investor.kforce.com/financials/annual-reports/default.aspx</u>.** <br>

------

<u>[**Table of Contents**](#ibde21b2946834ef1acfb04b1aa73fd7c_16)</u>

---

| |
|:---|
| ![Screenshot 2025-02-04 100659.jpg](kfrc-20260313_g7.jpg) |
| ![Proxy SH Banner_2026.jpg](kfrc-20260313_g8.jpg) |

---

**LETTER TO OUR SHAREHOLDERS**

At Kforce, we combine technical knowledge and industry expertise to create solutions that power the future. We are innovators, thought leaders and high performers who work with our clients, consultants and candidates to move Together Toward Tomorrow®.

In 2025, a persistently weak labor market and limited job growth contributed to the broader technology services sector seeing its third consecutive year of revenue declines. While companies remain cautious about permanent hiring, we believe they typically shift first to flexible talent as they assess the durability of macroeconomic conditions, an approach we believe may be reflected in our recent operating trends and suggestive of a more typical cyclical pattern. Over the past year-plus, AI and the surrounding noise have also materially influenced the market. Companies have been required to assess what this revolution in technology means to their technology roadmaps, which we believe also may have contributed to the relative restraint by clients in making significant long-term technology investments over the last several years. Against this backdrop of economic and technological uncertainty, demand for flexible talent is likely to increase as organizations prioritize agility. We remain confident that, over time, AI will be a net positive for our business both in terms of client demand and internal productivity gains.

Operating conditions across the technology services sector remained subdued throughout 2025, but our Technology business showed increasing signs of stabilization and momentum in the second half of the year. Performance strengthened sequentially, culminating in a fourth quarter that exceeded expectations. This momentum was carried into early 2026, which we believe reflects both the strength in our client portfolio and the critical nature of the work our teams deliver.

We made tremendous progress in 2025 with our strategic initiatives, including the future-state implementation of Workday as our enterprise cloud application for human capital management and financials, the evolution of our offshore delivery capability in India and the further integration of the full spectrum of our service offerings across the Firm as One Kforce. Mid-year, we formalized a fourth strategic priority to better coordinate and enhance significant investments already being made: Empowering our Firm strategy through AI. Each of our enterprise priorities are expected to meaningfully contribute to us attaining our future financial objectives.

Our expert team of technologists created meaningful change for clients throughout 2025, particularly when generating, strategizing and building AI solutions and helping our clients with extensive preparedness work ahead of AI. In 2025, we put in place the framework to launch the Kforce Innovation Experience, a living, breathing ecosystem where bold ideas become transformative realities. In 2026, clients will be able to join us at our Kforce Innovation Studio in Tampa to co-create alongside AI experts and domain practitioners in a space designed for rapid experimentation and breakthrough thinking. And Knowledgeforce India, which began supporting client engagements in January 2025, is evolving to contain a Center of Excellence, where our global AI team will turn prototypes into scalable platforms. Our capability in Pune, India, when combined with a strong U.S. sales and delivery capability and a high-quality vendor network, will help us more fully address the evolving needs of our clients, whether onshore, nearshore or offshore.

We believe generative AI, and its offshoots into agentic AI and cognitive AI, is in the early innings of evolution and provides opportunities for Kforce. Securing the right talent, organizing the right teams and launching focused enterprise-level initiatives is essential for organizations to successfully adopt and maximize these new tools. Our strong position should allow us to increase client-share and attract new clients, continuing our track record of gaining market share and reinforcing the solid foundation that drives lasting value for our shareholders. Our domestically focused, organic growth strategy continues to serve us well by minimizing distractions and enabling our people to fully concentrate on partnering with clients to solve their most critical business challenges.

We remain committed to sound governance, employee well-being and reducing our environmental impact. Our overall ESG strategy is outlined in our annual Sustainability Report, which will be published later this year.

Successful companies invest in both technology and people. At Kforce, our people are our strength. Their wisdom, creativity and resilience are our greatest assets. We are blessed to have a high performing team that is tenured, dedicated and passionate. We could not be more excited about the future of Kforce.

---

| | | |
|:---|:---|:---|
| ![dunkelsignaturea01.jpg](kfrc-20260313_g9.jpg) | ![EDR Sig 2 (002).jpg](kfrc-20260313_g10.jpg) | ![JLiberatore (002) resized.jpg](kfrc-20260313_g11.jpg) |
| **David L. Dunkel, *Chairman*** | **Elaine D. Rosen, *Lead Independent Director*** | **Joseph J. Liberatore, *President and Chief Executive Officer, Director*** |

---

2 Kforce 2026 Proxy Statement

------

<u>[**Table of Contents**](#ibde21b2946834ef1acfb04b1aa73fd7c_16)</u>

**TABLE OF CONTENTS**

---

| | | | |
|:---|:---|:---|:---|
| **BOARD AND CORPORATE GOVERNANCE** |  | &nbsp;&nbsp;**<u>[Role of the Board of Directors](#ibde21b2946834ef1acfb04b1aa73fd7c_22)</u>** | **<u>[4](#ibde21b2946834ef1acfb04b1aa73fd7c_22)</u>** |
| **BOARD AND CORPORATE GOVERNANCE** |  | &nbsp;&nbsp;**<u>[Leadership Structure](#ibde21b2946834ef1acfb04b1aa73fd7c_25)</u>** | **<u>[5](#ibde21b2946834ef1acfb04b1aa73fd7c_25)</u>** |
| **BOARD AND CORPORATE GOVERNANCE** |  | &nbsp;&nbsp;**<u>[Committee Structure](#ibde21b2946834ef1acfb04b1aa73fd7c_28)</u>** | **<u>[6](#ibde21b2946834ef1acfb04b1aa73fd7c_28)</u>** |
| **BOARD AND CORPORATE GOVERNANCE** |  | &nbsp;&nbsp;**<u>[Directors' Time Commitments](#ibde21b2946834ef1acfb04b1aa73fd7c_31)</u>** | **<u>[7](#ibde21b2946834ef1acfb04b1aa73fd7c_31)</u>** |
| **BOARD AND CORPORATE GOVERNANCE** |  | &nbsp;&nbsp;**<u>[Board's Role in Risk Oversight](#ibde21b2946834ef1acfb04b1aa73fd7c_34)</u>** | **<u>[8](#ibde21b2946834ef1acfb04b1aa73fd7c_34)</u>** |
| **BOARD AND CORPORATE GOVERNANCE** |  | &nbsp;&nbsp;**<u>[Our Board of Directors](#ibde21b2946834ef1acfb04b1aa73fd7c_37)</u>** | **<u>[10](#ibde21b2946834ef1acfb04b1aa73fd7c_37)</u>** |
| **BOARD AND CORPORATE GOVERNANCE** |  | &nbsp;&nbsp;**<u>[Biographical Information for Our Director Nominees](#ibde21b2946834ef1acfb04b1aa73fd7c_40)</u>** | **<u>[11](#ibde21b2946834ef1acfb04b1aa73fd7c_40)</u>** |
| **BOARD AND CORPORATE GOVERNANCE** | **Proposal 1** | &nbsp;&nbsp;**<u>[Election of Directors](#ibde21b2946834ef1acfb04b1aa73fd7c_43)</u>** | **<u>[12](#ibde21b2946834ef1acfb04b1aa73fd7c_43)</u>** |
| **BOARD AND CORPORATE GOVERNANCE** |  | &nbsp;&nbsp;**<u>[Biographical Information for Our Continuing Directors](#ibde21b2946834ef1acfb04b1aa73fd7c_46)</u>** | **<u>[13](#ibde21b2946834ef1acfb04b1aa73fd7c_46)</u>** |
| **BOARD AND CORPORATE GOVERNANCE** |  | &nbsp;&nbsp;**<u>[Composition and Diversity](#ibde21b2946834ef1acfb04b1aa73fd7c_49)</u>** | **<u>[15](#ibde21b2946834ef1acfb04b1aa73fd7c_49)</u>** |
| **BOARD AND CORPORATE GOVERNANCE** |  | &nbsp;&nbsp;**<u>[Environmental, Social and Governance (ESG) Oversight and Activities](#ibde21b2946834ef1acfb04b1aa73fd7c_52)</u>** | **<u>[16](#ibde21b2946834ef1acfb04b1aa73fd7c_52)</u>** |
| **BOARD AND CORPORATE GOVERNANCE** |  | &nbsp;&nbsp;**<u>[Related Party Transactions, Compensation Committee Interlocks and Insider Participation](#ibde21b2946834ef1acfb04b1aa73fd7c_58)</u>** | **<u>[17](#ibde21b2946834ef1acfb04b1aa73fd7c_58)</u>** |
| **BOARD AND CORPORATE GOVERNANCE** |  | &nbsp;&nbsp;**<u>[Director Compensation](#ibde21b2946834ef1acfb04b1aa73fd7c_61)</u>** | **<u>[18](#ibde21b2946834ef1acfb04b1aa73fd7c_61)</u>** |
| **BOARD AND CORPORATE GOVERNANCE** | **Proposal 2** | &nbsp;&nbsp;**<u>[Ratification of Appointment of Independent Registered Public Accountants](#ibde21b2946834ef1acfb04b1aa73fd7c_64)</u>** | **<u>[19](#ibde21b2946834ef1acfb04b1aa73fd7c_64)</u>** |
| **EXECUTIVE COMPENSATION** |  | &nbsp;&nbsp;**<u>[Executive Officers](#ibde21b2946834ef1acfb04b1aa73fd7c_70)</u>** | **<u>[21](#ibde21b2946834ef1acfb04b1aa73fd7c_70)</u>** |
| **EXECUTIVE COMPENSATION** |  | &nbsp;&nbsp;**<u>[Compensation Discussion and Analysis](#ibde21b2946834ef1acfb04b1aa73fd7c_73)</u>** | **<u>[22](#ibde21b2946834ef1acfb04b1aa73fd7c_73)</u>** |
| **EXECUTIVE COMPENSATION** |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Executive Summary](#ibde21b2946834ef1acfb04b1aa73fd7c_79)</u> | <u>[23](#ibde21b2946834ef1acfb04b1aa73fd7c_79)</u> |
| **EXECUTIVE COMPENSATION** |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Our Compensation Principles, Components and Practices](#ibde21b2946834ef1acfb04b1aa73fd7c_85)</u> | <u>[24](#ibde21b2946834ef1acfb04b1aa73fd7c_85)</u> |
| **EXECUTIVE COMPENSATION** |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Named Executive Officer Compensation](#ibde21b2946834ef1acfb04b1aa73fd7c_103)</u> | <u>[29](#ibde21b2946834ef1acfb04b1aa73fd7c_103)</u> |
| **EXECUTIVE COMPENSATION** |  | &nbsp;&nbsp;**<u>[Executive Compensation Tables](#ibde21b2946834ef1acfb04b1aa73fd7c_115)</u>** | **<u>[36](#ibde21b2946834ef1acfb04b1aa73fd7c_115)</u>** |
| **EXECUTIVE COMPENSATION** |  | &nbsp;&nbsp;**<u>[CEO Pay Ratio](#ibde21b2946834ef1acfb04b1aa73fd7c_139)</u>** | **<u>[43](#ibde21b2946834ef1acfb04b1aa73fd7c_139)</u>** |
| **EXECUTIVE COMPENSATION** |  | &nbsp;&nbsp;**<u>[Pay versus Performance](#ibde21b2946834ef1acfb04b1aa73fd7c_142)</u>** | **<u>[44](#ibde21b2946834ef1acfb04b1aa73fd7c_142)</u>** |
| **EXECUTIVE COMPENSATION** | **Proposal 3** | &nbsp;&nbsp;**<u>[Advisory Vote on Executive Compensation](#ibde21b2946834ef1acfb04b1aa73fd7c_145)</u>** | **<u>[48](#ibde21b2946834ef1acfb04b1aa73fd7c_145)</u>** |
| **EXECUTIVE COMPENSATION** | **Proposal 4** | &nbsp;&nbsp;**<u>[Approval of Kforce Inc. 202](#ibde21b2946834ef1acfb04b1aa73fd7c_148)[6](#ibde21b2946834ef1acfb04b1aa73fd7c_148)[Stock Incentive Plan](#ibde21b2946834ef1acfb04b1aa73fd7c_148)</u>** | **<u>[49](#ibde21b2946834ef1acfb04b1aa73fd7c_148)</u>** |
| **OTHER MATTERS** |  | &nbsp;&nbsp;**<u>[Securities Authorized for Issuance Under Equity Compensation Plans](#ibde21b2946834ef1acfb04b1aa73fd7c_154)</u>** | **<u>[56](#ibde21b2946834ef1acfb04b1aa73fd7c_154)</u>** |
| **OTHER MATTERS** |  | &nbsp;&nbsp;**<u>[Stock Ownership Information](#ibde21b2946834ef1acfb04b1aa73fd7c_157)</u>** | **<u>[56](#ibde21b2946834ef1acfb04b1aa73fd7c_157)</u>** |
| **OTHER MATTERS** |  | &nbsp;&nbsp;**<u>[General Information](#ibde21b2946834ef1acfb04b1aa73fd7c_166)</u>** | **<u>[58](#ibde21b2946834ef1acfb04b1aa73fd7c_166)</u>** |
| **OTHER MATTERS** |  | &nbsp;&nbsp;**<u>[Shareholder Communications, Proposals and Other Matters](#ibde21b2946834ef1acfb04b1aa73fd7c_169)</u>** | **<u>[60](#ibde21b2946834ef1acfb04b1aa73fd7c_169)</u>** |
| **OTHER MATTERS** |  | &nbsp;&nbsp;**<u>[Appendix A. Kforce Inc. 202](#ibde21b2946834ef1acfb04b1aa73fd7c_172)[6](#ibde21b2946834ef1acfb04b1aa73fd7c_172)[Stock Incentive Plan](#ibde21b2946834ef1acfb04b1aa73fd7c_172)</u>** | **<u>[61](#ibde21b2946834ef1acfb04b1aa73fd7c_172)</u>** |
| **OTHER MATTERS** |  | &nbsp;&nbsp;**<u>[Appendix](#ibde21b2946834ef1acfb04b1aa73fd7c_175)[B](#ibde21b2946834ef1acfb04b1aa73fd7c_175)[.](#ibde21b2946834ef1acfb04b1aa73fd7c_175)Reconciliation of (1) Adjusted Diluted Earnings Per Share and (2) EPS Financial Incentive Metric Attainment</u>** | **<u>[77](#ibde21b2946834ef1acfb04b1aa73fd7c_175)</u>** |

---

3 Kforce 2026 Proxy Statement

------

<u>[**Table of Contents**](#ibde21b2946834ef1acfb04b1aa73fd7c_16)</u>

**BOARD AND CORPORATE GOVERNANCE**

**ROLE OF THE BOARD OF DIRECTORS**

The primary functions of our Board of Directors (the Board) are to:

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **oversee** the performance of management on behalf of our shareholders; | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **monitor** adherence to the Firm's established procedures, standards and policies; |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **advocate** on behalf of the long-term interests of our shareholders; | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• provide **active oversight** of risks that could affect Kforce, including cybersecurity and AI risks; and |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **discuss and consider** the Firm's strategic planning and executive succession activities; | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **promote** sound corporate governance policies and practices; |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **review and approve** the Firm's long-term strategic plan developed by management; | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• provide **oversight** of the Firm's ESG program; |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• provide **active oversight** of the Firm's leverage of **artificial intelligence (AI)** internally and its positioning to capture future AI demand; and | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **carry out** other duties and responsibilities as may be required by state and federal laws, as well as the New York Stock Exchange ("NYSE") rules. |

---

We believe that sound corporate governance is fundamental to the overall success of Kforce (the "Firm"). Our key governance documents, including our Corporate Governance Guidelines and Commitment to Integrity, are available at http://investor.kforce.com/governance/governance-documents.

In conjunction with management reports and dialogue with executive leadership, the Board reviews various operational, strategic, financial, capital markets and legal compliance areas, business and sector trends, as well as the Firm's progress against established objectives and risks. At each quarterly Board meeting, our Board receives:

---

| | |
|:---|:---|
| an executive summary that includes, among other items, any pertinent risks related to our business | management's analysis on the current state of the staffing and solutions industries and corporate development activities |
| the Firm's financial and operational performance, including progress against our expectations and plans | insights on human capital trends and productivity metrics |
| an update on the Firm's accomplishments and near-term objectives associated with our strategic priorities | a report on the Firm's Enterprise Risk Management (ERM) program |
| updates on relevant matters from each of the committees of the Board | an update on significant claims and litigation and an ethics hotline summary |
| management's assessment of the current state of the capital markets and macro-economic environment | updates as needed on key legal and regulatory changes and potential impacts on our business |
| reports on other matters that may arise from time to time, including a quarterly update from the Audit Committee on any significant cybersecurity related items | |

---

On a monthly basis, our Board receives:

---

| |
|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**• A financial update from management, including operating trends against expectations;** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**• A description of certain significant events and risk factors, if any, that have occurred in the period; and** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**• Any other necessary items requiring the attention of the Board on an interim basis.** |

---

4 Kforce 2026 Proxy Statement

------

<u>[**Table of Contents**](#ibde21b2946834ef1acfb04b1aa73fd7c_16)</u>

On an annual basis, executive management and our Board discuss the Firm's near-term and longer-term strategic objectives, management's progress towards its objectives and any necessary changes to our strategies based on our position and the evolving external landscape. Additionally, management engages in dedicated sessions with the Board related to the Firm's cybersecurity program and shareholder engagement matters. Also, the full Board participates in annual education sessions on matters deemed pertinent by the Nomination Committee and full Board. The Board education topics have varied in recent years to include Generative AI (GenAI), the state of shareholder activism activities in the market, regulatory updates, ESG programs, cybersecurity, as well as other topics, and are usually facilitated by independent subject matter experts.

**LEADERSHIP STRUCTURE**

Our Board continues to be led by its Chairman, David L. Dunkel, who served as our CEO for more than 40 years before retiring from that role in 2021. Mr. Dunkel has continued his service to Kforce solely as non-executive Chairman of the Board. This leadership structure is complemented and balanced by a Lead Independent Director, fully independent Audit, Compensation, Nomination and Corporate Governance Committees, and a Board composed of a majority of independent directors.

The Lead Independent Director, among other responsibilities, presides over Board meetings in the Chairman's absence, assists in overseeing CEO performance and succession planning and is engaged in more significant Board matters. The Board believes this structure provides an effective, efficient and appropriate framework for oversight and governance.

Mr. Dunkel possesses a deep and unparalleled understanding of the Firm's business and operations. The Board believes that his extensive knowledge and experience uniquely position him to lead and support the execution of the Board's strategic direction as Chairman, while the Lead Independent Director enhances Board processes, controls and overall cohesiveness and effectiveness.

---

| | |
|:---|:---|
| Our commitment to Board independence is further reinforced by a Lead Independent Director, a majority of independent directors, and fully independent directors serving on each of the Audit, Compensation, Nomination and Corporate Governance Committees. This structure ensures that oversight of the key matters within each Committee's purview resides with independent directors, thereby strengthening the Firm's governance framework. <br>All continuing directors and director nominees are independent under the NYSE listing standards, with the exception of Mr. Dunkel and Mr. Liberatore. No family relationships exist among any of our continuing directors, director nominees or executive officers.<br>The Board and executive management are committed to maintaining ongoing dialogue with shareholders and regularly seek shareholder input on governance matters, including the Board's leadership structure. Shareholder perspectives are considered as part of the Board's evaluation and decision-making process. Additional information regarding our shareholder engagement efforts is summarized in the "Consideration of Shareholder Feedback" section of this Proxy Statement. | ![Picture34.jpg](kfrc-20260313_g12.jpg) |
| Our commitment to Board independence is further reinforced by a Lead Independent Director, a majority of independent directors, and fully independent directors serving on each of the Audit, Compensation, Nomination and Corporate Governance Committees. This structure ensures that oversight of the key matters within each Committee's purview resides with independent directors, thereby strengthening the Firm's governance framework. <br>All continuing directors and director nominees are independent under the NYSE listing standards, with the exception of Mr. Dunkel and Mr. Liberatore. No family relationships exist among any of our continuing directors, director nominees or executive officers.<br>The Board and executive management are committed to maintaining ongoing dialogue with shareholders and regularly seek shareholder input on governance matters, including the Board's leadership structure. Shareholder perspectives are considered as part of the Board's evaluation and decision-making process. Additional information regarding our shareholder engagement efforts is summarized in the "Consideration of Shareholder Feedback" section of this Proxy Statement. | ![Picture34.jpg](kfrc-20260313_g12.jpg) |

---

5 Kforce 2026 Proxy Statement

------

<u>[**Table of Contents**](#ibde21b2946834ef1acfb04b1aa73fd7c_16)</u>

**COMMITTEE STRUCTURE**

Our Board has established four standing committees: the Audit Committee, the Compensation Committee, the Nomination Committee and the Corporate Governance Committee. These Committees enable more comprehensive review and oversight of key areas than would be practical during quarterly Board meetings alone.

The Board has determined that the chair and all members of each of the Audit, Compensation, Nomination and Corporate Governance Committees are independent under the applicable NYSE listing standards and SEC Rules, as required. Committee members and the independent directors meet regularly in executive session without management present.

Each Committee is empowered to retain or obtain advice from independent legal counsel, accountants or other advisors as it deems necessary to fulfill its responsibilities. Each Committee also operates pursuant to a written charter, all of which are available on our website at http://investor.kforce.com/governance/governance-documents. Additional information regarding the composition and responsibilities of each Committee is described below.

---

| | |
|:---|:---|
| **Corporate Governance Committee** | **Corporate Governance Committee** |
| ***<u>Members:</u>*** | ***<u>Roles and Responsibilities of the Committee:</u>*** |
| **Elaine D. Rosen (Chair)** | The functions of the Corporate Governance Committee are to: encourage and enhance communication among independent directors; provide a forum for independent directors to meet separately from management; provide leadership and oversight related to ethical standards and governance practices (including ESG); and provide a channel for communication with the CEO. The Corporate Governance Committee also coordinates a formal annual evaluation of the performance of the Board, each of its committees and the CEO. <br>Each member of the Board who is independent (as determined under the NYSE listing standards) serves on the Corporate Governance Committee. This committee is designed to fulfill the requirements of §303A.03 of the NYSE Listed Company Manual (i.e., through the meetings of this committee, our independent directors meet regularly in executive session without any of our management present). The Firm's Lead Independent Director serves as the Chair of the Corporate Governance Committee and presides over each meeting of the committee. |
| **Derrick D. Brooks** | The functions of the Corporate Governance Committee are to: encourage and enhance communication among independent directors; provide a forum for independent directors to meet separately from management; provide leadership and oversight related to ethical standards and governance practices (including ESG); and provide a channel for communication with the CEO. The Corporate Governance Committee also coordinates a formal annual evaluation of the performance of the Board, each of its committees and the CEO. <br>Each member of the Board who is independent (as determined under the NYSE listing standards) serves on the Corporate Governance Committee. This committee is designed to fulfill the requirements of §303A.03 of the NYSE Listed Company Manual (i.e., through the meetings of this committee, our independent directors meet regularly in executive session without any of our management present). The Firm's Lead Independent Director serves as the Chair of the Corporate Governance Committee and presides over each meeting of the committee. |
| **Catherine H. Cloudman** | The functions of the Corporate Governance Committee are to: encourage and enhance communication among independent directors; provide a forum for independent directors to meet separately from management; provide leadership and oversight related to ethical standards and governance practices (including ESG); and provide a channel for communication with the CEO. The Corporate Governance Committee also coordinates a formal annual evaluation of the performance of the Board, each of its committees and the CEO. <br>Each member of the Board who is independent (as determined under the NYSE listing standards) serves on the Corporate Governance Committee. This committee is designed to fulfill the requirements of §303A.03 of the NYSE Listed Company Manual (i.e., through the meetings of this committee, our independent directors meet regularly in executive session without any of our management present). The Firm's Lead Independent Director serves as the Chair of the Corporate Governance Committee and presides over each meeting of the committee. |
| **Ann E. Dunwoody** | The functions of the Corporate Governance Committee are to: encourage and enhance communication among independent directors; provide a forum for independent directors to meet separately from management; provide leadership and oversight related to ethical standards and governance practices (including ESG); and provide a channel for communication with the CEO. The Corporate Governance Committee also coordinates a formal annual evaluation of the performance of the Board, each of its committees and the CEO. <br>Each member of the Board who is independent (as determined under the NYSE listing standards) serves on the Corporate Governance Committee. This committee is designed to fulfill the requirements of §303A.03 of the NYSE Listed Company Manual (i.e., through the meetings of this committee, our independent directors meet regularly in executive session without any of our management present). The Firm's Lead Independent Director serves as the Chair of the Corporate Governance Committee and presides over each meeting of the committee. |
| **Mark F. Furlong** | The functions of the Corporate Governance Committee are to: encourage and enhance communication among independent directors; provide a forum for independent directors to meet separately from management; provide leadership and oversight related to ethical standards and governance practices (including ESG); and provide a channel for communication with the CEO. The Corporate Governance Committee also coordinates a formal annual evaluation of the performance of the Board, each of its committees and the CEO. <br>Each member of the Board who is independent (as determined under the NYSE listing standards) serves on the Corporate Governance Committee. This committee is designed to fulfill the requirements of §303A.03 of the NYSE Listed Company Manual (i.e., through the meetings of this committee, our independent directors meet regularly in executive session without any of our management present). The Firm's Lead Independent Director serves as the Chair of the Corporate Governance Committee and presides over each meeting of the committee. |
| **Randall A. Mehl** | The functions of the Corporate Governance Committee are to: encourage and enhance communication among independent directors; provide a forum for independent directors to meet separately from management; provide leadership and oversight related to ethical standards and governance practices (including ESG); and provide a channel for communication with the CEO. The Corporate Governance Committee also coordinates a formal annual evaluation of the performance of the Board, each of its committees and the CEO. <br>Each member of the Board who is independent (as determined under the NYSE listing standards) serves on the Corporate Governance Committee. This committee is designed to fulfill the requirements of §303A.03 of the NYSE Listed Company Manual (i.e., through the meetings of this committee, our independent directors meet regularly in executive session without any of our management present). The Firm's Lead Independent Director serves as the Chair of the Corporate Governance Committee and presides over each meeting of the committee. |
| **N. John Simmons** | The functions of the Corporate Governance Committee are to: encourage and enhance communication among independent directors; provide a forum for independent directors to meet separately from management; provide leadership and oversight related to ethical standards and governance practices (including ESG); and provide a channel for communication with the CEO. The Corporate Governance Committee also coordinates a formal annual evaluation of the performance of the Board, each of its committees and the CEO. <br>Each member of the Board who is independent (as determined under the NYSE listing standards) serves on the Corporate Governance Committee. This committee is designed to fulfill the requirements of §303A.03 of the NYSE Listed Company Manual (i.e., through the meetings of this committee, our independent directors meet regularly in executive session without any of our management present). The Firm's Lead Independent Director serves as the Chair of the Corporate Governance Committee and presides over each meeting of the committee. |
| ***<u>Number of Meetings:</u>*** | The functions of the Corporate Governance Committee are to: encourage and enhance communication among independent directors; provide a forum for independent directors to meet separately from management; provide leadership and oversight related to ethical standards and governance practices (including ESG); and provide a channel for communication with the CEO. The Corporate Governance Committee also coordinates a formal annual evaluation of the performance of the Board, each of its committees and the CEO. <br>Each member of the Board who is independent (as determined under the NYSE listing standards) serves on the Corporate Governance Committee. This committee is designed to fulfill the requirements of §303A.03 of the NYSE Listed Company Manual (i.e., through the meetings of this committee, our independent directors meet regularly in executive session without any of our management present). The Firm's Lead Independent Director serves as the Chair of the Corporate Governance Committee and presides over each meeting of the committee. |
| **4** | The functions of the Corporate Governance Committee are to: encourage and enhance communication among independent directors; provide a forum for independent directors to meet separately from management; provide leadership and oversight related to ethical standards and governance practices (including ESG); and provide a channel for communication with the CEO. The Corporate Governance Committee also coordinates a formal annual evaluation of the performance of the Board, each of its committees and the CEO. <br>Each member of the Board who is independent (as determined under the NYSE listing standards) serves on the Corporate Governance Committee. This committee is designed to fulfill the requirements of §303A.03 of the NYSE Listed Company Manual (i.e., through the meetings of this committee, our independent directors meet regularly in executive session without any of our management present). The Firm's Lead Independent Director serves as the Chair of the Corporate Governance Committee and presides over each meeting of the committee. |
| **Audit Committee** | **Audit Committee** |
| ***<u>Members:</u>*** | ***<u>Roles and Responsibilities of the Committee:</u>*** |
| **Mark F. Furlong (Chair)** | The Audit Committee oversees the accounting and financial reporting processes of the Firm and the Firm's ERM program. The Board also delegated responsibility for the Firm's cybersecurity program and data privacy practices to the Audit Committee. In discharging this oversight role, the Audit Committee is empowered to investigate any matter brought to its attention, with full access to all books, records, facilities and personnel of Kforce, and the power to retain outside legal counsel or other experts. The Audit Committee also has the responsibility for selecting, evaluating, compensating and monitoring the independence and performance of the Firm's independent auditors in conducting its audits and reviews, reviewing and approving related party transactions, and overseeing the Firm's internal audit function and ERM program, including cybersecurity, data privacy, risks related to the use of AI and ESG disclosures. At each quarterly meeting, or more frequently as needed, the members of the Audit Committee meet in executive session and meet regularly in separate executive sessions with the Firm's Vice President of Internal Audit, General Counsel and independent registered public accountants, Deloitte & Touche LLP.<br>The Board has determined that Mr. Furlong, Ms. Cloudman and Mr. Simmons are considered audit committee financial experts, as defined by SEC Rules. |
| **Catherine H. Cloudman** | The Audit Committee oversees the accounting and financial reporting processes of the Firm and the Firm's ERM program. The Board also delegated responsibility for the Firm's cybersecurity program and data privacy practices to the Audit Committee. In discharging this oversight role, the Audit Committee is empowered to investigate any matter brought to its attention, with full access to all books, records, facilities and personnel of Kforce, and the power to retain outside legal counsel or other experts. The Audit Committee also has the responsibility for selecting, evaluating, compensating and monitoring the independence and performance of the Firm's independent auditors in conducting its audits and reviews, reviewing and approving related party transactions, and overseeing the Firm's internal audit function and ERM program, including cybersecurity, data privacy, risks related to the use of AI and ESG disclosures. At each quarterly meeting, or more frequently as needed, the members of the Audit Committee meet in executive session and meet regularly in separate executive sessions with the Firm's Vice President of Internal Audit, General Counsel and independent registered public accountants, Deloitte & Touche LLP.<br>The Board has determined that Mr. Furlong, Ms. Cloudman and Mr. Simmons are considered audit committee financial experts, as defined by SEC Rules. |
| **N. John Simmons** | The Audit Committee oversees the accounting and financial reporting processes of the Firm and the Firm's ERM program. The Board also delegated responsibility for the Firm's cybersecurity program and data privacy practices to the Audit Committee. In discharging this oversight role, the Audit Committee is empowered to investigate any matter brought to its attention, with full access to all books, records, facilities and personnel of Kforce, and the power to retain outside legal counsel or other experts. The Audit Committee also has the responsibility for selecting, evaluating, compensating and monitoring the independence and performance of the Firm's independent auditors in conducting its audits and reviews, reviewing and approving related party transactions, and overseeing the Firm's internal audit function and ERM program, including cybersecurity, data privacy, risks related to the use of AI and ESG disclosures. At each quarterly meeting, or more frequently as needed, the members of the Audit Committee meet in executive session and meet regularly in separate executive sessions with the Firm's Vice President of Internal Audit, General Counsel and independent registered public accountants, Deloitte & Touche LLP.<br>The Board has determined that Mr. Furlong, Ms. Cloudman and Mr. Simmons are considered audit committee financial experts, as defined by SEC Rules. |
| ***<u>Number of Meetings:</u>*** | The Audit Committee oversees the accounting and financial reporting processes of the Firm and the Firm's ERM program. The Board also delegated responsibility for the Firm's cybersecurity program and data privacy practices to the Audit Committee. In discharging this oversight role, the Audit Committee is empowered to investigate any matter brought to its attention, with full access to all books, records, facilities and personnel of Kforce, and the power to retain outside legal counsel or other experts. The Audit Committee also has the responsibility for selecting, evaluating, compensating and monitoring the independence and performance of the Firm's independent auditors in conducting its audits and reviews, reviewing and approving related party transactions, and overseeing the Firm's internal audit function and ERM program, including cybersecurity, data privacy, risks related to the use of AI and ESG disclosures. At each quarterly meeting, or more frequently as needed, the members of the Audit Committee meet in executive session and meet regularly in separate executive sessions with the Firm's Vice President of Internal Audit, General Counsel and independent registered public accountants, Deloitte & Touche LLP.<br>The Board has determined that Mr. Furlong, Ms. Cloudman and Mr. Simmons are considered audit committee financial experts, as defined by SEC Rules. |
| **5** | The Audit Committee oversees the accounting and financial reporting processes of the Firm and the Firm's ERM program. The Board also delegated responsibility for the Firm's cybersecurity program and data privacy practices to the Audit Committee. In discharging this oversight role, the Audit Committee is empowered to investigate any matter brought to its attention, with full access to all books, records, facilities and personnel of Kforce, and the power to retain outside legal counsel or other experts. The Audit Committee also has the responsibility for selecting, evaluating, compensating and monitoring the independence and performance of the Firm's independent auditors in conducting its audits and reviews, reviewing and approving related party transactions, and overseeing the Firm's internal audit function and ERM program, including cybersecurity, data privacy, risks related to the use of AI and ESG disclosures. At each quarterly meeting, or more frequently as needed, the members of the Audit Committee meet in executive session and meet regularly in separate executive sessions with the Firm's Vice President of Internal Audit, General Counsel and independent registered public accountants, Deloitte & Touche LLP.<br>The Board has determined that Mr. Furlong, Ms. Cloudman and Mr. Simmons are considered audit committee financial experts, as defined by SEC Rules. |
|  | The Audit Committee oversees the accounting and financial reporting processes of the Firm and the Firm's ERM program. The Board also delegated responsibility for the Firm's cybersecurity program and data privacy practices to the Audit Committee. In discharging this oversight role, the Audit Committee is empowered to investigate any matter brought to its attention, with full access to all books, records, facilities and personnel of Kforce, and the power to retain outside legal counsel or other experts. The Audit Committee also has the responsibility for selecting, evaluating, compensating and monitoring the independence and performance of the Firm's independent auditors in conducting its audits and reviews, reviewing and approving related party transactions, and overseeing the Firm's internal audit function and ERM program, including cybersecurity, data privacy, risks related to the use of AI and ESG disclosures. At each quarterly meeting, or more frequently as needed, the members of the Audit Committee meet in executive session and meet regularly in separate executive sessions with the Firm's Vice President of Internal Audit, General Counsel and independent registered public accountants, Deloitte & Touche LLP.<br>The Board has determined that Mr. Furlong, Ms. Cloudman and Mr. Simmons are considered audit committee financial experts, as defined by SEC Rules. |
|  | The Audit Committee oversees the accounting and financial reporting processes of the Firm and the Firm's ERM program. The Board also delegated responsibility for the Firm's cybersecurity program and data privacy practices to the Audit Committee. In discharging this oversight role, the Audit Committee is empowered to investigate any matter brought to its attention, with full access to all books, records, facilities and personnel of Kforce, and the power to retain outside legal counsel or other experts. The Audit Committee also has the responsibility for selecting, evaluating, compensating and monitoring the independence and performance of the Firm's independent auditors in conducting its audits and reviews, reviewing and approving related party transactions, and overseeing the Firm's internal audit function and ERM program, including cybersecurity, data privacy, risks related to the use of AI and ESG disclosures. At each quarterly meeting, or more frequently as needed, the members of the Audit Committee meet in executive session and meet regularly in separate executive sessions with the Firm's Vice President of Internal Audit, General Counsel and independent registered public accountants, Deloitte & Touche LLP.<br>The Board has determined that Mr. Furlong, Ms. Cloudman and Mr. Simmons are considered audit committee financial experts, as defined by SEC Rules. |

---

6 Kforce 2026 Proxy Statement

------

<u>[**Table of Contents**](#ibde21b2946834ef1acfb04b1aa73fd7c_16)</u>

---

| | |
|:---|:---|
| **Compensation Committee** | **Compensation Committee** |
| ***<u>Members:</u>*** | ***<u>Roles and Responsibilities of the Committee:</u>*** |
| **Randall A. Mehl (Chair)** | The Compensation Committee is responsible for the development of the compensation principles that guide the design of the Firm's named executive officer compensation program, which includes: reviewing and approving the named executive officer compensation plans; approving any new or amended employment agreements for the Firm's named executive officers; issuing grants or awards to the Firm's named executive officers under its long-term incentive program; and preparing an annual report on the Firm's named executive compensation policies and practices as required by SEC Rules. In the discharge of its duties, the Compensation Committee also has the authority to select and utilize an independent compensation consultant to assist in the evaluation of director and named executive officer compensation. The Compensation Committee engages an independent compensation consultant each year, including 2025, to assist in discharging its responsibilities. |
| **Mark F. Furlong** | The Compensation Committee is responsible for the development of the compensation principles that guide the design of the Firm's named executive officer compensation program, which includes: reviewing and approving the named executive officer compensation plans; approving any new or amended employment agreements for the Firm's named executive officers; issuing grants or awards to the Firm's named executive officers under its long-term incentive program; and preparing an annual report on the Firm's named executive compensation policies and practices as required by SEC Rules. In the discharge of its duties, the Compensation Committee also has the authority to select and utilize an independent compensation consultant to assist in the evaluation of director and named executive officer compensation. The Compensation Committee engages an independent compensation consultant each year, including 2025, to assist in discharging its responsibilities. |
| **Elaine D. Rosen** | The Compensation Committee is responsible for the development of the compensation principles that guide the design of the Firm's named executive officer compensation program, which includes: reviewing and approving the named executive officer compensation plans; approving any new or amended employment agreements for the Firm's named executive officers; issuing grants or awards to the Firm's named executive officers under its long-term incentive program; and preparing an annual report on the Firm's named executive compensation policies and practices as required by SEC Rules. In the discharge of its duties, the Compensation Committee also has the authority to select and utilize an independent compensation consultant to assist in the evaluation of director and named executive officer compensation. The Compensation Committee engages an independent compensation consultant each year, including 2025, to assist in discharging its responsibilities. |
| ***<u>Number of Meetings:</u>*** | The Compensation Committee is responsible for the development of the compensation principles that guide the design of the Firm's named executive officer compensation program, which includes: reviewing and approving the named executive officer compensation plans; approving any new or amended employment agreements for the Firm's named executive officers; issuing grants or awards to the Firm's named executive officers under its long-term incentive program; and preparing an annual report on the Firm's named executive compensation policies and practices as required by SEC Rules. In the discharge of its duties, the Compensation Committee also has the authority to select and utilize an independent compensation consultant to assist in the evaluation of director and named executive officer compensation. The Compensation Committee engages an independent compensation consultant each year, including 2025, to assist in discharging its responsibilities. |
| **5** | The Compensation Committee is responsible for the development of the compensation principles that guide the design of the Firm's named executive officer compensation program, which includes: reviewing and approving the named executive officer compensation plans; approving any new or amended employment agreements for the Firm's named executive officers; issuing grants or awards to the Firm's named executive officers under its long-term incentive program; and preparing an annual report on the Firm's named executive compensation policies and practices as required by SEC Rules. In the discharge of its duties, the Compensation Committee also has the authority to select and utilize an independent compensation consultant to assist in the evaluation of director and named executive officer compensation. The Compensation Committee engages an independent compensation consultant each year, including 2025, to assist in discharging its responsibilities. |

---

---

| | |
|:---|:---|
| **Nomination Committee** | **Nomination Committee** |
| ***<u>Members:</u>*** | ***<u>Roles and Responsibilities of the Committee:</u>*** |
| **Ann E. Dunwoody**<br>**(Chair)** | The Nomination Committee is responsible for: identifying and recommending candidates; assessing the size and composition of the Board; ensuring appropriate Board diversity; establishing procedures for the nomination process; and overseeing board education and training. The Nomination Committee has the authority to retain a search firm to be used to identify director candidates and to approve the search firm's fees and other retention terms. <br>The Nomination Committee has not established minimum qualifications for director nominees because it is the view of this committee that the establishment of rigid minimum qualifications might preclude the consideration of otherwise desirable and qualified candidates for election to the Board. However, the Nomination Committee is committed to selecting directors who bring diversity, experience and integrity to the Board, as further described in the section titled "Composition and Diversity" in this Proxy Statement. The Nomination Committee will consider director candidates recommended by shareholders. Refer to the section titled "Shareholder Communications, Proposals and Other Matters" in this Proxy Statement for more information on shareholder nominations. |
| **Derrick D. Brooks** | The Nomination Committee is responsible for: identifying and recommending candidates; assessing the size and composition of the Board; ensuring appropriate Board diversity; establishing procedures for the nomination process; and overseeing board education and training. The Nomination Committee has the authority to retain a search firm to be used to identify director candidates and to approve the search firm's fees and other retention terms. <br>The Nomination Committee has not established minimum qualifications for director nominees because it is the view of this committee that the establishment of rigid minimum qualifications might preclude the consideration of otherwise desirable and qualified candidates for election to the Board. However, the Nomination Committee is committed to selecting directors who bring diversity, experience and integrity to the Board, as further described in the section titled "Composition and Diversity" in this Proxy Statement. The Nomination Committee will consider director candidates recommended by shareholders. Refer to the section titled "Shareholder Communications, Proposals and Other Matters" in this Proxy Statement for more information on shareholder nominations. |
| **Randall A. Mehl** | The Nomination Committee is responsible for: identifying and recommending candidates; assessing the size and composition of the Board; ensuring appropriate Board diversity; establishing procedures for the nomination process; and overseeing board education and training. The Nomination Committee has the authority to retain a search firm to be used to identify director candidates and to approve the search firm's fees and other retention terms. <br>The Nomination Committee has not established minimum qualifications for director nominees because it is the view of this committee that the establishment of rigid minimum qualifications might preclude the consideration of otherwise desirable and qualified candidates for election to the Board. However, the Nomination Committee is committed to selecting directors who bring diversity, experience and integrity to the Board, as further described in the section titled "Composition and Diversity" in this Proxy Statement. The Nomination Committee will consider director candidates recommended by shareholders. Refer to the section titled "Shareholder Communications, Proposals and Other Matters" in this Proxy Statement for more information on shareholder nominations. |
| ***<u>Number of Meetings:</u>*** | The Nomination Committee is responsible for: identifying and recommending candidates; assessing the size and composition of the Board; ensuring appropriate Board diversity; establishing procedures for the nomination process; and overseeing board education and training. The Nomination Committee has the authority to retain a search firm to be used to identify director candidates and to approve the search firm's fees and other retention terms. <br>The Nomination Committee has not established minimum qualifications for director nominees because it is the view of this committee that the establishment of rigid minimum qualifications might preclude the consideration of otherwise desirable and qualified candidates for election to the Board. However, the Nomination Committee is committed to selecting directors who bring diversity, experience and integrity to the Board, as further described in the section titled "Composition and Diversity" in this Proxy Statement. The Nomination Committee will consider director candidates recommended by shareholders. Refer to the section titled "Shareholder Communications, Proposals and Other Matters" in this Proxy Statement for more information on shareholder nominations. |
| **4** | The Nomination Committee is responsible for: identifying and recommending candidates; assessing the size and composition of the Board; ensuring appropriate Board diversity; establishing procedures for the nomination process; and overseeing board education and training. The Nomination Committee has the authority to retain a search firm to be used to identify director candidates and to approve the search firm's fees and other retention terms. <br>The Nomination Committee has not established minimum qualifications for director nominees because it is the view of this committee that the establishment of rigid minimum qualifications might preclude the consideration of otherwise desirable and qualified candidates for election to the Board. However, the Nomination Committee is committed to selecting directors who bring diversity, experience and integrity to the Board, as further described in the section titled "Composition and Diversity" in this Proxy Statement. The Nomination Committee will consider director candidates recommended by shareholders. Refer to the section titled "Shareholder Communications, Proposals and Other Matters" in this Proxy Statement for more information on shareholder nominations. |
|  | The Nomination Committee is responsible for: identifying and recommending candidates; assessing the size and composition of the Board; ensuring appropriate Board diversity; establishing procedures for the nomination process; and overseeing board education and training. The Nomination Committee has the authority to retain a search firm to be used to identify director candidates and to approve the search firm's fees and other retention terms. <br>The Nomination Committee has not established minimum qualifications for director nominees because it is the view of this committee that the establishment of rigid minimum qualifications might preclude the consideration of otherwise desirable and qualified candidates for election to the Board. However, the Nomination Committee is committed to selecting directors who bring diversity, experience and integrity to the Board, as further described in the section titled "Composition and Diversity" in this Proxy Statement. The Nomination Committee will consider director candidates recommended by shareholders. Refer to the section titled "Shareholder Communications, Proposals and Other Matters" in this Proxy Statement for more information on shareholder nominations. |

---

During 2025, the Board held five meetings, and the four committees of the Board held a total of 18 meetings. Each director attended 100% of the Board meetings, and all of the directors attended 100% of the committee meetings on which he or she served. Our Corporate Governance Guidelines invite, but do not require, our directors to attend our annual meeting of shareholders. Two directors attended the annual meeting of shareholders held on April 23, 2025.

**DIRECTORS' TIME COMMITMENTS**

Pursuant to Kforce's Corporate Governance Guidelines, non-employee directors are limited to serving on no more than four public-company boards, and the Chief Executive Officer is limited to serving on no more than two public-company boards, in each case including Kforce. The Audit Committee's charter generally prohibits a member of the Audit Committee from serving on more than three audit committees of public-company boards (including Kforce). In the context of reviewing our directors' continued ability to dedicate sufficient time to our Board, Kforce assesses each director's compliance with these policies. Each of our directors is currently compliant with these policies.

7 Kforce 2026 Proxy Statement

------

<u>[**Table of Contents**](#ibde21b2946834ef1acfb04b1aa73fd7c_16)</u>

**BOARD'S ROLE IN RISK OVERSIGHT**

Identifying, assessing and managing risks, including cybersecurity, AI or ESG-related risks, could affect our business and is essential to our long-term success and our ability to create sustained shareholder value. The Board, both as a whole and through its Committees, plays an active role in overseeing the Firm's risk profile and the processes designed to manage and mitigate those risks. The Board's primary framework for evaluating enterprise-wide risk and monitoring management's mitigation efforts is through a comprehensive, integrated ERM program.

**Enterprise Risk Management**

Our ERM program is designed to regularly evaluate the Firm's risk landscape and, takes it a step further in certain areas, to test our preparedness for a broad range of potential events, including severe weather incidents, threats to our systems and data security, financial fraud or loss, and other significant operational or strategic risks. As part of this process, potential and actual risks are assessed, ranked, and prioritized into one of the following four categories:

---

| | |
|:---|:---|
| ![Picture7.jpg](kfrc-20260313_g13.jpg) | ![Picture6.jpg](kfrc-20260313_g14.jpg) |
| Traditional monetary risks, including those related to cash and treasury management activities, risks inherent in achieving our profitability objectives, compliance with regulatory reporting requirements, and exposure to potential fraudulent activities. | Risks associated with the general execution of the business, including key operational processes and strategies such as payroll and business continuity; cybersecurity and data privacy risks; and risks from evolving, disruptive or enabling technologies (e.g., AI).  |
| ![Picture8.jpg](kfrc-20260313_g15.jpg) | ![Picture5.jpg](kfrc-20260313_g16.jpg) |
| Risks associated with the acquisition, development and retention of our clients, including contractual compliance and any associated concentration risks, as well as retention risks involving our associates who support our clients, candidates and consultants. | Compliance risks arising from areas including, but not limited to, worker classification and related claims, hiring practices, foreign worker compliance and other employment-related risks. These risks may originate from local, state or federal regulations. |

---

Our Vice President of Internal Audit, in collaboration with our General Counsel, oversees and facilitates the Firm's ERM process. Each of the four risk categories described above encompass specific risks that could materially impact Kforce. Each category is the focus of a designated fiscal quarter, enabling a comprehensive assessment of all risks at least annually. During these in-depth reviews, the team engages the relevant stakeholders, including key members of senior management, to evaluate the potential business impact and likelihood of residual risk. This evaluation incorporates external factors and current mitigation efforts and is used to determine whether additional action plans are warranted. Our internal audit team, which reports directly to the Audit Committee, uses insights from the ERM program to develop a risk-based audit plan that is reviewed and approved by the Audit Committee each year. The ERM program itself is also evaluated annually, with support from independent third parties, to benchmark practices and implement enhancements as appropriate.

To support the Audit Committee in fulfilling its oversight responsibilities related to compliance and risk, the Vice President of Internal Audit provides the Committee with a quarterly report on the risk category under review for that period. This interaction also enables the Audit Committee to offer guidance on existing and future risk mitigation strategies. The Board also receives a summary of the ERM report each quarter to maintain visibility into the Firm's overall risk profile.

**Cybersecurity and Other**

The Board is actively engaged in the oversight of cybersecurity and data privacy. The Audit Committee assists the Board in meeting its responsibility to oversee cybersecurity and data privacy strategies and practices. On a quarterly basis, the Audit Committee receives updates on (a) our progress meeting objectives established in our cybersecurity maturity roadmap, (b) relevant reported cybersecurity events in the overall market (and for Kforce, if any) and evolving risks, (c) results of work performed by our information security organization (ex. penetration tests, cybersecurity program maturity assessments) and (d) detailed reports of cybersecurity trends within the Firm. We engage subject matter experts in conducting independent assessments of our cybersecurity program maturity, penetration tests and other evaluations to benchmark and enhance our security posture.

8 Kforce 2026 Proxy Statement

------

<u>[**Table of Contents**](#ibde21b2946834ef1acfb04b1aa73fd7c_16)</u>

Senior management, including our Chief Information Security Officer (CISO), brief the Board on an annual basis on our cybersecurity and information security posture and cybersecurity incidents deemed to have a moderate business impact (even if the incidents do not rise to the level of being material). Annually, the Board and management participate in a strategy discussion on cybersecurity, among others.

To further enhance the Board and Audit Committee's role in overseeing cybersecurity risks, the Board formed a special working group that is comprised of two members of the Audit Committee, Ms. Cloudman and Mr. Simmons, to have more frequent and detailed dialogue with executive management (including our COO, CFO, CISO and VP of Internal Audit) on all areas pertaining to cybersecurity. This working group provides updates on a quarterly basis, or more frequently if necessary, to the Audit Committee. As a result, in part, of our ongoing efforts to strengthen our cybersecurity program, the Firm has not experienced a material breach to date.

Management also provides the Audit Committee with an annual overview of Kforce's various lines of insurance that we maintain, including our cybersecurity insurance policy. The Audit Committee provides the Board with quarterly updates on the Firm's risks and ERM program findings, including cybersecurity risk and data privacy practices. Additional information can be found in Item 1C. Cybersecurity, in our Form 10-K for the fiscal year ended December 31, 2025.

In addition, the Board oversees the Firm's ESG policies and strategy, with certain responsibilities delegated to Board committees that play an active role in ESG-related compliance and oversight.

Each Committee considers risk within its respective area of responsibility as summarized below. Committee chairs report on their respective areas to the Board at each quarterly Board meeting, including significant risks identified within its purview and management's response to those risks.

---

| | | | |
|:---|:---|:---|:---|
| **Audit** | **Compensation** | **Nomination** | **Corporate Governance** |
| Oversees risk assessment <br>activities, ERM program <br>(including cybersecurity, <br>data privacy, AI and ESG <br>disclosures) and annual <br>internal audit plan | Oversees executive<br> compensation plan design,<br> including evolving trends <br>and best practices | Oversees Board refreshment<br> activities including director<br> succession risk | Provides leadership<br> oversight of ethical<br> standards and governance<br> practices |
| Monitors and receives reports on the Firm's cybersecurity risks and incidents and ensures data privacy practices comply with rules and regulations | Responsible for preparing<br> required disclosures<br> regarding executive<br> compensation practices | Establishes procedures for<br> the Board's nomination<br> process | Provides a forum for the<br> independent directors to<br> meet without management |
| Monitors risks related to the Firm's financial statements, systems, reporting process and compliance | Reviews executive <br>compensation and benefits <br>policies and practices | Recommends candidates for<br>election to the Board | Reviews and recommends <br>changes to the Corporate <br>Governance Guidelines |
| Reviews and approves <br>related-party transactions <br>and relationships involving <br>directors and executive <br>officers | Determines whether <br>executive compensation and <br>benefits policies and <br>practices are reasonably <br>likely to have a material <br>adverse effect on the Firm | Oversees education and <br>training (e.g., AI, shareholder <br>engagement matters, ESG), <br>recommends board diversity <br>representation and <br>evaluates director <br>composition to support ESG-related responsibilities | Conducts and oversees the evaluation of the CEO and Board's performance and assesses the sufficiency of their respective responsibilities |

---

9 Kforce 2026 Proxy Statement

------

<u>[**Table of Contents**](#ibde21b2946834ef1acfb04b1aa73fd7c_16)</u>

**OUR BOARD OF DIRECTORS**

The Board currently consists of three nominees and six continuing directors. The directors are divided into three classes serving staggered three-year terms. The following table sets forth (as of the date of this filing) the names, ages and certain other information for each of our directors (including those who are nominees for election at the Annual Meeting).

---

| | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Name** | **Age** | **Position** | **Director Since** | **Current Term Expires** | **Expiration of Term for Which Nominated** | **Independent** | **Audit Comm** | **Comp. Comm** | **Nomin. Comm** | **Corp. Gov. Comm** |
| | ***Board of Director Nominees for Election*** | ***Board of Director Nominees for Election*** | ***Board of Director Nominees for Election*** | ***Board of Director Nominees for Election*** | ***Board of Director Nominees for Election*** | ***Board of Director Nominees for Election*** | ***Board of Director Nominees for Election*** | ***Board of Director Nominees for Election*** | ***Board of Director Nominees for Election*** | ***Board of Director Nominees for Election*** | ***Board of Director Nominees for Election*** |
| **Class II** | **Derrick D. Brooks** | 52 | Director | 2021 | 2026 | 2029 | ![Checkmark.jpg](kfrc-20260313_g17.jpg) |  |  | ![Member.jpg](kfrc-20260313_g18.jpg) | ![Member.jpg](kfrc-20260313_g18.jpg) |
| **Class II** | **Ann E. Dunwoody** | 73 | Director | 2016 | 2026 | 2029 | ![Checkmark.jpg](kfrc-20260313_g17.jpg) |  |  | ![Chair.jpg](kfrc-20260313_g19.jpg) | ![Member.jpg](kfrc-20260313_g18.jpg) |
| **Class II** | **N. John Simmons** | 70 | Director | 2014 | 2026 | 2029 | ![Checkmark.jpg](kfrc-20260313_g17.jpg) | ![Financial Expert.jpg](kfrc-20260313_g20.jpg) |  |  | ![Member.jpg](kfrc-20260313_g18.jpg) |
|  | ***Continuing Directors*** | ***Continuing Directors*** | ***Continuing Directors*** | ***Continuing Directors*** | ***Continuing Directors*** | ***Continuing Directors*** | ***Continuing Directors*** | ***Continuing Directors*** | ***Continuing Directors*** | ***Continuing Directors*** | ***Continuing Directors*** |
| **Class III** | **Catherine H. Cloudman** | 56 | Director | 2020 | 2027 | N/A | ![Checkmark.jpg](kfrc-20260313_g17.jpg) | ![Financial Expert.jpg](kfrc-20260313_g20.jpg) |  |  | ![Member.jpg](kfrc-20260313_g18.jpg) |
| **Class III** | **David L. Dunkel** | 72 | Chairman | 1994 | 2027 | N/A |  |  |  |  |  |
| **Class III** | **Mark F. Furlong** | 68 | Director | 2001 | 2027 | N/A | ![Checkmark.jpg](kfrc-20260313_g17.jpg) | ![All.jpg](kfrc-20260313_g21.jpg) | ![Member.jpg](kfrc-20260313_g18.jpg) |  | ![Member.jpg](kfrc-20260313_g18.jpg) |
| **Class I** | **Joseph J. Liberatore** | 63 | CEO Director | 2021 | 2028 | N/A |  |  |  |  |  |
| **Class I** | **Randall A. Mehl** | 58 | Director | 2017 | 2028 | N/A | ![Checkmark.jpg](kfrc-20260313_g17.jpg) |  | ![Chair.jpg](kfrc-20260313_g19.jpg) | ![Member.jpg](kfrc-20260313_g18.jpg) | ![Member.jpg](kfrc-20260313_g18.jpg) |
| **Class I** | **Elaine D. Rosen** | 73 | Director | 2003 | 2028 | N/A | ![Checkmark in a box.jpg](kfrc-20260313_g22.jpg) |  | ![Member.jpg](kfrc-20260313_g18.jpg) |  | ![Chair.jpg](kfrc-20260313_g19.jpg) |

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| Legend: | ![Checkmark in a box.jpg](kfrc-20260313_g22.jpg) | Lead Independent Director | ![Chair.jpg](kfrc-20260313_g19.jpg) | Chair | ![Member.jpg](kfrc-20260313_g18.jpg) | Member | ![Financial Expert.jpg](kfrc-20260313_g20.jpg) | Financial Expert |

---

The Class II nominees identified above have been nominated to serve as directors for a three-year term expiring at the 2029 annual meeting of shareholders. All of the nominees are currently directors of Kforce and were previously elected by our shareholders.

10 Kforce 2026 Proxy Statement

------

<u>[**Table of Contents**](#ibde21b2946834ef1acfb04b1aa73fd7c_16)</u>

**BIOGRAPHICAL INFORMATION FOR OUR DIRECTOR NOMINEES**

The biographies of each director nominee are set forth below, together with a description of the experiences, qualifications, attributes or skills that the Nomination Committee and the Board considered in determining that each nominee is well-qualified to serve as a director of Kforce.

**NOMINEES FOR ELECTION, CLASS II DIRECTORS - TERMS EXPIRE IN 2029**

---

| | | | |
|:---|:---|:---|:---|
| **Derrick D. Brooks** | **Derrick D. Brooks** | **Derrick D. Brooks** | **Derrick D. Brooks** |
| ![brooks-derrick.jpg](kfrc-20260313_g23.jpg) | ![brooks-derrick.jpg](kfrc-20260313_g23.jpg) | Mr. Brooks was named the Chief Operating Officer of the University of South Florida Athletics in October 2025. He also serves as an on-field appeals officer for the National Football League. He was the Executive Vice President of Corporate and Community Development of Vinik Sports Group from 2019 to October 2025. He previously served as the President of Tampa Bay Sports & Football Entertainment LLC and was the owner of the Tampa Bay Storm Arena Football Team from 2011 to 2019. Mr. Brooks served as the Managing Member of Brooks 55 Labor Enterprises, L.L.C., a full-service temporary and direct hire staffing company that provided staffing, administrative solutions and on-time labor needs, from 2006 to 2012. He also served as an NFL analyst for ESPN from 2009 to 2011. From 1995 to 2009, Mr. Brooks played for the Tampa Bay Buccaneers, was a Super Bowl Champion and a nine time All-Pro. In 2014, Mr. Brooks was inducted into the Pro Football Hall of Fame and the Capital One Academic All-America Hall of Fame and was named the 2000 Walter Payton NFL Man of the Year Award Winner.<br>Mr. Brooks has a long history of community leadership. Among his other activities and services, Mr. Brooks has been the President and Founder of the Derrick Brooks Charities, Inc. since 2003, and has served on the board of Brooks Debartolo Charities, Inc. since 2006. He previously served on the board of the Florida State Fair Authority from 2017 to 2022. He served as a member of the board of trustees of Florida State University from 2003 to 2011. He has also served on the boards of the Florida Department of Education Foundation from 2004 to 2010, St. Leo's University from 2007 to 2010, and the Florida Governor's Council on Physical Fitness from 2007 to 2010. The Board believes that Mr. Brooks brings a unique perspective to the Board through his experience in the sports and entertainment industry and provides valuable leadership experience and knowledge through his community involvement and familiarity with the staffing solutions industry.  | Mr. Brooks was named the Chief Operating Officer of the University of South Florida Athletics in October 2025. He also serves as an on-field appeals officer for the National Football League. He was the Executive Vice President of Corporate and Community Development of Vinik Sports Group from 2019 to October 2025. He previously served as the President of Tampa Bay Sports & Football Entertainment LLC and was the owner of the Tampa Bay Storm Arena Football Team from 2011 to 2019. Mr. Brooks served as the Managing Member of Brooks 55 Labor Enterprises, L.L.C., a full-service temporary and direct hire staffing company that provided staffing, administrative solutions and on-time labor needs, from 2006 to 2012. He also served as an NFL analyst for ESPN from 2009 to 2011. From 1995 to 2009, Mr. Brooks played for the Tampa Bay Buccaneers, was a Super Bowl Champion and a nine time All-Pro. In 2014, Mr. Brooks was inducted into the Pro Football Hall of Fame and the Capital One Academic All-America Hall of Fame and was named the 2000 Walter Payton NFL Man of the Year Award Winner.<br>Mr. Brooks has a long history of community leadership. Among his other activities and services, Mr. Brooks has been the President and Founder of the Derrick Brooks Charities, Inc. since 2003, and has served on the board of Brooks Debartolo Charities, Inc. since 2006. He previously served on the board of the Florida State Fair Authority from 2017 to 2022. He served as a member of the board of trustees of Florida State University from 2003 to 2011. He has also served on the boards of the Florida Department of Education Foundation from 2004 to 2010, St. Leo's University from 2007 to 2010, and the Florida Governor's Council on Physical Fitness from 2007 to 2010. The Board believes that Mr. Brooks brings a unique perspective to the Board through his experience in the sports and entertainment industry and provides valuable leadership experience and knowledge through his community involvement and familiarity with the staffing solutions industry.  |
| **Director since 2021** | **Director since 2021** | **Other Current Public Company Board(s):**<br>None | **Kforce Board Committee(s):**<br>Nomination and Corporate Governance |
| **Age** | **52** | **Other Current Public Company Board(s):**<br>None | **Kforce Board Committee(s):**<br>Nomination and Corporate Governance |

---

---

| | | | |
|:---|:---|:---|:---|
| **Ann E. Dunwoody** | **Ann E. Dunwoody** | **Ann E. Dunwoody** | **Ann E. Dunwoody** |
| ![dunwoody-ann.jpg](kfrc-20260313_g24.jpg) | ![dunwoody-ann.jpg](kfrc-20260313_g24.jpg) | General (Ret.) Dunwoody was the first woman in U.S. military history to achieve the rank of four-star general. In November 2025, General (Ret.) Dunwoody became a member of the J.P. Morgan External Advisors Council to guide that firm's new Security and Resiliency Initiative. She currently serves on the Fidelity Fixed Income Asset Allocation (FIAA) Board of Trustees and Audit Committee, and she joined the Nomination and Governance Committees in November 2025. She also serves on the Board of Directors of the Automattic Inc. Board of Directors. From 2008 until her retirement in 2012, she led and ran the largest global logistics command in the Army comprising 69,000 military and civilian individuals, located in all 50 states and over 140 countries with an annual budget of $60 billion dollars. Her prior board service includes Republic Services Inc., L-3 Communications, and the Florida Institute of Technology. She also served as the President of First 2 Four LLC and as a director of Noble Reach Foundation, a nonprofit formerly part of Logistics Management Institute. General (Ret.) Dunwoody is the author of "A Higher Standard: Leadership Strategies from the First Female Four Star General", and has received numerous honors, including the Theodore Roosevelt NCAA award, the Ellis Island Medal of Honor, the Orde National du Merite and U.S. Military Academy's 2019 Thayer Award.<br>General (Ret.) Dunwoody brings to the Board extensive military and management experience, including managing a significant portion of the United States Army's budget as Commanding General, U.S. Army Materiel Command. General (Ret.) Dunwoody is also certified as an NACD Governance Fellow. She has also served as a member of the Board of Directors on other publicly traded, private and not for profit companies. She is engaged in numerous charitable and civic activities, which the Board believes allows her to provide a valuable and varied perspective to the Board. | General (Ret.) Dunwoody was the first woman in U.S. military history to achieve the rank of four-star general. In November 2025, General (Ret.) Dunwoody became a member of the J.P. Morgan External Advisors Council to guide that firm's new Security and Resiliency Initiative. She currently serves on the Fidelity Fixed Income Asset Allocation (FIAA) Board of Trustees and Audit Committee, and she joined the Nomination and Governance Committees in November 2025. She also serves on the Board of Directors of the Automattic Inc. Board of Directors. From 2008 until her retirement in 2012, she led and ran the largest global logistics command in the Army comprising 69,000 military and civilian individuals, located in all 50 states and over 140 countries with an annual budget of $60 billion dollars. Her prior board service includes Republic Services Inc., L-3 Communications, and the Florida Institute of Technology. She also served as the President of First 2 Four LLC and as a director of Noble Reach Foundation, a nonprofit formerly part of Logistics Management Institute. General (Ret.) Dunwoody is the author of "A Higher Standard: Leadership Strategies from the First Female Four Star General", and has received numerous honors, including the Theodore Roosevelt NCAA award, the Ellis Island Medal of Honor, the Orde National du Merite and U.S. Military Academy's 2019 Thayer Award.<br>General (Ret.) Dunwoody brings to the Board extensive military and management experience, including managing a significant portion of the United States Army's budget as Commanding General, U.S. Army Materiel Command. General (Ret.) Dunwoody is also certified as an NACD Governance Fellow. She has also served as a member of the Board of Directors on other publicly traded, private and not for profit companies. She is engaged in numerous charitable and civic activities, which the Board believes allows her to provide a valuable and varied perspective to the Board. |
| **Director since 2016** | **Director since 2016** | **Other Current Public Company Board(s):**<br>None | **Kforce Board Committee(s):**<br>Nomination (Chair) and Corporate Governance  |
| **Age** | **73** | **Other Current Public Company Board(s):**<br>None | **Kforce Board Committee(s):**<br>Nomination (Chair) and Corporate Governance  |

---

11 Kforce 2026 Proxy Statement

------

<u>[**Table of Contents**](#ibde21b2946834ef1acfb04b1aa73fd7c_16)</u>

---

| | | | |
|:---|:---|:---|:---|
| **N. John Simmons** | **N. John Simmons** | **N. John Simmons** | **N. John Simmons** |
| ![simmons-n-john.jpg](kfrc-20260313_g25.jpg) | ![simmons-n-john.jpg](kfrc-20260313_g25.jpg) | Mr. Simmons has been the CEO of Growth Advisors, LLC, an advisory firm focused on high-growth companies, since 2012. He previously served as the COO and CFO of DeMert Brands, Inc., a manufacturer and distributor of haircare products. He has served on various boards of directors, including Bonds.com Group, Inc. from 2013 to 2014; Loyola University New Orleans Board of Trustees from 2009 to 2015, during which he was Chairman of the Audit Committee and an Executive Committee member; Lifestyle Family Fitness, Inc. from 2001 to 2012; Technology Research Corporation as Chairman of the Compensation Committee from 2010 to 2011 and Lead Director and Chairman of the Governance and Nominating Committee from 2009 to 2010; Medquist, Inc. as Chairman of the Audit Committee from 2005 to 2007; and SRI Surgical Express, Inc. as Lead Director, then Chairman of the Board from 2001 to 2008. Earlier in his career, Mr. Simmons' served as the CEO and President of Lifestyle Family Fitness, Inc.; President of New Homes Realty, a residential real estate company; President of Quantum Capital Partners, a venture capital firm; VP and Controller of Eckerd Corporation; CFO of Checkers Drive-In Restaurants; and audit partner for KPMG Peat Marwick.<br>Mr. Simmons is an Audit Committee financial expert. He has extensive financial, accounting, management and director experience in several different industries. As a result, the Board believes that he brings valuable insight due to his extensive and varied experiences as a chief executive officer, chief financial officer, audit partner and director. | Mr. Simmons has been the CEO of Growth Advisors, LLC, an advisory firm focused on high-growth companies, since 2012. He previously served as the COO and CFO of DeMert Brands, Inc., a manufacturer and distributor of haircare products. He has served on various boards of directors, including Bonds.com Group, Inc. from 2013 to 2014; Loyola University New Orleans Board of Trustees from 2009 to 2015, during which he was Chairman of the Audit Committee and an Executive Committee member; Lifestyle Family Fitness, Inc. from 2001 to 2012; Technology Research Corporation as Chairman of the Compensation Committee from 2010 to 2011 and Lead Director and Chairman of the Governance and Nominating Committee from 2009 to 2010; Medquist, Inc. as Chairman of the Audit Committee from 2005 to 2007; and SRI Surgical Express, Inc. as Lead Director, then Chairman of the Board from 2001 to 2008. Earlier in his career, Mr. Simmons' served as the CEO and President of Lifestyle Family Fitness, Inc.; President of New Homes Realty, a residential real estate company; President of Quantum Capital Partners, a venture capital firm; VP and Controller of Eckerd Corporation; CFO of Checkers Drive-In Restaurants; and audit partner for KPMG Peat Marwick.<br>Mr. Simmons is an Audit Committee financial expert. He has extensive financial, accounting, management and director experience in several different industries. As a result, the Board believes that he brings valuable insight due to his extensive and varied experiences as a chief executive officer, chief financial officer, audit partner and director. |
| **Director since 2014** | **Director since 2014** | **Other Current Public Company Board(s):**<br>None  | **Kforce Board Committee(s):**<br>Audit and Corporate Governance |
| **Age** | **70** | **Other Current Public Company Board(s):**<br>None  | **Kforce Board Committee(s):**<br>Audit and Corporate Governance |

---

**PROPOSAL 1. ELECTION OF DIRECTORS**

**NOMINEES**

The Nomination Committee has recommended, and our Board has approved, each of Derrick D. Brooks, Ann E. Dunwoody and N. John Simmons as nominees for election as Class II directors at the Annual Meeting. If elected, the Class II directors will serve until our 2029 annual meeting of shareholders and until their successors are duly elected and qualified. Each of the nominees is currently a director of the Firm and was previously elected by our shareholders. For information concerning the nominees, please see the section titled "Biographical Information for our Director Nominees." Each of the nominees is willing and able to stand for election at the Annual Meeting, and we do not know of any reason why any of the nominees would be unable to serve as a director. If any nominee becomes unable or unwilling to stand for election, the Board may reduce its size or designate a substitute. If a substitute is designated, proxies voting for the original nominee will be cast for the substituted nominee.

**VOTE REQUIRED**

We use a majority voting standard for uncontested elections. The election of directors at this year's Annual Meeting is an uncontested election, and thus, the majority voting standard applies. To be elected, the votes for a director must exceed 50% of the votes actually cast with respect to the director's election. Votes actually cast excludes abstentions and broker non-votes.

**THE BOARD UNANIMOUSLY RECOMMENDS A VOTE FOR PROPOSAL 1.**<br>

12 Kforce 2026 Proxy Statement

------

<u>[**Table of Contents**](#ibde21b2946834ef1acfb04b1aa73fd7c_16)</u>

**BIOGRAPHICAL INFORMATION FOR OUR CONTINUING DIRECTORS**

---

| | | | |
|:---|:---|:---|:---|
| **CLASS III DIRECTORS - TERMS EXPIRE IN 2027** | **CLASS III DIRECTORS - TERMS EXPIRE IN 2027** | **CLASS III DIRECTORS - TERMS EXPIRE IN 2027** | **CLASS III DIRECTORS - TERMS EXPIRE IN 2027** |
| **Catherine H. Cloudman** | **Catherine H. Cloudman** | **Catherine H. Cloudman** | **Catherine H. Cloudman** |
| ![Cloudman, Catherine_2025Headshot_Creative Services 2.jpg](kfrc-20260313_g26.jpg) | ![Cloudman, Catherine_2025Headshot_Creative Services 2.jpg](kfrc-20260313_g26.jpg) | Ms. Cloudman joined the board of D.J. St. Germain Company, LLC, an investment management company, in December 2025. She also serves on the board of Hussey Seating Company, a manufacturer of telescopic and stadium seating, where she has chaired the Personnel and Compensation Committee since 2015. In addition, Ms. Cloudman is a board member of Maine Community Bank, chairing the Director's Loan Committee and serving on the Audit, Technology and Director's Loan Risk Assessment committees. Prior to her Maine Community Bank board service, she was a board member of Gorham Savings Bank, which merged with Maine Community Bank as of January 1, 2025. She was also a board member of Systems Engineering, an employee-owned IT managed services company,from 2015 to December 2025. Ms. Cloudman sits on the Board of Zachau Construction, an employee-owned commercial construction firm, the Advisory Board of the engineering firm Sebago Technics and serves on the Investment Committee of the University of New England. Her previous board roles include Waynflete School, a PreK-12 independent day school, where she was Vice Chair, President and Board Chair until 2025, and Village Fertility Pharmacy until 2020. Earlier in her career, Ms. Cloudman co-founded and served as CFO of Apothecary by Design and its successor, Village Fertility Pharmacy, both national specialty pharmacies.<br>Ms. Cloudman is an Audit Committee financial expert. The Board believes her considerable expertise and entrepreneurial background, including her experience as CFO at Apothecary by Design and its successor company, Village Fertility Pharmacy, brings unique insight to the Board with her in-depth knowledge of various ownership structures, experience as a CPA and management consultant, and overall financial and strategic management expertise. | Ms. Cloudman joined the board of D.J. St. Germain Company, LLC, an investment management company, in December 2025. She also serves on the board of Hussey Seating Company, a manufacturer of telescopic and stadium seating, where she has chaired the Personnel and Compensation Committee since 2015. In addition, Ms. Cloudman is a board member of Maine Community Bank, chairing the Director's Loan Committee and serving on the Audit, Technology and Director's Loan Risk Assessment committees. Prior to her Maine Community Bank board service, she was a board member of Gorham Savings Bank, which merged with Maine Community Bank as of January 1, 2025. She was also a board member of Systems Engineering, an employee-owned IT managed services company,from 2015 to December 2025. Ms. Cloudman sits on the Board of Zachau Construction, an employee-owned commercial construction firm, the Advisory Board of the engineering firm Sebago Technics and serves on the Investment Committee of the University of New England. Her previous board roles include Waynflete School, a PreK-12 independent day school, where she was Vice Chair, President and Board Chair until 2025, and Village Fertility Pharmacy until 2020. Earlier in her career, Ms. Cloudman co-founded and served as CFO of Apothecary by Design and its successor, Village Fertility Pharmacy, both national specialty pharmacies.<br>Ms. Cloudman is an Audit Committee financial expert. The Board believes her considerable expertise and entrepreneurial background, including her experience as CFO at Apothecary by Design and its successor company, Village Fertility Pharmacy, brings unique insight to the Board with her in-depth knowledge of various ownership structures, experience as a CPA and management consultant, and overall financial and strategic management expertise. |
| **Director since 2020** | **Director since 2020** | **Other Current Public Company Board(s):**<br>None | **Kforce Board Committee(s):**<br>Audit and Corporate Governance |
| **Age** | **56** | **Other Current Public Company Board(s):**<br>None | **Kforce Board Committee(s):**<br>Audit and Corporate Governance |
| **David L. Dunkel** | **David L. Dunkel** | **David L. Dunkel** | **David L. Dunkel** |
| ![dunkel-dave.jpg](kfrc-20260313_g27.jpg) | ![dunkel-dave.jpg](kfrc-20260313_g27.jpg) | Mr. Dunkel currently serves as the Chairman of the Board and previously served as Kforce's CEO from the Firm's incorporation in 1994 until his retirement in 2021. Due to his longstanding tenure at the Firm, Mr. Dunkel possesses a deep and unique understanding of the Firm's business and operations. Prior to 1994, he served as President and CEO of Romac-FMA, one of Kforce's predecessors, for 14 years. After his retirement, he continued as Chairman of the Board while serving in a limited, part-time non-executive role until 2023 upon the successful completion of the CEO transition. Today, Mr. Dunkel remains Kforce's non-executive Chairman of the Board. In October 2025, Mr. Dunkel joined the Advisory Board of One Touch Direct, a Tampa-based call center company. The Board believes that Mr. Dunkel's experience, coupled with his extensive knowledge of the staffing industry, provides strong, consistent leadership for the Firm. | Mr. Dunkel currently serves as the Chairman of the Board and previously served as Kforce's CEO from the Firm's incorporation in 1994 until his retirement in 2021. Due to his longstanding tenure at the Firm, Mr. Dunkel possesses a deep and unique understanding of the Firm's business and operations. Prior to 1994, he served as President and CEO of Romac-FMA, one of Kforce's predecessors, for 14 years. After his retirement, he continued as Chairman of the Board while serving in a limited, part-time non-executive role until 2023 upon the successful completion of the CEO transition. Today, Mr. Dunkel remains Kforce's non-executive Chairman of the Board. In October 2025, Mr. Dunkel joined the Advisory Board of One Touch Direct, a Tampa-based call center company. The Board believes that Mr. Dunkel's experience, coupled with his extensive knowledge of the staffing industry, provides strong, consistent leadership for the Firm. |
| **Director since 1994** | **Director since 1994** | **Other Current Public Company Board(s):**<br>None |  |
| **Age** | **72** | **Other Current Public Company Board(s):**<br>None |  |
| **Mark F. Furlong** | **Mark F. Furlong** | **Mark F. Furlong** | **Mark F. Furlong** |
| ![furlong-mark2.jpg](kfrc-20260313_g28.jpg) | ![furlong-mark2.jpg](kfrc-20260313_g28.jpg) | Mr. Furlong has served as a member of the Board of Directors of ALTi Global, a global wealth and asset management firm, since 2023. In addition to his Board role, he is the Chair of the Audit and Transaction Committees and serves on the Compensation Committee. Previously, Mr. Furlong was a director of Heska Corporation, a provider of advanced veterinary diagnostic products, from 2019 until its sale in 2023, and a director of Antares Capital, a provider of financing solutions for private equity-backed transactions, from 2015 to 2023. From 2011 to 2015, Mr. Furlong served as President and Chief Executive Officer of BMO Harris Bank, N.A. Prior to its acquisition by BMO Harris Bank N.A. in 2011, he held several senior leadership roles at Marshall & Ilsley Corporation, including Chief Financial Officer in 2001, President in 2004, Chief Executive Officer in 2007 and Chairman in 2010. Earlier in his career, Mr. Furlong was an audit partner with Deloitte & Touche LLP.<br>Mr. Furlong is an Audit Committee financial expert. The Board values his extensive experience, including his tenure as President and CEO of BMO Harris Bank, N.A., former Chairman, President, and CEO of Marshall & Ilsley Corporation, and his background as an audit partner with Deloitte & Touche LLP. This depth of expertise provides the Board with unique insights into capital allocation strategies, banking and accounting matters, as well as broad management and financial leadership. | Mr. Furlong has served as a member of the Board of Directors of ALTi Global, a global wealth and asset management firm, since 2023. In addition to his Board role, he is the Chair of the Audit and Transaction Committees and serves on the Compensation Committee. Previously, Mr. Furlong was a director of Heska Corporation, a provider of advanced veterinary diagnostic products, from 2019 until its sale in 2023, and a director of Antares Capital, a provider of financing solutions for private equity-backed transactions, from 2015 to 2023. From 2011 to 2015, Mr. Furlong served as President and Chief Executive Officer of BMO Harris Bank, N.A. Prior to its acquisition by BMO Harris Bank N.A. in 2011, he held several senior leadership roles at Marshall & Ilsley Corporation, including Chief Financial Officer in 2001, President in 2004, Chief Executive Officer in 2007 and Chairman in 2010. Earlier in his career, Mr. Furlong was an audit partner with Deloitte & Touche LLP.<br>Mr. Furlong is an Audit Committee financial expert. The Board values his extensive experience, including his tenure as President and CEO of BMO Harris Bank, N.A., former Chairman, President, and CEO of Marshall & Ilsley Corporation, and his background as an audit partner with Deloitte & Touche LLP. This depth of expertise provides the Board with unique insights into capital allocation strategies, banking and accounting matters, as well as broad management and financial leadership. |
| **Director since 2001** | **Director since 2001** | **Other Current Public Company Board(s):**<br>ALTi Global (NASDAQ: ALTI) | **Kforce Board Committee(s):**<br>Audit (Chair), Compensation and Corporate Governance  |
| **Age** | **68** | **Other Current Public Company Board(s):**<br>ALTi Global (NASDAQ: ALTI) | **Kforce Board Committee(s):**<br>Audit (Chair), Compensation and Corporate Governance  |

---

13 Kforce 2026 Proxy Statement

------

<u>[**Table of Contents**](#ibde21b2946834ef1acfb04b1aa73fd7c_16)</u>

---

| | | |
|:---|:---|:---|
| **CLASS I DIRECTORS - TERMS EXPIRE IN 2028** | **CLASS I DIRECTORS - TERMS EXPIRE IN 2028** | **CLASS I DIRECTORS - TERMS EXPIRE IN 2028** |
| **Joseph J. Liberatore** | **Joseph J. Liberatore** | **Joseph J. Liberatore** |
| ![Liberatore, Joe HS.jpg](kfrc-20260313_g29.jpg) | ![Liberatore, Joe HS.jpg](kfrc-20260313_g29.jpg) | Mr. Liberatore has served as the Chief Executive Officer of Kforce since January 2022. He joined the Board as a director in November 2021, and was elected by shareholders in April 2022. He has served as Kforce's President since January 2013 and previously served as Corporate Secretary from February 2007 to February 2013, Chief Financial Officer from October 2004 to December 2012, Executive Vice President from July 2008 to December 2012, Senior Vice President from 2000 to July 2008, Chief Talent Officer from 2001 to 2004 and Chief Sales Officer from September 2000 to August 2001. Mr. Liberatore has served in various other roles in Kforce (and its predecessors) since he joined the Firm in 1988. <br>The Board believes that this experience, coupled with his extensive knowledge of the staffing industry, provides strong, consistent leadership and allows him to serve as a highly effective bridge between the Board and management. In addition, in his capacity as CEO, Mr. Liberatore frequently meets with shareholders, clients and other Firm stakeholders to communicate our business and strategy and to understand their various perspectives and insights, which he is then able to relay to the Board for consideration and assessment.  |
| **Director since 2021** | **Director since 2021** | **Other Current Public Company Board(s):**<br>None |
| **Age** | **63** | **Other Current Public Company Board(s):**<br>None |

---

---

| | | | |
|:---|:---|:---|:---|
| **Randall A. Mehl** | **Randall A. Mehl** | **Randall A. Mehl** | **Randall A. Mehl** |
| ![mehl-randall.jpg](kfrc-20260313_g30.jpg) | ![mehl-randall.jpg](kfrc-20260313_g30.jpg) | Since 2017, Mr. Mehl has served as the President and Chief Investment Officer of Stewardship Capital Advisors, LLC, which manages a family office fund focused on investments in various technology and services sectors. He also currently serves on the Board of Directors of two public companies, Insperity, Inc. and ICF International, Inc., where he chairs the Human Capital Committee. Mr. Mehl also serves on the board of Krueger International, a provider of contract furniture systems. He was Managing Director and partner at Baird Capital, a middle market private equity group, from 2005 to 2016, where he led a team specializing in business and technology services investments. From 1996 to 2005, Mr. Mehl was a senior equity research analyst with Robert W. Baird & Company, covering various areas within the technology and services sectors, including staffing.<br>Mr. Mehl has previously served on the boards of several private technology and services companies and participated on investment committees for multiple private equity funds. He brings valuable expertise to the Board through his deep domain knowledge in technology services and staffing, his experience in assessing and supporting executive leadership and governance practices, and his experience in evaluating, acquiring and selling services-oriented businesses. | Since 2017, Mr. Mehl has served as the President and Chief Investment Officer of Stewardship Capital Advisors, LLC, which manages a family office fund focused on investments in various technology and services sectors. He also currently serves on the Board of Directors of two public companies, Insperity, Inc. and ICF International, Inc., where he chairs the Human Capital Committee. Mr. Mehl also serves on the board of Krueger International, a provider of contract furniture systems. He was Managing Director and partner at Baird Capital, a middle market private equity group, from 2005 to 2016, where he led a team specializing in business and technology services investments. From 1996 to 2005, Mr. Mehl was a senior equity research analyst with Robert W. Baird & Company, covering various areas within the technology and services sectors, including staffing.<br>Mr. Mehl has previously served on the boards of several private technology and services companies and participated on investment committees for multiple private equity funds. He brings valuable expertise to the Board through his deep domain knowledge in technology services and staffing, his experience in assessing and supporting executive leadership and governance practices, and his experience in evaluating, acquiring and selling services-oriented businesses. |
| **Director since 2017** | **Director since 2017** | **Other Current Public Company Board(s):**<br>ICF International, Inc. (NASDAQ: ICFI); Insperity, Inc. (NYSE: NSP) | **Kforce Board Committee(s):**<br>Compensation (Chair), Nomination and Corporate Governance |
| **Age** | **58** | **Other Current Public Company Board(s):**<br>ICF International, Inc. (NASDAQ: ICFI); Insperity, Inc. (NYSE: NSP) | **Kforce Board Committee(s):**<br>Compensation (Chair), Nomination and Corporate Governance |

---

---

| | | | |
|:---|:---|:---|:---|
| **Elaine D. Rosen** | **Elaine D. Rosen** | **Elaine D. Rosen** | **Elaine D. Rosen** |
| ![rosen-elaine.jpg](kfrc-20260313_g31.jpg) | ![rosen-elaine.jpg](kfrc-20260313_g31.jpg) | Ms. Rosen has served as a director of Assurant, Inc., a leading provider of specialized insurance and insurance-related products and services, since March 2009 and became the non-executive Chair of its Board in November 2010. She previously served as Chair of the Board of The Kresge Foundation from 2007 to 2022. Ms. Rosen is actively involved in the nonprofit sector, serving as trustee or director for several organizations. She is a past Chair of the Board of Preble Street, a homeless services collaborative in Portland, Maine, and has been a trustee of the Foundation for Maine's Community Colleges since 2008. She also served as a director of the Elmina B. Sewall Foundation from 2008 to 2012 and as a director of Downeast Energy Corp., a privately held provider of heating products and building supplies, from 2003 to 2012. Earlier in her career, Ms. Rosen held numerous leadership roles at Unum Life Insurance Company of America, including serving as President, from 1975 to 2001.<br>Ms. Rosen brings extensive experience as a senior executive in the insurance industry and as a director of both corporate and charitable organizations, including serving as Chair of one of the nation's largest private foundations. Her leadership roles - as prior Chair of Kforce's Compensation Committee, non-executive Chair of Assurant, Inc.'s Board, and Lead Independent Director at Kforce - underscore her deep expertise in board governance, executive compensation, and overall board leadership. The Board believes these qualifications are significant assets that enhance its effectiveness. | Ms. Rosen has served as a director of Assurant, Inc., a leading provider of specialized insurance and insurance-related products and services, since March 2009 and became the non-executive Chair of its Board in November 2010. She previously served as Chair of the Board of The Kresge Foundation from 2007 to 2022. Ms. Rosen is actively involved in the nonprofit sector, serving as trustee or director for several organizations. She is a past Chair of the Board of Preble Street, a homeless services collaborative in Portland, Maine, and has been a trustee of the Foundation for Maine's Community Colleges since 2008. She also served as a director of the Elmina B. Sewall Foundation from 2008 to 2012 and as a director of Downeast Energy Corp., a privately held provider of heating products and building supplies, from 2003 to 2012. Earlier in her career, Ms. Rosen held numerous leadership roles at Unum Life Insurance Company of America, including serving as President, from 1975 to 2001.<br>Ms. Rosen brings extensive experience as a senior executive in the insurance industry and as a director of both corporate and charitable organizations, including serving as Chair of one of the nation's largest private foundations. Her leadership roles - as prior Chair of Kforce's Compensation Committee, non-executive Chair of Assurant, Inc.'s Board, and Lead Independent Director at Kforce - underscore her deep expertise in board governance, executive compensation, and overall board leadership. The Board believes these qualifications are significant assets that enhance its effectiveness. |
| **Director since 2003** | **Director since 2003** | **Other Current Public Company Board(s):**<br>Assurant, Inc. (NYSE: AIZ) | **Kforce Board Committee(s):** <br>Lead Independent Director, Corporate Governance (Chair) and Compensation |
| **Age** | **73** | **Other Current Public Company Board(s):**<br>Assurant, Inc. (NYSE: AIZ) | **Kforce Board Committee(s):** <br>Lead Independent Director, Corporate Governance (Chair) and Compensation |

---

14 Kforce 2026 Proxy Statement

------

<u>[**Table of Contents**](#ibde21b2946834ef1acfb04b1aa73fd7c_16)</u>

**COMPOSITION AND DIVERSITY**

Our diverse Board exhibits a wide range of backgrounds, skills, attributes, experiences and tenure. Our directors have served in senior leadership, executive management or directorship positions across industries such as banking, executive compensation, investment management, strategic advisory, insurance, government, military, professional sports and staffing. In the context of our Board's experience serving in senior leadership and executive management capacities, the Board brings valuable insights into how to adapt to emerging technologies. Our Board also continues to educate themselves and consult with experts, where appropriate. These fields provide valuable and diverse insights into our business and promote a broad understanding of the markets, products and industries of our client base. The Nomination Committee periodically reviews the composition of the Board and its Committees to ensure a well-functioning mix of diverse backgrounds and expertise.

The Nomination Committee strives to identify directors who will: (1) bring to the Board diversity in thought and insights by leveraging their different skills and backgrounds; (2) bring substantial senior management experience, strategic insight, financial expertise and other skills that would enhance the Board's effectiveness; and (3) represent the balanced, best interests of our shareholders and stakeholders, as a whole. In selecting individual nominees, the Nomination Committee assesses each nominee's independence, character and integrity, potential conflicts of interest, experience, diversity and the willingness to devote sufficient time to carrying out the responsibilities of a director.

While the Board has not adopted a formal policy on diversity, the Nomination Committee is committed to achieving diversity, including but not limited to diversity of thought, experiences, and skillsets, during the director nomination process with the goal of creating a Board that best serves Kforce and the interests of its shareholders.

The Nomination Committee has established a detailed director recruitment process by which the Firm's independent directors and key management play a role in the identification, review, screening and interviewing of director candidates and, as necessary, would consider engaging an independent qualified director search firm. The Nomination Committee's process for identifying and selecting director candidates is designed to ensure each candidate is evaluated for qualifications, independence, potential conflicts and other issues of importance to the Firm and composition of the Board. When identifying candidates, the Nomination Committee takes into account overall board composition. The priorities for recruiting new directors are based on the overall Board's composition, the Firm's strategic needs, diversity and desired skills at the time of recruitment.

The Nomination Committee recognizes the importance of Board refreshment for the generation of new ideas and strategies and is committed to the process in a manner that promotes a balance of perspective, experience and continuity. The Nomination Committee is committed to engaging in Board refreshment activities to promote a balance of tenure, experience and independence across our Board. As a result of refreshment efforts, the Board has a significantly lower average tenure, a larger percentage of independent directors and greater diversity.

**Directors' Qualifications and Skills** 

The following table summarizes the collective qualifications and skills in several areas that we believe are important to the long-term success of Kforce. Although all of our directors have experience in each of these categories, the table below represents the number of directors whose expertise in each category is deemed to be particularly significant.

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | ![Building.jpg](kfrc-20260313_g32.jpg) | ![Leader.jpg](kfrc-20260313_g33.jpg) | ![Caution.jpg](kfrc-20260313_g34.jpg) | ![Money.jpg](kfrc-20260313_g35.jpg) | ![Staff.jpg](kfrc-20260313_g36.jpg) | ![Human Capital.jpg](kfrc-20260313_g37.jpg) | ![Tech.jpg](kfrc-20260313_g38.jpg) | ![Skyscrapers.jpg](kfrc-20260313_g39.jpg) | ![Markerting.jpg](kfrc-20260313_g40.jpg) |
| **1** |  |  |  |  |  |  |  |  |  |
| **2** |  |  |  |  |  |  |  |  |  |
| **3** |  |  |  |  |  |  |  |  |  |
| **4** |  |  |  |  |  |  |  |  |  |
| **5** |  |  |  |  |  |  |  |  |  |
| **6** |  |  |  |  |  |  |  |  |  |
| **7** |  |  |  |  |  |  |  |  |  |
| **8** |  |  |  |  |  |  |  |  |  |
| **9** |  |  |  |  |  |  |  |  |  |
| **TOTAL** | **8** | **7** | **5** | **8** | **6** | **7** | **2** | **5** | **4** |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Legend** | **Legend** | **Legend** | **Legend** | **Legend** | **Legend** |
| ![Building.jpg](kfrc-20260313_g32.jpg) | ***Corporate Governance /*** <br>***Board Experience*** | ![Money.jpg](kfrc-20260313_g35.jpg) | ***Financial*** | ![Tech.jpg](kfrc-20260313_g38.jpg) | ***Technology / Cybersecurity*** |
| ![Leader.jpg](kfrc-20260313_g33.jpg) | ***Executive Leadership / Strategy*** | ![Staff.jpg](kfrc-20260313_g36.jpg) | ***Staffing / Solutions Industry*** | ![Skyscrapers.jpg](kfrc-20260313_g39.jpg) | ***Business and Operational Transformation*** |
| ![Caution.jpg](kfrc-20260313_g34.jpg) | ***Risk Management*** | ![Human Capital.jpg](kfrc-20260313_g37.jpg) | ***Human Capital Management*** | ![Markerting.jpg](kfrc-20260313_g40.jpg) | ***Brand and Marketing*** |

---

15 Kforce 2026 Proxy Statement

------

<u>[**Table of Contents**](#ibde21b2946834ef1acfb04b1aa73fd7c_16)</u>

**ESG OVERSIGHT AND ACTIVITIES**

![ESG header.jpg](kfrc-20260313_g41.jpg)

We believe that at the heart of Kforce is a deep understanding of, and unwavering commitment to, our core values. Our core values guide us in every interaction, inspire us to shape a better world and support our overall ESG efforts. Our core values are:

![Core.jpg](kfrc-20260313_g42.jpg)

**Our Mission and Vision**

We take a people-first approach to all aspects of our business. We understand that each day is an opportunity to build up our people and create a world in which we all want to live - one that is grounded in inclusion, empowerment and fulfillment. We believe that the services we provide impact peoples' lives and careers while helping companies achieve success. This is reflected in our mission, *Uniting Professionals to Achieve Success Through Lasting Personal Relationships*<sup>®</sup>, and our vision, *To Have a Meaningful Impact on All the Lives We Serve*<sup>®</sup>.

<u>SOCIAL</u>

Our people are the keystone of our success. As a people-focused solutions business, we dedicate significant energy to ensuring the well-being and fulfillment of each individual, which we believe helps us to deliver superior results to our shareholders. This section includes our commitment to well-being, flexibility and balance, and learning and development.

**Well-Being, Flexibility & Balance**

We are committed to the health, safety and wellness of our associates and consultants. We provide our people and their families the tools and resources to improve and maintain their health, including access to a variety of flexible and convenient health and wellness programs. These programs include retirement savings plans, paid time off, employee support, mental wellness and the development of what we believe is a thoughtful and supportive remote-first work model that we refer to as Office Occasional<sup>®</sup>.

**Learning & Development**

Our commitment to learning and development is a core element of our people-first strategy, reinforcing our efforts to cultivate talent from within and sustain a strong corporate culture. We are continuing to invest in the tools, resources and training that empower our people to succeed at every stage of their careers. Most of our training programs are designed to build the required capabilities to perform effectively throughout the leadership pipeline. We provide specialized training for our director-level and above leaders that address evolving developments and current events shaping the business landscape and programs geared towards identifying our future leaders and beginning their leadership ambitions and journey.

Members of our Board and executive leadership are periodically engaged to participate in our learning and development programs to enrich the experience for our people.

16 Kforce 2026 Proxy Statement

------

<u>[**Table of Contents**](#ibde21b2946834ef1acfb04b1aa73fd7c_16)</u>

<u>GOVERNANCE</u>

Our Board of Directors and Executive Leadership Team guide our Corporate Governance activities. They set strategy and expectations with the highest standards, extending the culture and commitment throughout the Firm. Our Board strengthened overall ESG oversight by establishing an ESG Committee in 2024, composed of members of executive management to oversee the company's ESG-related risks, opportunities, strategies, policies and procedures. This committee is guided by an ESG Committee charter. The Board receives periodic updates on ESG progress and educational sessions with subject matter experts, as appropriate.

<u>ENVIRONMENT</u>

We strive to serve as responsible stewards of the environment. We recognize the importance of minimizing our impact on the environment and have continued to measure our efforts. Through Office Occasional® – our remote-first work model – we have successfully and dramatically lowered our greenhouse gas (GHG) emissions due to a reduced real-estate footprint resulting in lower office electricity consumption and less employee commutes.

Our ongoing efforts will continue to focus on reductions in GHG emissions as a result of our real-estate strategy. Our GHG emissions calculations are published in our Sustainability Reports, available on Kforce.com. Our environmental disclosures have been informed by the Financial Stability Board's Task Force on Climate-Related Financial Disclosures (TCFD) framework.

**RELATED PARTY TRANSACTIONS, COMPENSATION COMMITTEE INTERLOCKS AND INSIDER PARTICIPATION**

The Audit Committee is responsible for review, approval or ratification of all related party transactions that Kforce is required to disclose in accordance with Item 404 of Regulation S-K. While the Board has not adopted a written policy, the Board believes that the Audit Committee's practices and processes around the review, approval and ratification of transactions with related persons provides adequate evaluations of all potential related party transactions, including considerations on whether the transaction is on terms that are in the best interests of Kforce and our shareholders. There are no related party transactions that require disclosure for the year ended December 31, 2025.

The Firm's Compensation Committee consists of Randall A. Mehl (Chair), Mark F. Furlong and Elaine D. Rosen. None of the members of the Compensation Committee are currently, or were formerly, an officer or an employee of Kforce or its subsidiaries, or had any relationship with Kforce, requiring disclosure under Item 404 of Regulation S-K. During 2025, none of the Firm's executive officers served on the board of directors or compensation committee of any entity that had one or more of its executive officers serving on the Board or the Compensation Committee.

17 Kforce 2026 Proxy Statement

------

<u>[**Table of Contents**](#ibde21b2946834ef1acfb04b1aa73fd7c_16)</u>

**DIRECTOR COMPENSATION**

The following table shows the annual compensation components for our directors for the year ended December 31, 2025, and the aggregate outstanding stock awards as of December 31, 2025, except for Mr. Liberatore who does not receive compensation for his service on the Board:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Name** | **Fees Earned or**<br>**Paid in Cash** <sup>(1)</sup><br>**($)** | **Stock**<br>**Awards** <sup>(2)</sup><br>**($)** | **All Other**<br>**Compensation** <sup>(3)</sup><br>**($)** | **Total <br>($)** | **Unvested Restricted**<br>**Stock** <sup>(4)</sup> | **Deferred Restricted Stock Units** <sup>(4)</sup> |
| **Derrick D. Brooks** | $95000 | $139985 | $14433 | $249418 | 3304 | 10324 |
| **Catherine H. Cloudman** | $95000 | $139985 | $8328 | $243313 | 3304 | 5626 |
| **David L. Dunkel** | $212000 | $139985 | $10207 | $362192 | 3304 | 7535 |
| **Ann E. Dunwoody** | $110000 | $139985 | $8963 | $258948 | 3304 | 5625 |
| **Mark F. Furlong** | $125000 | $139985 | $4661 | $269646 | 3304 | 3304 |
| **Randall A. Mehl** | $125000 | $139985 | $36018 | $301003 | 3304 | 24609 |
| **Elaine D. Rosen** | $135000 | $139985 | $54157 | $329142 | 3304 | 36620 |
| **N. John Simmons** | $95000 | $139985 | $4661 | $239646 | 3304 | 3304 |

---

<sup>(1)</sup> For 2025, non-employee directors received the following annual compensation as approved by the Board:

---

| | |
|:---|:---|
| **Board retainer:** | |
| &nbsp;&nbsp;&nbsp;&nbsp;Chairman | $145000 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other Directors | $45000 |
| **Committee retainer:** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Audit Committee, Chair | $15000 |
| &nbsp;&nbsp;&nbsp;&nbsp;Compensation Committee, Chair | $15000 |
| &nbsp;&nbsp;&nbsp;&nbsp;Nomination Committee, Chair | $15000 |
| **Service fees:** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Board service fees for Chairman | $67000 |
| &nbsp;&nbsp;&nbsp;&nbsp;Board service fees for Other Directors | $20000 |
| &nbsp;&nbsp;&nbsp;&nbsp;Committee service fees for each Committee Chair and Member | $15000 |
| **Other:** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Lead Independent Director | $40000 |

---

<sup>(2)</sup> On April 25, 2025, all directors were granted 3,188 shares of restricted stock that vest on April 24, 2026. The amounts in this column represent the aggregate grant date fair value in accordance with FASB ASC 718, using the closing stock price on the grant date of $43.91.

<sup>(3)</sup> The amounts reported in this column for all directors represent the dollar value of dividend equivalents credited on unvested restricted stock and deferred restricted stock units in the form of additional restricted stock.

<sup>(4)</sup> The beneficial ownership of common shares as of the Record Date for each of our directors is reported in the "Security Ownership of Certain Beneficial Owners and Management" section of this report.

18 Kforce 2026 Proxy Statement

------

<u>[**Table of Contents**](#ibde21b2946834ef1acfb04b1aa73fd7c_16)</u>

**PROPOSAL 2. RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTANTS**

Our consolidated financial statements for the year ended December 31, 2025, have been audited by Deloitte & Touche LLP, independent auditors. The Audit Committee of the Board has selected Deloitte & Touche LLP, subject to ratification by shareholders, to audit our consolidated financial statements for the year ending December 31, 2026, to provide review services for each of the quarters in the year then ended, and to perform other appropriate services that may be necessary. A representative of Deloitte & Touche LLP is expected to be present at the Annual Meeting to respond to appropriate questions and to make any other statements deemed appropriate.

Deloitte & Touche LLP has audited Kforce's financial statements since the fiscal year ended December 31, 2000.

**INDEPENDENT REGISTERED PUBLIC ACCOUNTANTS - FEE INFORMATION**

---

| | | |
|:---|:---|:---|
| **Fee Type** | **2025** | **2024** |
| Audit Fees <sup>(1)</sup>  | $1022193 | $984240 |
| Audit-Related Fees <sup>(2)</sup>  | $15000 | $— |
| Tax Fees <sup>(3)</sup>  | $22544 | $47750 |
| All Other Fees <sup>(4)</sup>  | $1895 | $1895 |

---

<sup>(1)</sup> Relates to the annual audit of our financial statements and internal control over financial reporting, the review of our quarterly financial statements and audit services provided in connection with other statutory and regulatory filings.

<sup>(2)</sup> Relates to the preparation and filing of the Form S-8 registration statement associated with our 2025 Stock Incentive Plan.

<sup>(3)</sup> Relates to tax advice, tax planning and tax consultation services.

<sup>(4)</sup> Relates to annual subscription to a Deloitte & Touche LLP research database.

The Audit Committee considered whether Deloitte & Touche LLP's provision of the above non-audit services is compatible with maintaining such firm's independence and satisfied itself as to Deloitte & Touche LLP's independence.

**POLICY ON AUDIT COMMITTEE PRE-APPROVAL OF AUDIT AND PERMISSIBLE NON-AUDIT SERVICES OF INDEPENDENT AUDITORS**

The Audit Committee's policy is to pre-approve all audit and permissible non-audit services provided by the independent auditors to ensure that the provision of such services does not impair the auditor's independence. These services may include audit services, audit-related services, tax services and other services. Pre-approval is generally provided for up to one year and any pre-approval is detailed as to the particular service or category of services and is generally subject to a specific limit above which separate pre-approval is required. Management periodically reports to the Audit Committee the pre-approved services provided by the independent auditors as well as the fees for the services performed.

During the year ended December 31, 2025, 100% of services were pre-approved by the Audit Committee in accordance with this policy.

**VOTE REQUIRED**

Approval of this proposal requires the affirmative vote of a majority of the shares entitled to vote on the matter. An abstention is considered as present and entitled to vote and will have the effect of a vote against the proposal. A broker non-vote is considered not entitled to vote and will not affect the voting.

**THE BOARD UNANIMOUSLY RECOMMENDS A VOTE FOR PROPOSAL 2.**<br>

19 Kforce 2026 Proxy Statement

------

<u>[**Table of Contents**](#ibde21b2946834ef1acfb04b1aa73fd7c_16)</u>

**AUDIT COMMITTEE REPORT**

Kforce Inc.'s Audit Committee is composed of three directors, all of whom the Board has determined to be independent within the meaning of the NYSE and SEC Rules. The Audit Committee assists the Board in general oversight of Kforce Inc.'s financial accounting and reporting process, system of internal control and audit process.

Kforce Inc.'s management has primary responsibility for Kforce Inc.'s consolidated financial statements and for maintaining effective internal control over financial reporting. Kforce Inc.'s independent auditors, Deloitte & Touche LLP, are responsible for expressing an opinion on Kforce Inc.'s consolidated financial statements as to whether they present fairly, in all material respects, Kforce Inc.'s financial position, results of operations and cash flows, in conformity with GAAP and an opinion on the effectiveness of Kforce Inc.'s internal control over financial reporting based on the criteria established in *Internal Control – Integrated Framework* issued by the Committee of Sponsoring Organizations of the Treadway Commission. This opinion is based on their audits.

In this context, the Audit Committee reports as follows:

1. The Audit Committee has reviewed and discussed the audited consolidated financial statements with Kforce Inc.'s management;

2. The Audit Committee has discussed with the independent auditors the matters required to be discussed by PCAOB Standard No. 1301 (Communications with Audit Committees) and the SEC;

3. The Audit Committee has received the written disclosures and the letter from the independent auditors required by the applicable requirements of the PCAOB regarding the independent auditor's communications with the audit committee concerning independence, and has discussed with the independent auditors the independent auditors' independence; and

4. Based on the review and discussion referred to in the above paragraphs, the Audit Committee recommended to the Board that the audited financial statements be included in Kforce Inc.'s Annual Report on Form 10-K for the year ended December 31, 2025, for filing with the SEC. The Audit Committee has also selected Deloitte & Touche LLP, subject to ratification by shareholders, to audit our consolidated financial statements for the year ending December 31, 2026, and to provide review services for each of the quarters in the year ending December 31, 2026.

Submitted by the Audit Committee,

Mark F. Furlong (Chair)

Catherine H. Cloudman

N. John Simmons

*The above report shall not be deemed "soliciting material" or "filed" with the SEC, or subject to the liabilities of Section 18 of the Exchange Act, except to the extent that we specifically incorporate it by reference into such filings.*

20 Kforce 2026 Proxy Statement

------

<u>[**Table of Contents**](#ibde21b2946834ef1acfb04b1aa73fd7c_16)</u>

**EXECUTIVE COMPENSATION**

**EXECUTIVE OFFICERS**

The ages and biographies for each of our executive officers is set forth below.

---

| | | |
|:---|:---|:---|
| **Joseph J. Liberatore** | **Age:** | **63** |
| Chief Executive Officer, President and Director<br>![Liberatore, Joe HS.jpg](kfrc-20260313_g29.jpg) | Mr. Liberatore has served as the Chief Executive Officer of Kforce since January 2022. He joined the Board as a director in November 2021, and was elected by shareholders in April 2022. He has served as Kforce's President since January 2013 and previously served as Corporate Secretary from February 2007 to February 2013, Chief Financial Officer from October 2004 to December 2012, Executive Vice President from July 2008 to December 2012, Senior Vice President from 2000 to July 2008, Chief Talent Officer from 2001 to 2004 and Chief Sales Officer from September 2000 to August 2001. Mr. Liberatore has served in various other roles in Kforce (and its predecessors) since he joined the Firm in 1988. | Mr. Liberatore has served as the Chief Executive Officer of Kforce since January 2022. He joined the Board as a director in November 2021, and was elected by shareholders in April 2022. He has served as Kforce's President since January 2013 and previously served as Corporate Secretary from February 2007 to February 2013, Chief Financial Officer from October 2004 to December 2012, Executive Vice President from July 2008 to December 2012, Senior Vice President from 2000 to July 2008, Chief Talent Officer from 2001 to 2004 and Chief Sales Officer from September 2000 to August 2001. Mr. Liberatore has served in various other roles in Kforce (and its predecessors) since he joined the Firm in 1988. |
| **David M. Kelly** | **Age:** | **60** |
| Chief Operating Officer<br>![Kelly, David HS - zoomed in.jpg](kfrc-20260313_g43.jpg) | Mr. Kelly has served as Kforce's Chief Operating Officer since September 2023 and Corporate Secretary since February 2013. Mr. Kelly joined Kforce in 2000 and, prior to being appointed as Chief Operating Officer, served as Chief Financial Officer from January 2013 until September 2023, Senior Vice President of Finance and Accounting from February 2009 to December 2012, Corporate Assistant Secretary from October 2010 to February 2013, Vice President of Finance from January 2005 to February 2009, Chief Accounting Officer from November 2000 to January 2005 and Group Financial Officer from January 2000 to November 2000. Before joining Kforce, Mr. Kelly served in various roles with different companies that included treasury director, vice president and controller. | Mr. Kelly has served as Kforce's Chief Operating Officer since September 2023 and Corporate Secretary since February 2013. Mr. Kelly joined Kforce in 2000 and, prior to being appointed as Chief Operating Officer, served as Chief Financial Officer from January 2013 until September 2023, Senior Vice President of Finance and Accounting from February 2009 to December 2012, Corporate Assistant Secretary from October 2010 to February 2013, Vice President of Finance from January 2005 to February 2009, Chief Accounting Officer from November 2000 to January 2005 and Group Financial Officer from January 2000 to November 2000. Before joining Kforce, Mr. Kelly served in various roles with different companies that included treasury director, vice president and controller. |
| **Jeffrey B. Hackman** | **Age:** | **47** |
| Chief Financial Officer<br>![Hackman, Jeffrey HS - zoomed in.jpg](kfrc-20260313_g44.jpg) | Mr. Hackman has served as Kforce's Chief Financial Officer and Principal Financial Officer since September 2023 and Corporate Assistant Secretary since February 2024. Before his appointment to Chief Financial Officer, he served as Senior Vice President of Finance and Accounting and Principal Accounting Officer since October 2015. Mr. Hackman is responsible for overseeing Kforce's investor relations, legal, internal audit, finance and accounting, tax, treasury, procurement and real estate functions. He previously served as the Firm's Chief Accounting Officer and Principal Accounting Officer from February 2009 until September 2013 and as Kforce's SEC Reporting Director from September 2007 to February 2009. Mr. Hackman served as the Global Chief Accounting Officer of Cunningham Lindsey from September 2013 until he rejoined Kforce in March 2015. Prior to September 2007, he was an Audit Senior Manager with Grant Thornton LLP and began his professional career with Arthur Andersen. | Mr. Hackman has served as Kforce's Chief Financial Officer and Principal Financial Officer since September 2023 and Corporate Assistant Secretary since February 2024. Before his appointment to Chief Financial Officer, he served as Senior Vice President of Finance and Accounting and Principal Accounting Officer since October 2015. Mr. Hackman is responsible for overseeing Kforce's investor relations, legal, internal audit, finance and accounting, tax, treasury, procurement and real estate functions. He previously served as the Firm's Chief Accounting Officer and Principal Accounting Officer from February 2009 until September 2013 and as Kforce's SEC Reporting Director from September 2007 to February 2009. Mr. Hackman served as the Global Chief Accounting Officer of Cunningham Lindsey from September 2013 until he rejoined Kforce in March 2015. Prior to September 2007, he was an Audit Senior Manager with Grant Thornton LLP and began his professional career with Arthur Andersen. |
| **Andrew G. Thomas** | **Age:** | **59** |
| Chief Experience Officer<br>![Thomas, Andrew HS - zoomed in.jpg](kfrc-20260313_g45.jpg) | Mr. Thomas has served as Kforce's Chief Experience Officer since September 2023. He is responsible for leading the Firm's marketing, digital strategy, training and development, human resources, compensation and benefits organizations. He previously served as Chief Marketing Officer from July 2018 until September 2023, Chief Field Services Officer from December 2013 to July 2018, and Executive Director of Kforce's Finance and Accounting product offering where he oversaw strategy development and operations and other activities, as well as various other roles in Kforce since he joined the Firm in 1997. | Mr. Thomas has served as Kforce's Chief Experience Officer since September 2023. He is responsible for leading the Firm's marketing, digital strategy, training and development, human resources, compensation and benefits organizations. He previously served as Chief Marketing Officer from July 2018 until September 2023, Chief Field Services Officer from December 2013 to July 2018, and Executive Director of Kforce's Finance and Accounting product offering where he oversaw strategy development and operations and other activities, as well as various other roles in Kforce since he joined the Firm in 1997. |

---

21 Kforce 2026 Proxy Statement

------

<u>[**Table of Contents**](#ibde21b2946834ef1acfb04b1aa73fd7c_16)</u>

**COMPENSATION DISCUSSION AND ANALYSIS**

***Compensation Committee Report***<br>The Compensation Committee of Kforce (the Committee) has reviewed and discussed the Compensation Discussion and Analysis (CD&A) required by Item 402(b) of Regulation S-K with management and based on such review and discussions, the Committee recommended to the Board that the CD&A be included in this Proxy Statement and incorporated into Kforce Inc.'s Annual Report on Form 10-K for the year ended December 31, 2025.<br>Submitted by the Compensation Committee on March 6, 2026 <br>Randall A. Mehl (Chair) ¦ Mark F. Furlong ¦ Elaine D. Rosen<br>

*The above report shall not be deemed soliciting material or filed with the SEC, or subject to the liabilities of Section 18 of the Exchange Act, except to the extent that we specifically incorporate it by reference into such filings.*

22 Kforce 2026 Proxy Statement

------

<u>[**Table of Contents**](#ibde21b2946834ef1acfb04b1aa73fd7c_16)</u>

**EXECUTIVE SUMMARY**

This CD&A primarily focuses on the compensation of our Named Executive Officers (NEOs) for the year ended December 31, 2025.

---

| | |
|:---|:---|
| **Name** | **Title** |
| **Joseph J. Liberatore** | **Chief Executive Officer** |
| **David M. Kelly** | **Chief Operating Officer** |
| **Jeffrey B. Hackman** | **Chief Financial Officer** |
| **Andrew G. Thomas** | **Chief Experience Officer** |

---

Management and the Board reaffirmed the Firm's strategic priorities, including (i) the implementation of Workday as our future state enterprise cloud application for HCM and financials, (ii) our integrated strategy efforts, (iii) the evolution of our offshore delivery capability in Pune, India, and (iv) advancing our Firm's strategies through leverage of AI. The objectives for the NEOs in 2025 were not limited to but were centered around the Firm's strategic priorities given their depth and expected contribution to attaining our future financial objectives and, as a result, generating significant shareholder value.

In light of the ongoing macroeconomic uncertainties, management continued to advance the Firm's transformational strategic priorities in 2025, achieving measurable progress across several enterprise initiatives that remain central to our long-term value-creation objectives. We believe these efforts reflect disciplined execution in a year marked by persistent macroeconomic uncertainty and ongoing softness in the broader technology services market.

For the year ended December 31, 2025, the Firm:

• Experienced a year-over-year decline in revenue of 5.4% (5.1% per billing day) and adjusted diluted EPS of 22.0% while exercising disciplined cost management to mitigate the pressure on the bottom line from the lower revenues.

• Delivered top-tier Technology organic revenue performance compared to our most comparable publicly-traded peers.

• Our organic growth strategy has continued to put us in a solid position to return significant capital to our shareholders. In 2025, we returned $76 million in capital in the form of open market repurchases totaling $48.5 million and dividends of $27.5 million.

Each of our strategic priorities represents a multi-year transformational effort and our people made tremendous progress in 2025, as we:

• Achieved substantial advancements on the implementation of Workday through disciplined execution across key program milestones. During 2025, management completed initial testing for both human capital management and financial modules within our initial prototype tenant containing the full suite of Workday functionality. The team also enhanced data migration and resource plans to ensure continued data fidelity, and revised the program timeline to incorporate refinements stemming from the updated data migration approach. We remain on track for an early 2027 implementation date.

• We made significant progress further integrating our consulting solutions offering throughout the Firm. Our integrated strategy efforts are centered around enhancing enterprise execution and ensuring a more cohesive go-to-market approach across sales, recruiting, consulting solutions and technology practice teams with the goal of accelerating future revenue growth and profitability enhancements. During 2025, we made several changes that better optimized the compensation practices across the Firm, unified our margin expectations across our Technology business, laid the foundation for enhanced productivity expectations, among several other items. Our consulting solutions offering contributed positively in 2025 to our financial results.

• Completed the foundational build-out of our delivery capability in Pune, India in 2025 referred to as Knowledgeforce India. Our India operation enhances the Firm's ability to serve clients through a multi-shore delivery model and expands access to highly skilled technical talent. We began supporting our U.S. client engagements in January 2025, marking a significant milestone in the evolution of the Firm's delivery strategy.

• Formalized the Firm's artificial intelligence strategy and related efforts by establishing a structured adoption roadmap to accelerate productivity gains and build baseline AI proficiency across the organization as well as define the necessary investments within the Firm to best position Kforce to capture AI-related future demand .

In addition to the significant advancements made with respect to our strategic priorities, there were many other notable advancements and accolades.

• During 2025, Kforce received several notable third-party recognitions that reinforce the strength of our culture, our people-first philosophy, and the effectiveness of our leadership. These awards include, but are not limited to: Best Workplace in Consulting and Professional Services, America's Best Recruiting Firms, Top Workplace in Tampa Bay and Great Place to Work.

23 Kforce 2026 Proxy Statement

------

<u>[**Table of Contents**](#ibde21b2946834ef1acfb04b1aa73fd7c_16)</u>

• Our business, among many others, has historically been susceptible to candidate embellishments. This has escalated over the last few years to be more organized, technology-enabled and systemic fraudulent misrepresentations, which created a heightened reputational risk for Kforce (and others in our space). We responded quickly to significantly bolster existing processes and procedures to address this, including additional identity validation steps and the implementation of AI-enabled technologies to assist in our efforts.

As a result of our overall financial, operational and TSR performance, the Committee approved:

• No incentive payout for the Revenue component due to below threshold performance partly due to the rigor in the financial performance metrics, and below target EPS annual incentive payout.

• Near maximum attainment of individual performance objectives (MBOs) for each NEO due to the tremendous progress in our multi-year strategic initiatives, as noted in this section above.

• Equity Long Term Incentive (LTI) payouts slightly below target payout levels based on Kforce's TSR being slightly below the average TSR performance of the Performance Peer Group.

Overall, the Committee believes the compensation levels for 2025 are reasonably aligned with the Firm's performance and accomplishments.

**OUR COMPENSATION PRINCIPLES, COMPONENTS AND PRACTICES**

---

| | | | |
|:---|:---|:---|:---|
| **What We Do** | **What We Do** | **What We Don't Do** | **What We Don't Do** |
| ![Checkmark in a box.jpg](kfrc-20260313_g22.jpg) | Target Annual NEO Compensation at Market Median for Market Median Performance | ![x.jpg](kfrc-20260313_g46.jpg) | Define Market Median by Comparison to Companies Outside of our Primary Sector |
| ![Checkmark in a box.jpg](kfrc-20260313_g22.jpg) | Align Pay with Performance by Paying Higher Compensation for Above Median Performance and Lower Compensation for Below Median Performance | ![x.jpg](kfrc-20260313_g46.jpg) | Set Targets for Incentive Plans that are Easy to Attain |
| ![Checkmark in a box.jpg](kfrc-20260313_g22.jpg) | Ensure Performance-Based Compensation is the Largest Part of Total Compensation | ![x.jpg](kfrc-20260313_g46.jpg) | Provide Excessive Perquisites |
| ![Checkmark in a box.jpg](kfrc-20260313_g22.jpg) | Maintain a Clawback Policy | ![x.jpg](kfrc-20260313_g46.jpg) | Allow Repricing or Cash Buyouts of Previous Equity-Based LTI Grants |
| ![Checkmark in a box.jpg](kfrc-20260313_g22.jpg) | Ensure Equity-Based LTI Compensation is a Significant Component of Performance-Based Compensation | ![x.jpg](kfrc-20260313_g46.jpg) | Allow Hedging or Pledging of Company Stock or Other Related Activities |
| ![Checkmark in a box.jpg](kfrc-20260313_g22.jpg) | Require Minimum Levels of Share Ownership (for our Board and our executives) | ![x.jpg](kfrc-20260313_g46.jpg) | Create New Excise Tax Gross-ups |
| ![Checkmark in a box.jpg](kfrc-20260313_g22.jpg) | Adhere to Minimum Levels of Financial Performance that Must be Attained to Achieve Threshold Payout Levels Even in Adverse Economic Environments | ![x.jpg](kfrc-20260313_g46.jpg) | Create New or Materially Amend Executive Employment Agreements with Provisions for Severance Payouts Exceeding 1x Cash Compensation or Change in Control Severance Payouts Exceeding 2x Cash Compensation |
| ![Checkmark in a box.jpg](kfrc-20260313_g22.jpg) | Benchmark Compensation Against Other Similarly Sized (Considering Median Revenue and Market Capitalization Levels) Companies in our Sector  |  |  |

---

24 Kforce 2026 Proxy Statement

------

<u>[**Table of Contents**](#ibde21b2946834ef1acfb04b1aa73fd7c_16)</u>

**Our Executive Compensation Philosophy and Practices**

Our executive compensation philosophy is to attract, motivate and retain highly qualified executives who can advance the Firm's long-term shareholder value. To support this philosophy, the Committee, the Board and management apply clearly defined principles that guide both the structure of our compensation programs and oversight.

---

| | |
|:---|:---|
| ***Attract and Retain Key Executives*** | Attracting and retaining key executive talent is critical to the success of a professional staffing and solutions firm in which people represent the true assets. The Committee believes an understanding of competitive market pay levels and compensation best practices are essential to hiring and retaining qualified executives who are able to create and drive business strategies, long-term profitable growth and long-term shareholder value. |

---

---

| | |
|:---|:---|
| ***Target Annual NEO Compensation at Market Median*** | The executive compensation plan is designed to target the total pay level for our NEOs at the median of reasonably comparable companies. To accomplish this, the Committee annually reviews compensation data from several independent sources with the assistance of an independent executive compensation consultant. Our competitive market for executive talent is primarily staffing and solutions organizations; however, the Committee also reviews pay data for other professional service and consulting organizations of comparable size and similar business models. |

---

---

| | |
|:---|:---|
| ***Align Pay with Performance by Paying Higher Compensation for Above Median Performance and Lower Compensation for Below Median Performance*** | The Committee believes executive compensation should align with our revenue, profitability and TSR performance and provide superior cash and equity compensation opportunities for superior performance. The same is true for below median performance resulting in compensation that is below the median.<br>The Committee also believes the design of our compensation programs provides incentives for our NEOs to exceed targeted performance, which results in significant relative shareholder value creation and creates a positive perception of Kforce in the highly competitive market for executive talent. |

---

---

| | |
|:---|:---|
| ***Ensure Performance-Based Compensation is the Largest Part of Total Compensation*** | The Committee designs the compensation framework with significant emphasis on performance-based compensation over fixed compensation to motivate our NEOs to drive operational performance without encouraging unreasonable risk. Performance-based compensation comprised 83% of total target direct compensation for our CEO and between 72% and 77% for our other NEOs in 2025. |

---

---

| | |
|:---|:---|
| ***Ensure Equity-Based LTI Compensation is a Significant Component of Performance-Based Compensation*** | The Committee believes equity-based LTI compensation should be a significant component of performance-based compensation to further align our NEOs' interests with our shareholders in generating long-term shareholder returns. Equity LTI ranged from 65% to 74% of target total performance-based compensation for our NEOs in 2025. We believe the opportunity to earn the designated equity LTI performance objectives motivates the achievement of higher relative TSR and drives continued improved shareholder value; it also serves to retain our executives for the long term, given that our LTI awards have time-based vesting provisions of generally four years. |

---

---

| | |
|:---|:---|
| ***Require Minimum Levels of Share Ownership*** | The Committee believes our executives should have a personal financial stake in Kforce's ongoing future success, primarily driven by a desire to match their interests with those of our shareholders. <br>To further align the interests of our executives and Board of Directors with those of our long-term shareholders, the Board has adopted formal share ownership guidelines. Please refer to the "Minimum Required Share Ownership Guidelines" in this section. |

---

---

| | |
|:---|:---|
| ***Set Challenging Performance Objectives*** | The Committee seeks to establish rigorous yet attainable financial performance objectives for the NEOs under the annual incentive plan. These goals are intentionally calibrated to be demanding, as demonstrated by the fact that threshold and target levels have not been attained in every plan year, including 2023, 2024 and 2025. The performance objectives are structured to incentivize the NEOs to outpace market expectations, drive market share expansion, and strengthen profitability.  |

---

25 Kforce 2026 Proxy Statement

------

<u>[**Table of Contents**](#ibde21b2946834ef1acfb04b1aa73fd7c_16)</u>

The Firm's compensation program has the following features for alignment with best practices:

---

| | | |
|:---|:---|:---|
| ***Minimum Required Share Ownership Guidelines*** | Our Corporate Governance Guidelines include a stock ownership policy for our directors and executives. The minimum level of holdings for each position is as follows: | Our Corporate Governance Guidelines include a stock ownership policy for our directors and executives. The minimum level of holdings for each position is as follows: |
| ***Minimum Required Share Ownership Guidelines*** |  | **Target Holding Level** |
| ***Minimum Required Share Ownership Guidelines*** | **Position** | **Annual Board Cash Retainer / Salary** |
| ***Minimum Required Share Ownership Guidelines*** | Member of the Board of Directors | 5x *(recently increased from 4x)* |
| ***Minimum Required Share Ownership Guidelines*** | Chief Executive Officer | 5x |
| ***Minimum Required Share Ownership Guidelines*** | Chief Operating Officer | 3x |
| ***Minimum Required Share Ownership Guidelines*** | Other Named Executive Officers | 2x |
| ***Minimum Required Share Ownership Guidelines*** | Other members of Kforce's Executive Leadership Team | 1x |
| ***Minimum Required Share Ownership Guidelines*** |  |  |
| ***Minimum Required Share Ownership Guidelines*** | In accordance with this policy, directors have five years from the effective date of joining the Board, and executives have five years from the effective date of a promotion or salary increase, to attain the target ownership level. As of the date of this Proxy Statement, all directors, NEOs and other members of our executive leadership team were in compliance with the policy.  | In accordance with this policy, directors have five years from the effective date of joining the Board, and executives have five years from the effective date of a promotion or salary increase, to attain the target ownership level. As of the date of this Proxy Statement, all directors, NEOs and other members of our executive leadership team were in compliance with the policy.  |

---

---

| | |
|:---|:---|
| ***Clawback Policy*** | In 2024, the Board adopted the Amended and Restated Policy Relating to Recovery of Erroneously Awarded Compensation ("Clawback Policy") in compliance with the NYSE rules. Our Clawback Policy applies to all incentive-based compensation (including time-based compensation) awarded to current and former executive officers. Accordingly, in the event of a restatement of our financial statements because of material noncompliance with financial reporting requirements under federal securities laws, the Board will, if determined appropriate, recover from current and former executives any erroneously awarded incentive-based compensation paid for any applicable performance periods. Our Clawback Policy is included as an exhibit to our most recent Annual Report on Form 10-K. |

---

---

| | |
|:---|:---|
| ***Equity Plan Features and Practices*** | The Committee believes Kforce's equity plans are structured to avoid problematic pay practices and features that could be detrimental to shareholder interests.<br>None of our Stock Incentive Plans (as approved by shareholders since 2013) permit repricing or cash buyouts of underwater options or stock appreciation rights without shareholder approval. Our Stock Incentive Plans since 2017 require a minimum vesting period of one year on all award types although our typical vesting terms are between 4 and 10 years. In addition, our Stock Incentive Plans since 2019 require a minimum holding period of one year after exercise of any options and stock appreciation rights for all NEOs; we will also apply this policy to any awards granted outside of this plan. <br>We do not currently grant stock options as a part of our equity compensation program to executive officers. If stock options were to be granted in the future, the Firm would not grant such options in anticipation of the release of nonpublic information that is likely to result in changes to the price of our common stock and would not time the disclosure of material nonpublic information for the purpose of affecting the value of executive compensation. <br>During 2025, (i) none of our NEOs were awarded stock options with an effective grant date during any period beginning four business days before the filing or furnishing of a Form 10-Q, Form 10-K or Form 8-K that disclosed material nonpublic information, ending one business day after the filing or furnishing of such reports, and (ii) we did not time the disclosure of material nonpublic information for the purpose of affecting the value of executive compensation. |

---

---

| | |
|:---|:---|
| ***Insider Trading*** | Our Insider Trading Policy governs the purchase, sale and other dispositions of our securities undertaken by the Firm's, or its subsidiaries: (i) directors, officers, employees, consultants and contractors; (ii) any member of the immediate family or household of any such person, including family members who do not reside in the household but whose investment decisions are directed by, or otherwise conferred with, such person when making investment decisions with respect to Firm securities; and (iii) any entities controlled by such person (a Firm Insider). We believe our policy is reasonably designed to promote compliance with insider trading laws, rules and regulations, and the NYSE listing standards.<br>Our Insider Trading Policy is included as an exhibit to our most recent Annual Report on Form 10-K and reflects the SEC's final rules pertaining to 10b5-1 trading plans and related disclosures. The policy restrictions include, but are not limited to:<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• No trading while in the possession of material, nonpublic information<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• No trading during the Firm's designated black-out periods<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Mandatory cooling-off periods that conform with the SEC's final 10b5-1 rules <br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• No trading without pre-approval from the Insider Trading Compliance Committee |

---

26 Kforce 2026 Proxy Statement

------

<u>[**Table of Contents**](#ibde21b2946834ef1acfb04b1aa73fd7c_16)</u>

---

| | |
|:---|:---|
| ***No Hedging or Pledging (including Margin Accounts)*** | Our Insider Trading Policy expressly prohibits engaging in any hedging transaction related to the Firm's securities (including, without limitation, prepaid variable forwards, equity swaps, collars and exchange funds) or otherwise trading in any interest or position relating to the future price of the Firm's securities, such as a put, call or short sale. This policy similarly prohibits any Firm Insider from holding any of the Firm's securities in a margin account or otherwise pledging any of the Firm's securities as collateral unless approved in advance by the Insider Trading Compliance Committee or, in the case of Section 16 insiders, the Compensation Committee of the Board of Directors. There were no executive officers or directors that held the Firm's securities in a margin account or otherwise pledged the Firm's securities as collateral during the fiscal year ended December 31, 2025.  |

---

---

| | |
|:---|:---|
| ***Elimination of Excise Tax Gross-Up*** | In 2009, the Committee resolved to not enter into any new employment agreements, or materially amend any existing employment agreements with its executives that contain excise tax gross-up provisions in the event of a change-in-control event going forward. Since the Committee's resolution, all new or amended executive employment agreements have excluded excise tax gross-up provisions. As a result, the only remaining employment agreement which continues to include excise tax gross-up provisions is for Mr. Liberatore, which was last amended in 2008.  |

---

**Roles and Responsibilities**

*<u>Role of the Compensation Committee</u>*

The Committee, composed entirely of independent directors, oversees the development and application of the compensation principles that guide the design of the Firm's NEO compensation program, including related benefit policies and practices. The Committee has determined that the Firm's compensation policies and practices do not create risks reasonably likely to have a material adverse effect on Kforce.

In carrying out its responsibilities, the Committee maintains strict independence and objectivity and meets in executive session on a quarterly basis to discuss and determine matters related to executive compensation. While the Committee considers input from the CEO, COO and CFO, all decisions regarding the compensation of the CEO and the other executives are made solely at the Committee's discretion. The Committee may delegate any of its responsibilities to subcommittees when appropriate.

The Committee is committed to:

• ensuring that Kforce's executive compensation program reflects best practices and serves the long-term interests of shareholders;

• establishing and maintaining a pay-for-performance executive compensation program consistent with our shareholders' interests while providing appropriate incentives to our executives;

• engaging, as appropriate and in coordination with management, with shareholders to understand their perspectives and feedback; and

• remaining informed on current and emerging compensation trends and best practices, including through ongoing engagement with its independent compensation consultant.

*<u>Role of the Independent Compensation Consultant</u>*

During 2025, the Committee retained Pay Governance LLC, a national independent consulting firm, (Pay Governance) to serve as the Committee's independent compensation consultant. The Committee conducted an independence assessment, considering all relevant factors, and concluded that Pay Governance's engagement and services did not present any conflicts of interest. Other than the work performed for the Committee, Pay Governance did not provide any additional services to the Firm.

Pay Governance supports the Committee by providing objective analysis and guidance on a range of matters, including the alignment of our executive compensation framework with approved objectives, assessments of program effectiveness, benchmarking and market competitiveness studies, and evaluations of our compensation levels and structures, including base salary, annual incentives, and long-term incentive opportunities, as directed by the Committee. Through this engagement, the Committee ensures that Kforce's executive compensation program remains competitive, performance-aligned, and consistent with best practices.

**Peer Group and Benchmarking**

For the year ended December 31, 2025, the Committee used two peer groups to evaluate and structure executive compensation: the Performance Peer Group and the Compensation Peer Group. The Compensation Peer Group reflects a broader set of companies that are more closely aligned with Kforce in terms of size (revenue and market capitalization), although they may operate outside our primary industry or provide different services. The Committee believes that using multiple peer groups provides a more comprehensive and appropriate framework for benchmarking and supports a robust, well-aligned compensation program. The Committee reviews the composition of both peer groups on an annual basis with the assistance of Pay Governance.

27 Kforce 2026 Proxy Statement

------

<u>[**Table of Contents**](#ibde21b2946834ef1acfb04b1aa73fd7c_16)</u>

*<u>Performance Peer Group</u>*

The Performance Peer Group consists of publicly traded staffing and solutions companies that are engaged, or have subsidiaries, divisions or portions of their business engaged, in providing services that are reasonably comparable to Kforce. We utilize the financial performance of the companies included in the Performance Peer Group - or the performance of the portions of these companies that focus in providing services reasonably comparable to Kforce - to assess Kforce's relative performance.

For 2025, the Performance Peer Group consisted of the following companies:

---

| | |
|:---|:---|
| **ASGN Incorporated** | **Randstad AMS** |
| **Korn Ferry** | **Resources Connection, Inc.** |
| **ManpowerGroup Inc.** | **Robert Half Inc.** |

---

As it relates to the 2025 NEO compensation plan, the Performance Peer Group was specifically used to determine the value of equity LTI compensation by comparing Kforce's TSR performance (over a three-year period) to the average TSR performance of the Performance Peer Group.

The Performance Peer Group was not utilized in establishing target levels of compensation as that is the purpose of the Compensation Peer Group.

*<u>Compensation Peer Group</u>*

The Compensation Peer Group is based on a broader set of peers, which are more similar in terms of size (revenue and market capitalization) but may not be in the same industry. The primary objective for peer selection in this group is to benchmark executive compensation levels and gather insights into relevant market practices and trends.

The Committee focuses on selecting peers that are publicly-traded professional staffing, technology solutions providers and human capital centric companies, including certain companies we consider to be our competitors. The Committee also selects peers that are similar in terms of size (as measured by revenue and market capitalization) that are in adjacent markets, but may not be considered a direct business competitor. The Committee reviews the median size of peer companies relative to Kforce's size by balancing the inclusion of both larger and smaller companies.

For 2025, our Compensation Peer Group consisted of the following companies:

---

| | | |
|:---|:---|:---|
| **ASGN Incorporated** | **Huron Consulting Group Inc.** | **Resources Connection, Inc.** |
| **Barrett Business Services, Inc.** | **ICF International, Inc.** | **Robert Half Inc.** |
| **CBIZ, Inc.** | **Kelly Services, Inc.** | **TrueBlue, Inc.** |
| **The Hackett Group, Inc.** | **Korn Ferry** | |
| **Heidrick & Struggles International Inc.** | **ManpowerGroup, Inc.** | |

---

The following table shows the financial statistics for the year ended December 31, 2024 and includes our percentile rank among the Compensation Peer Group:

---

| | | |
|:---|:---|:---|
| **(in thousands, except percentile rank)** | **Revenue** | **Market Capitalization** |
| **25th Percentile** | $1210 | $859 |
| **Median** | $1690 | $1661 |
| **75th Percentile** | $3780 | $3315 |
| **Kforce Inc.** | $**1405** | $**1090** |
| **Percentile Rank** | **31** | **38** |

---

**Consideration of Shareholder Feedback**

We believe shareholder feedback helps to strengthen our corporate governance practices and executive compensation framework. The feedback from both our annual shareholder outreach program, and the results of our advisory votes on executive compensation, enhances our understanding of our shareholders' concerns and areas of focus. We remain committed to open and transparent communication and engagement with our shareholders and taking their feedback into consideration. Our shareholders are invited to communicate with any of our directors, either individually or as a group, by writing to the attention of our Corporate Secretary at Kforce Inc., 1150 Assembly Drive, Suite 500, Tampa, Florida 33607. Such communications will be delivered directly to our Board.

28 Kforce 2026 Proxy Statement

------

<u>[**Table of Contents**](#ibde21b2946834ef1acfb04b1aa73fd7c_16)</u>

Annually, we reach out to our top 25 institutional shareholders, which represent nearly 68% of our shares outstanding, to solicit feedback on various topics, including corporate governance practices, executive compensation programs and ESG efforts, among others. As part of this outreach, we offer conversations with executive management and members of the Board, including the Chairman and Lead Independent Director. We have evolved our corporate governance and compensation programs in recent years based on the feedback received during these outreach efforts and through other ongoing communications.

Over the past several years, our say on pay proposal has received substantial support from our shareholders. The following shows the percentage of votes (excluding brokers non-votes) cast for the advisory vote to approve executive compensation:

![1726](kfrc-20260313_g47.jpg)

**NAMED EXECUTIVE OFFICER COMPENSATION**

**Financial and Operational Summary**

While early 2025 began with optimism around U.S. economic growth and increased investment in technology initiatives, the macro environment remained challenging throughout the year, with significant disruption beginning in April 2025 as a result of global trade policy negotiations and the labor market data continuing to reflect a persistently weak and largely frozen hiring landscape characterized by prolonged stagnation in job gains. We believe the relative impact of AI on our client's technology roadmaps and the effects of a fairly soft economy and weak labor market has created uncertainty, leading many organizations to proceed cautiously in their strategic planning and near-term technology investments. Despite these conditions, our recent operating trends, combined with our historical experience, give us confidence that companies typically turn to flexible talent solutions as an initial step prior to making permanent hires while they assess the durability of the macro environment. The potential use of flexible talent solutions may be further influenced by the growing belief that the returns that will be generated from continuing AI investments may take longer to realize and may be more specific in nature to unique business problems rather than an overarching solution to all technology challenges. Our results in the fourth quarter of 2025 and the relatively stronger start to 2026 suggest greater confidence in the operating environment heading into 2026. We believe clients have maintained a meaningful backlog of strategically essential technology initiatives that they expect to advance once confidence in the macroeconomic outlook improves and their technology roadmaps are better defined.

The following presents our Revenue and Adjusted Diluted Earnings per Share ("EPS") performance over the last three fiscal years.

![1722](kfrc-20260313_g48.jpg)![1723](kfrc-20260313_g49.jpg)

*\*Represents non-GAAP Adjusted Diluted EPS for 2023 and 2024, as previously reported. The reconciliation of 2025 Adjusted Diluted EPS is included in Appendix B to this Proxy Statement.*

29 Kforce 2026 Proxy Statement

------

<u>[**Table of Contents**](#ibde21b2946834ef1acfb04b1aa73fd7c_16)</u>

Revenue for the year ended December 31, 2025 decreased 5% to $1.33 billion, and Adjusted Diluted EPS of $2.09 per share declined 22% year over year. GAAP diluted EPS of $1.96 was adjusted by $0.13 related to the negative impact from organizational realignments and other non-recurring costs, net of income taxes, as detailed in Appendix B. While the Firm continues to operate efficiently, it became clear to us that we needed to adjust our structural costs to align with lower revenue levels without compromising investments in our strategic initiatives. We expect the annualized benefit from these difficult actions to be approximately $7.0 million.

We generated a return on equity of 30% in 2025 and continued our historical practice of returning significant cash to our shareholders. We returned approximately $76.0 million of capital to our shareholders in the form of open market repurchases totaling $48.5 million and quarterly dividends totaling nearly $27.5 million during the year ended December 31, 2025.

Since 2007, we have returned nearly $1.1 billion in capital to our shareholders, which represents approximately 75% of the cash our business has generated during such period. We believe our strong balance sheet and liquidity positions us to continue investing in our strategic priorities even in an uncertain macro environment, which we believe will benefit our shareholders in the long term. We remain confident in our strategic position and our ability to deliver above-market results while continuing to invest in initiatives that drive long-term growth and support our profitability objective of achieving approximately 8% operating margin when annual revenues return to $1.7 billion, which is more than 100 basis points higher than when that level was achieved in 2022.

Our three-year TSR performance (the metric upon which equity LTI payouts are based) was slightly below the average TSR among our Performance Peer Group, which resulted in an equity LTI award for the NEOs that was slightly below Target. The following graph presents the three-year TSR performance of the Performance Peer Group and the comparison of Kforce's three-year average TSR again the average TSR performance of the Performance Peer Group.

![Proxy TSR vs Peer Group.jpg](kfrc-20260313_g50.jpg)

**2025 NEO Compensation Components, Results and Determinations**

The following section discusses the compensation components and results for our NEOs during 2025. The compensation framework was comprised of base salary and performance-based components, including:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Annual incentive compensation, which was based on certain financial metrics (revenue and adjusted diluted EPS) and, to a lesser extent, individual NEO MBOs; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Equity LTI compensation was based on Kforce's three-year TSR performance relative to the average TSR of the Performance Peer Group.

30 Kforce 2026 Proxy Statement

------

<u>[**Table of Contents**](#ibde21b2946834ef1acfb04b1aa73fd7c_16)</u>

The Committee emphasizes the use of variable performance-based compensation over fixed compensation to effectively motivate our NEOs to drive operational performance. The following charts show fixed compensation (equal to salary) and the performance-based compensation components, each as a percentage of total direct compensation (TDC) for the CEO and for the other NEOs in the aggregate for 2025. We define TDC as the amount of total compensation derived from salary, annual incentives and equity LTI.

**2025 COMPENSATION AT TARGET**<br>

![1028](kfrc-20260313_g51.jpg)![1029](kfrc-20260313_g52.jpg)

The charts below summarize the actual outcomes for 2025, which show:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The 2025 financial performance resulted in no revenue incentive payout and a below target EPS annual incentive payout, and near maximum attainment of individual MBOs.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Grant of LTIs that was slightly below target due to Kforce's three-year TSR falling slightly below the average TSR of the Performance Peer Group.

**2025 ACTUAL COMPENSATION PAYOUTS**<br>

![1408](kfrc-20260313_g53.jpg)![1409](kfrc-20260313_g54.jpg)

We discuss each compensation component separately below in more detail.

31 Kforce 2026 Proxy Statement

------

<u>[**Table of Contents**](#ibde21b2946834ef1acfb04b1aa73fd7c_16)</u>

***<u>Salary</u>***

The Committee's desire is to target salaries at the market median. The following table shows each NEO's salary for 2025 and 2024:

---

| | | | |
|:---|:---|:---|:---|
| **Name** | **2025 Salary** | **2024 Salary** | **Percentage Increase** |
| **Joseph J. Liberatore** | $925000 | $875000 | 6% |
| **David M. Kelly** | $650000 | $540000 | 20% |
| **Jeffrey B. Hackman** | $500000 | $400000 | 25% |
| **Andrew G. Thomas** | $425000 | $400000 | 6% |

---

Messrs. Kelly and Hackman had not received a base salary increase since 2022, despite their promotions to COO and CFO, respectively, in September 2023. The salary adjustments reflect the expanded responsibilities associated with their new roles, their expected future contributions, and their depth of experience. The most recent base salary increases for Messrs. Liberatore and Thomas occurred in 2023 and 2022, respectively. In consultation with Pay Governance, the Committee considered comparative market data from our Compensation Peer Group to ensure their compensation remained competitive and appropriately aligned with external benchmarks.

***<u>Annual Incentive Compensation</u>***

Annual incentive compensation for 2025 was targeted at the median of our Compensation Peer Group. Actual payout levels of the annual incentive awards may be above or below target based on actual performance. In addition, our annual incentive awards require minimum performance thresholds for any payout to occur for specific performance measures and objectives. We believe the annual incentive effectively motivates our NEOs to drive operational performance without encouraging unreasonable risk. The Committee believes the achievement of year-over-year revenue growth and adjusted diluted EPS goals, when combined with other individual objectives, will result in sustainable long-term shareholder value creation.

The annual incentive compensation for our NEOs for 2025 consisted of the following performance-based components:

1. A financial metric incentive (the Financial Performance Incentive). The 2025 Financial Performance Incentive represented 70% of the total target incentive award and was based on pre-determined levels of revenue growth and EPS performance. Revenue and EPS incentives continue to be the metrics we believe best demonstrate our annual progression towards generating long-term shareholder value and align to our profitability objectives of achieving double digit operating margins and returning significant capital to our shareholders.

2. An objectives-based incentive (the MBO Incentive) for individual accomplishments and management business objectives. The MBO Incentive represented 30% of the total target incentive award, which represents an increase from 20% in the 2024 NEO compensation plan. This weighting increase was based upon a market benchmarking study conducted by Pay Governance.

Each of the above components is calculated as follows: (Salary) x (Target Annual Incentive Percentage) x (Target Annual Incentive Allocation Percentage) x (Payout Percentage of Target).

The Target Annual Incentive Percentage and Allocation across each component is shown below.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | | **2025 Annual Incentive** | **2025 Target Annual Incentive Allocation** | **2025 Target Annual Incentive Allocation** | **2025 Target Annual Incentive Allocation** |
|<br>**Name** |<br>**2025 Salary** | **%** | **Revenue<br>(20%)** | **EPS<br>(50%)** | **MBO<br>(30%)** |
| **Joseph J. Liberatore** | $925000 | 125% | $231250 | $578125 | $346875 |
| **David M. Kelly** | $650000 | 100% | $130000 | $325000 | $195000 |
| **Jeffrey B. Hackman** | $500000 | 90% | $90000 | $225000 | $135000 |
| **Andrew G. Thomas** | $425000 | 90% | $76500 | $191250 | $114750 |

---

32 Kforce 2026 Proxy Statement

------

<u>[**Table of Contents**](#ibde21b2946834ef1acfb04b1aa73fd7c_16)</u>

The following table provides the potential Financial Performance Incentive payout ranges as determined by the Committee, based on Revenue and adjusted diluted EPS. In determining the 2025 objectives for Revenue and adjusted diluted EPS, the Committee referenced a combination of average market growth rates in the staffing industry and average expectations among our Compensation Peer Group, along with analyst consensus expectations for Kforce.

Revenue and Adjusted Diluted EPS amounts and the related year-over-year changes at Threshold, Target and Maximum performance levels are shown, and the levels between Threshold, Target and Maximum are interpolated.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Revenue (in millions)** | **Revenue Year-over-Year Growth** <sup>(1)</sup> | **Payout %<br>of Target** | **Adjusted Diluted EPS** | **Year-over-Year Change** | **Payout %<br>of Target** |
| **Threshold** | $1400 | —% | 25% | $2.28 | (15)% | 25% |
| **Target** | $1442 | 3% | 100% | $2.68 | —% | 100% |
| **Maximum** | $1484 | 6% | 200% | $3.08 | 15% | 200% |

---

<sup>(1)</sup> Consistent with historical practice, we have taken a market-based approach to establishing target year-over-year revenue growth performance levels. Maximum revenue growth levels are two times target market-based growth, and threshold levels represent flat year-over-year revenue growth due to our historical compensation philosophy of not paying our NEOs for negative revenue growth.

When establishing the 2025 performance objectives, the Committee considered the prevailing macroeconomic environment, the demand backdrop in the technology staffing and services sector, and external market expectations, including Staffing Industry Analyst (SIA) and other industry analyst consensus expectations. At the time targets were set, the Firm, and the broader industry, had experienced a prolonged period of year-over-year revenue declines, and external forecasts reflected continued uncertainty regarding the pace and timing of recovery.

The Committee maintained a rigorous pay-for-performance structure with meaningful performance leverage and clear differentiation across threshold, target, and maximum outcomes. The Committee also continued to emphasize metrics that align with sustained value creation, including revenue performance and profitability (adjusted diluted EPS). Additionally, the plan design preserved downside protection through minimum performance requirements such that payouts would not occur absent achievement of specified threshold levels. The Committee believes this approach balanced appropriate rigor with realistic goal-setting, supported strong motivational value, and maintained alignment between incentives, operating performance, and shareholder outcomes.

For 2025, we achieved revenue of $1.33 billion, which fell below threshold levels and resulted in no revenue incentive payout being achieved. In addition, we achieved adjusted diluted EPS of $2.09 for 2025. In assessing EPS attainment for 2025 for purposes of the Financial Performance Incentive, the Committee considered the unanticipated negative impact that the Federal Government disruption (ex. Department of Government Efficiency ("DOGE"), U.S. tariffs, U.S. government shutdown) had on the Firm in addition to certain other items (that were both positive and negative impacts). The Committee approved EPS attainment of $2.53, a $0.44 difference, which is between threshold and target levels (resulting in a 67% payout for the EPS metric). The Committee believes this EPS attainment was a more accurate representation of performance because of certain unique circumstances that were outside of the Firm's control and unknown at the time of the approval of the plan. See Appendix B for a quantitative reconciliation.

For purposes of the MBO Incentive, the Committee considers each individual's accomplishments based on pre-established management business objectives and overall operational performance. As with the Financial Performance Incentive goals, the Committee strives to establish individual goals at levels intended to effectively motivate superior operational performance and advance the strategies of the Firm without encouraging unreasonable risk.

The 2025 MBO Incentive for the NEOs, as described previously, was primarily focused on our multi-year strategic objectives: (i) the implementation of Workday as our future state enterprise cloud application for HCM and financials, (ii) our integrated strategy efforts, (iii) the evolution of our offshore delivery capability in Pune, India, and (iv) advancing our Firm's strategies through leverage of AI. The 2025 MBO Incentive also included various individual objectives for each NEO outside of the Firm's strategic objectives. In 2025, as described earlier in the CD&A, our NEOs significantly advanced each of our multi-year transformational strategic initiatives while delivering strong relative financial performance, including our top-tier Technology organic revenue performance compared to our most comparable publicly-traded peers. Our NEOs also took decisive actions to navigate the challenges posed by lower revenue and profitability levels, ensuring the business remained resilient and positioned for long-term value creation.

Due to the aforementioned items, the Committee approved the MBO Incentive payout at 185% for the NEOs for the year ended December 31, 2025. When taken together with 0% and 67% being earned for the Revenue and EPS components, respectively, and, as a result, overall annual incentive compensation was below target levels (89% of target) for the NEOs.

33 Kforce 2026 Proxy Statement

------

<u>[**Table of Contents**](#ibde21b2946834ef1acfb04b1aa73fd7c_16)</u>

The annual incentives earned in 2025 for each NEO is shown in the table below:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | | **2025 Attainment as a % of Target** | **2025 Attainment as a % of Target** | **2025 Attainment as a % of Target** | **2025 Incentive Payouts** | **2025 Incentive Payouts** | **2025 Incentive Payouts** | **2025 Incentive Payouts** |
|<br>**Name** |<br> **Target<br>Annual Incentive** | **Revenue<br>(20%)** | **EPS<br>(50%)** | **MBO<br>(30%)** | **Revenue** | **EPS** | **MBO** | **Total** |
| **Joseph J. Liberatore** | $1156250 | —% | 67% | 185% | $— | $387344 | $641719 | $1029063 |
| **David M. Kelly** | $650000 | —% | 67% | 185% | $— | $217750 | $360750 | $578500 |
| **Jeffrey B. Hackman** | $450000 | —% | 67% | 185% | $— | $150750 | $249750 | $400500 |
| **Andrew G. Thomas** | $382500 | —% | 67% | 185% | $— | $128138 | $212288 | $340426 |

---

The increase in Target Annual Incentive for Messrs. Liberatore, Kelly, Hackman and Thomas are directly related to the increase in base salaries for 2025, as noted above.

***<u>Equity Long-Term Incentive</u>***

Equity LTI awards are 100% performance based, and our LTI performance objectives are set to align executive and shareholder interests. Actual payout levels for the equity LTI may be above or below target based on actual performance and require minimum performance thresholds for any payout to occur. Equity LTI awards for performance relative to our Performance Peer Group, after having been deemed achieved based on our relative performance, are awarded by the Committee in the form of a restricted stock grant that has three to four-year time-based vesting periods.

The equity LTI compensation was based on three-year TSR performance (January 1, 2023 to December 31, 2025) relative to our Performance Peer Group. The following table shows the dollar value of the equity LTI grant for each of the NEOs at threshold, target and max based on our TSR performance versus the average TSR of the Performance Peer Group:

---

| | | | |
|:---|:---|:---|:---|
| **Name** | **Threshold** | **Target** | **Max** |
| **Joseph J. Liberatore** | $1625000 | $3250000 | $4875000 |
| **David M. Kelly** | $750000 | $1500000 | $2250000 |
| **Jeffrey B. Hackman** | $588000 | $1175000 | $1763000 |
| **Andrew G. Thomas** | $350000 | $700000 | $1050000 |

---

Payout with respect to our three-year TSR performance compared to the average three-year TSR of the Performance Peer Group is determined as the absolute mathematical difference between our TSR performance percentage and the average percentage of TSR of the Performance Peer Group on an interpolated basis:

---

| | |
|:---|:---|
| **Three-Year TSR Performance** | **TSR Performance Payout Percentage** |
| More than 25% below the average TSR for the Performance Peer Group | —% |
| 25% below the average TSR for the Performance Peer Group | 50% (Threshold) |
| 0% difference between the average TSR for the Performance Peer Group | 100% (Target) |
| 25% or more above the average TSR for the Performance Peer Group | 150% (Max) |

---

The table below illustrates the key performance results and resulting grant information for the 2025 LTI awards:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Measurement Period** | **Kforce TSR Performance** | **Average TSR Performance of Performance Peer Group** | **Result** | **Grant Date of Restricted Stock Award** | **Grant Date Closing Stock Price** |
| 2023-2025 | (38.1)% | (37.6)% | (0.5)% - Below Target | 12/31/2025 | $30.92 |

---

The table below illustrates the equity LTI awards, including the number of shares and the grant date fair value. Having made equity grants based upon attainment of performance criteria, the Committee believes the restricted stock awards' additional time-based vesting requirements further align compensation with our long-term performance and our shareholders' interests, and also act as a significant retention vehicle for these executives.

---

| | | | |
|:---|:---|:---|:---|
| **Name** | **Type of Award** | **# of Shares** | **Grant Date Fair Value** |
| **Joseph J. Liberatore** | Annual LTI | 104059 | $3217504 |
| **David M. Kelly** | Annual LTI | 48027 | $1484995 |
| **Jeffrey B. Hackman** | Annual LTI | 37622 | $1163272 |
| **Andrew G. Thomas** | Annual LTI | 22413 | $693010 |

---

34 Kforce 2026 Proxy Statement

------

<u>[**Table of Contents**](#ibde21b2946834ef1acfb04b1aa73fd7c_16)</u>

**Other Compensation Practices, Policies and Information**

The following benefit plans and other items discussed below are available to our NEOs. The Committee considers the benefits expected to be received under the plans described below when determining overall compensation for our executives.

---

| | |
|:---|:---|
| ***Kforce Nonqualified Deferred Compensation Plan*** | Kforce maintains a nonqualified deferred compensation plan in which eligible management and highly compensated key employees, as defined by IRS regulations, may elect to defer all or part of their compensation to later years. Amounts deferred are indexed to investment options selected by the eligible employees, and the increase or decrease in value is based upon the performance of the selected investments. Eligible employees are permitted to change investment options and scheduled distributions annually. Kforce has insured the lives of certain participants in the deferred compensation plan to assist in the funding of the deferred compensation liability. Employer matching contributions to the nonqualified deferred compensation plan are discretionary and are funded annually, as approved by the Board. |

---

---

| | |
|:---|:---|
| ***Employment, Severance and Change in Control Agreements*** | Kforce has employment agreements in place with each of its NEOs that provide severance benefits under specified termination scenarios, including termination following a change in control, as defined in those employment agreements. The Committee believes these arrangements serve the best interests of Kforce and its shareholders by supporting the retention of key leadership and recognizing the critical contributions of the NEOs. The specific amounts the NEOs would receive under the employment agreements are described in the "Potential Payments Upon Termination or Change in Control" section of this Proxy Statement below. The Committee believes the employment agreements are an essential component of the executive compensation program and are helpful in attracting and retaining executive talent in a competitive market. The Committee periodically evaluates the benefits provided under the employment agreements to ensure they continue to support Kforce's retention objectives, remain aligned with market practice, and are reasonable.<br>In 2009, the Committee resolved to not enter into any new employment agreements, or materially amend any existing employment agreements with its executives, that contain excise tax gross-up provisions going forward. In 2017, the Committee resolved to not enter into any new employment agreements, or materially amend any existing employment agreements with its executives, that contain provisions for severance payments that exceed 1x cash compensation or change in control severance payments that exceed 2x cash compensation. Mr. Liberatore is the only NEO with an employment agreement containing an excise tax gross-up provision and provisions for severance payment of 2.00 times cash compensation and change in control severance payment of 2.99 times cash compensation, since his agreement was executed in December 2006. |

---

---

| | |
|:---|:---|
| ***Perquisites and Other Personal Benefits*** | Kforce does not provide perquisites or other personal benefits to its NEOs. |

---

35 Kforce 2026 Proxy Statement

------

<u>[**Table of Contents**](#ibde21b2946834ef1acfb04b1aa73fd7c_16)</u>

**EXECUTIVE COMPENSATION TABLES**

**SUMMARY COMPENSATION TABLE (SCT)**

***For Fiscal Years Ended December 31, 2025, 2024 and 2023***

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Name and Principal Position** | **Year** | **Salary** | **Stock**<br>**Awards** <sup>(1)</sup>  | **Non-Equity**<br>**Incentive Plan**<br>**Compensation** <sup>(2) (3)</sup>  | **All Other**<br>**Compensation** <sup>(4)</sup>  | **Total** |
| **Joseph J. Liberatore** | 2025 | $925000 | $3217504 | $1029063 | $244254 | $5415821 |
| Chief Executive Officer | 2024 | $875000 | $2699997 | $393750 | $237077 | $4205824 |
|  | 2023 | $875000 | $3034998 | $437500 | $224328 | $4571826 |
| **David M. Kelly** | 2025 | $650000 | $1484995 | $578500 | $85968 | $2799463 |
| Chief Operating Officer | 2024 | $540000 | $1206009 | $194400 | $82828 | $2023237 |
|  | 2023 | $540000 | $1130009 | $194400 | $85339 | $1949748 |
| **Jeffrey B. Hackman** | 2025 | $500000 | $1163272 | $400500 | $50391 | $2114163 |
| Chief Financial Officer | 2024 | $400000 | $819995 | $129600 | $41998 | $1391593 |
|  | 2023 | $400000 | $452517 | $144000 | $43654 | $1040171 |
| **Andrew G. Thomas** | 2025 | $425000 | $693010 | $340426 | $48068 | $1506504 |
| Chief Experience Officer | 2024 | $400000 | $639973 | $129600 | $43219 | $1212792 |
|  | 2023 | $400000 | $520009 | $144000 | $44810 | $1108819 |

---

<sup>(1)</sup> The amounts in this column represent the aggregate grant date fair value in accordance with FASB ASC 718.

<sup>(2)</sup> Represents annual incentive compensation earned by the NEOs.

<sup>(3)</sup> For 2023, in order to further align compensation with our shareholders' interests, the MBO Incentive portion of the non-equity incentive plan compensation was awarded in stock on December 31, 2023 and vest(ed) equally on December 27, 2024, 2025, 2026 and 2027. The fair market value of restricted stock was determined based on the closing stock price of Kforce's common stock on the date of grant.

<sup>(4)</sup> The "All Other Compensation" column for 2025 includes:

---

| | | | |
|:---|:---|:---|:---|
| **Name** | **Dividends** <sup>(a)</sup>  | **Defined Contribution Plans** <sup>(b)</sup>  | **Total** |
| **Joseph J. Liberatore** | $244254 | $— | $244254 |
| **David M. Kelly** | $82493 | $3475 | $85968 |
| **Jeffrey B. Hackman** | $48041 | $2350 | $50391 |
| **Andrew G. Thomas** | $45718 | $2350 | $48068 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<sup>(a)</sup> This column reflects the value of dividend equivalents issued on unvested restricted stock in the form of additional shares of restricted stock.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<sup>(b)</sup> This column reflects the value of employer matching contributions attributable to our defined contribution 401(k) plan.

36 Kforce 2026 Proxy Statement

------

<u>[**Table of Contents**](#ibde21b2946834ef1acfb04b1aa73fd7c_16)</u>

**OUTSTANDING EQUITY AWARDS AT FISCAL YEAR-END**

***At Fiscal Year Ended December 31, 2025***

---

| | | | |
|:---|:---|:---|:---|
| | **Restricted Stock Awards** | **Restricted Stock Awards** | **Restricted Stock Awards** |
|<br>**Name** | **Unvested Shares** | | **Market Value of Unvested Shares ($)** <sup>(1)</sup> |
| **Joseph J. Liberatore** | 104059 | <sup>(2)</sup> | $3217504 |
|  | 37290 | <sup>(4)</sup> | $1153007 |
|  | 27492 | <sup>(5)</sup> | $850053 |
|  | 13973 | <sup>(6)</sup> | $432045 |
|  | 33399 | <sup>(8)</sup> | $1032697 |
| **David M. Kelly** | 48027 | <sup>(3)</sup> | $1484995 |
|  | 16658 | <sup>(4)</sup> | $515065 |
|  | 10485 | <sup>(5)</sup> | $324196 |
|  | 4498 | <sup>(6)</sup> | $139078 |
|  | 2968 | <sup>(7)</sup> | $91771 |
| **Jeffrey B. Hackman** | 37622 | <sup>(3)</sup> | $1163272 |
|  | 11325 | <sup>(4)</sup> | $350169 |
|  | 4724 | <sup>(5)</sup> | $146066 |
|  | 2309 | <sup>(6)</sup> | $71394 |
|  | 2968 | <sup>(7)</sup> | $91771 |
| **Andrew G. Thomas** | 22413 | <sup>(3)</sup> | $693010 |
|  | 8840 | <sup>(4)</sup> | $273333 |
|  | 5256 | <sup>(5)</sup> | $162516 |
|  | 2701 | <sup>(6)</sup> | $83515 |
|  | 2968 | <sup>(7)</sup> | $91771 |

---

<sup>(1)</sup> Amounts in this column are calculated using a market value of $30.92 per share, which was the closing stock price on December 31, 2025.

<sup>(2)</sup> With respect to the restricted stock granted to Mr. Liberatore on December 31, 2025, 33.33% of the total shares granted vest on: December 27, 2026, 2027 and 2028.

<sup>(3)</sup> With respect to the restricted stock granted to Messrs. Kelly, Hackman and Thomas on December 31, 2025, 25% of the total shares granted vest on: December 27, 2026, 2027, 2028 and 2029.

 <sup>(4)</sup> With respect to the restricted stock granted to Messrs. Liberatore, Kelly, Hackman and Thomas on December 31, 2024, and the associated dividend equivalents, 25% of the total shares granted vest(ed) on: December 27, 2025, 2026, 2027 and 2028.

<sup>(5)</sup> With respect to the restricted stock granted to Messrs. Liberatore, Kelly, Hackman and Thomas on December 31, 2023, and the associated dividend equivalents, 25% of the total shares granted vest(ed) on: December 27, 2024, 2025, 2026 and 2027.

<sup>(6)</sup> With respect to the restricted stock granted to Messrs. Liberatore, Kelly, Hackman and Thomas on December 31, 2022, and the associated dividend equivalents, 25% of the total shares granted vest(ed) on: December 27, 2023, 2024, 2025 and 2026.

<sup>(7)</sup> For the Special Leadership restricted stock award granted to Messrs. Kelly, Hackman and Thomas on December 31, 2021, and the associated dividend equivalents, 25% of the total shares granted vest on December 27, 2026 and 2027, and the remaining 50% vest on December 27, 2028.

<sup>(8)</sup> With respect to the restricted stock award granted to Mr. Liberatore on December 31, 2021, and the associated dividend equivalents, 100% of the total shares granted will vest on December 27, 2026.

37 Kforce 2026 Proxy Statement

------

<u>[**Table of Contents**](#ibde21b2946834ef1acfb04b1aa73fd7c_16)</u>

**GRANTS OF PLAN-BASED AWARDS**

***For Fiscal Year Ended December 31, 2025***

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Name** | **Type of Award** | **Date Plan Approved** | **Grant Date** | **Estimated Future Payouts Under<br> Non-Equity Incentive Plan Awards** | **Estimated Future Payouts Under<br> Non-Equity Incentive Plan Awards** | **Estimated Future Payouts Under<br> Non-Equity Incentive Plan Awards** | **All Other Stock Awards No. of Shares of Stock** | **Grant Date<br>Fair Value** |
| **Name** | **Type of Award** | **Date Plan Approved** | **Grant Date** | **Threshold<br>($)** | **Target<br>($)** | **Maximum<br>($)** | **All Other Stock Awards No. of Shares of Stock** | **Grant Date<br>Fair Value** |
| **Joseph J. Liberatore** | Annual Incentive <sup>(1)</sup> | 1/30/2025 |  | $289063 | $1156250 | $2312500 |  | $— |
| **Joseph J. Liberatore** | Equity LTI <sup>(2)</sup> | 1/30/2025 | 12/31/2025 | $— | $— | $— | 104059 | $3217504 |
| **David M. Kelly** | Annual Incentive <sup>(1)</sup> | 1/30/2025 |  | $162500 | $650000 | $1300000 |  | $— |
| **David M. Kelly** | Equity LTI <sup>(2)</sup> | 1/30/2025 | 12/31/2025 | $— | $— | $— | 48027 | $1484995 |
| **Jeffrey B. Hackman** | Annual Incentive <sup>(1)</sup> | 1/30/2025 |  | $112500 | $450000 | $900000 |  | $— |
| **Jeffrey B. Hackman** | Equity LTI <sup>(2)</sup> | 1/30/2025 | 12/31/2025 | $— | $— | $— | 37622 | $1163272 |
| **Andrew G. Thomas** | Annual Incentive <sup>(1)</sup> | 1/30/2025 |  | $95625 | $382500 | $765000 |  | $— |
| **Andrew G. Thomas** | Equity LTI <sup>(2)</sup> | 1/30/2025 | 12/31/2025 | $— | $— | $— | 22413 | $693010 |

---

<sup>(1)</sup> These amounts represent the estimated payouts under the 2025 annual incentive compensation plan. The threshold, as defined in Item 402(d) of Regulation S-K, represents the minimum amount payable upon attaining minimum performance thresholds established by the Committee each year. If the minimum performance thresholds are not attained, there would be no payout. The maximum payout is 200% of the target multiplier for all components of the 2025 annual incentive compensation plan. Actual payments for annual incentive compensation earned during 2025 are listed in the "Non-Equity Incentive Plan Compensation" column of the SCT.

<sup>(2)</sup> The performance based equity LTI awards granted in the form of restricted stock under the 2025 Stock Incentive Plan on December 31, 2025 had a three-year or four-year vesting period, vesting equally on an annual basis. Restricted stock awards contain the right to forfeitable dividends in the form of additional shares of restricted stock at the same rate as the cash dividend on common stock and containing the same vesting provisions as the underlying award. The fair market value of restricted stock is determined based on the closing stock price of Kforce's common stock on the date of grant. The stock price and grant date fair value for these awards was $30.92, which was the closing stock price on December 31, 2025. The aggregate grant date fair value of the awards is included within the amounts presented in the "Stock Awards" column of the SCT.

**OPTION EXERCISES AND STOCK VESTED**

***For Fiscal Year Ended December 31, 2025***

---

| | | |
|:---|:---|:---|
| | **Stock Awards** <sup>(1)</sup>  | **Stock Awards** <sup>(1)</sup>  |
|<br>**Name** | **Number of Shares<br>Acquired on Vesting** | **Value Realized**<br>**on Vesting** <sup>(2)</sup>  |
| **Joseph J. Liberatore** | 49060 | $1540975 |
| **David M. Kelly** | 19861 | $623834 |
| **Jeffrey B. Hackman** | 11829 | $391145 |
| **Andrew G. Thomas** | 10444 | $328046 |

---

<sup>(1)</sup> This represents the vesting of restricted stock awards only. Kforce generally does not grant stock options, and there were no stock option awards outstanding as of and for the year ended December 31, 2025.

<sup>(2)</sup> The value realized for Kforce restricted stock vesting represents the market value of Kforce common stock at the time of vesting multiplied by the number of shares vested.

38 Kforce 2026 Proxy Statement

------

<u>[**Table of Contents**](#ibde21b2946834ef1acfb04b1aa73fd7c_16)</u>

**NONQUALIFIED DEFERRED COMPENSATION**

***For Fiscal Year Ended December 31, 2025***

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Name** | **Executive**<br>**Contributions**<br>**in Last FY** <sup>(1)</sup> <br>**($)** | **Registrant<br>Contributions<br>in Last FY <br>($)** | **Aggregate**<br>**Earnings**<br>**in Last FY** <sup>(2)</sup><br>**($)** | **Aggregate<br>Withdrawals/<br>Distributions <br>($)** | **Aggregate**<br>**Balance**<br>**at Last FYE** <sup>(3)</sup><br>**($)** |
| **Joseph J. Liberatore** | $— | $— | $— | $— | $— |
| **David M. Kelly** | $— | $— | $— | $— | $— |
| **Jeffrey B. Hackman** | $— | $— | $— | $— | $— |
| **Andrew G. Thomas** | $— | $— | $227870 | $— | $1315650 |

---

<sup>(1)</sup> None of our NEOs participated in Kforce's nonqualified deferred compensation plan during 2025.

<sup>(2)</sup> The aggregate earnings for 2025 represents appreciation or depreciation in the market value of the respective accounts' holdings and interest and dividends generated thereon. These amounts were not reported in the "Nonqualified Deferred Compensation" column of the SCT for 2025 as there were no above-market or preferential earnings generated.

<sup>(3)</sup> The aggregate balance includes amounts related to employer contributions made by Kforce that were previously reported in the SCTs for prior years.

39 Kforce 2026 Proxy Statement

------

<u>[**Table of Contents**](#ibde21b2946834ef1acfb04b1aa73fd7c_16)</u>

**POTENTIAL PAYMENTS UPON TERMINATION OR CHANGE IN CONTROL**

This section describes amounts that would have been payable to the NEOs for various service termination or change in control (CIC) scenarios on December 31, 2025.

***NEOs***

In 2009, the Committee resolved to not enter into any new employment agreements or materially amend any existing employment agreements with its executives that contain excise tax gross-up provisions going forward. In 2017, the Committee resolved not to enter into any new employment agreements, or materially amend any existing employment agreements, with its executives that contain provisions for severance payments that exceed 1x cash compensation or change in control severance payments that exceed 2x cash compensation. Mr. Liberatore is the only NEO with an employment agreement containing an excise tax gross-up provision and provisions for severance payment of 2.00 times cash compensation and change in control severance payment of 2.99 times cash compensation, since his agreement was executed in December 2006.

The employment agreements for each NEO have been publicly filed and condition the receipt of certain severance and CIC benefits based on confidentiality and client and employee non-solicitation provisions, as specified in those agreements; the typical length of the non-solicitation restrictions is two years. In addition, the Firm's standard severance and release agreements condition the receipt of severance benefits on continuing to honor these restrictions; these severance agreements also include standard non-disparagement clauses.

***Employment Agreement Severance Based on Termination By Employer For Cause or By Employee Without Good Reason***

Pursuant to the provisions of each NEO's respective employment agreement, upon a termination either by the employer for cause or by the employee without good reason, the NEOs would be eligible to receive all earned and accrued salary, annual incentive and employee benefits such as paid-time off, as of the termination date and would also have the ability to exercise, if necessary, all plan-based awards that were vested as of the termination date. Under this scenario, none of the NEOs would be eligible for a severance payment or accelerated vesting of any unvested equity awards. As a result, a column for this scenario has been omitted from the table below.

***Employment Agreement Severance Based on Termination By Employer Without Cause or By Employee For Good Reason***

Pursuant to the provisions of each NEO's respective employment agreement, upon a termination by the employer without cause or by the employee for good reason, the NEO would be eligible for a severance payment. For Mr. Liberatore, the severance is calculated using a factor of 2.00 times the sum of his salary on the date of termination plus the average of his cash bonus over a period of two years. For Messrs. Kelly and Thomas, the severance is calculated as the sum of their salaries on the date of termination plus (1) the average of their cash bonuses over a period of two years and (2) the lesser of the average value of any stock, restricted stock, stock appreciation rights or alternative LTI over a period of two years, or $200,000. For Mr. Hackman, the severance is calculated as the sum of his salary on the date of termination plus the average of his cash bonus over a period of two years.

***Employment Agreement Severance Based on Termination By Employer Without Cause or By Employee For Good Reason - Following a Change in Control***

Pursuant to the provisions of each NEO's respective employment agreement, upon a termination by the employer without cause or by the employee for good reason following a CIC, the NEO would be eligible for a severance payment, calculated differently from the scenario directly above. For Mr. Liberatore, the severance is calculated using a factor of 2.99 and applying it to the sum of his salary on the date of termination plus the average of his cash bonus and the value of any stock, restricted stock or stock options over a period of three years. For Messrs. Kelly and Thomas, the severance is calculated using a factor of 2.00 times the sum of their salaries on the date of termination plus (1) the average of their cash bonuses over a period of two years and (2) the average value of any stock, restricted stock, stock appreciation rights or alternative LTI over a period of two years. For Mr. Hackman, the severance is calculated using a factor of 1.50 times the sum of his salary on the date of termination plus the average of his cash bonuses over a period of two years.

Pursuant to the provisions of each NEO's respective employment agreement, upon a termination by the employer without cause or by the employee for good reason following a CIC, the NEO would be eligible for a continuation of healthcare benefits. After the termination date, the benefits shall continue for a period of three years for Mr. Liberatore; two years for Messrs. Kelly and Thomas; and one year for Mr. Hackman.

Pursuant to the terms of all of the NEOs' outstanding restricted stock award agreements, the remaining unvested restricted stock would immediately vest upon a CIC.

***Change in Control***

Pursuant to the provisions of each NEO's respective employment agreement, there would be no severance payment subsequent to a CIC in the absence of a termination.

40 Kforce 2026 Proxy Statement

------

<u>[**Table of Contents**](#ibde21b2946834ef1acfb04b1aa73fd7c_16)</u>

Pursuant to the terms of all of the NEOs' outstanding restricted stock award agreements, the remaining unvested restricted stock would immediately vest upon a CIC.

***Death or Disability***

Pursuant to the provisions of each NEO's respective employment agreement, none of the NEOs would be eligible for a severance payment upon death or disability.

Each of the respective employment agreements for our NEOs provides for a continuation of salary and healthcare benefits under certain situations. Upon death, the NEO's beneficiary would continue to receive the NEO's salary and benefits for a period of time (2.99 years for Mr. Liberatore and one year for Messrs. Kelly and Thomas). Mr. Hackman's beneficiary would not receive any additional salary or benefits upon death. Upon disability, the NEO's salary and benefits would be continued until the earlier of (1) death, (2) the NEO's 65<sup>th</sup> birthday or (3) 2.99 years for Mr. Liberatore and two years for Messrs. Kelly and Thomas. Mr. Hackman would not receive any additional salary or benefits upon disability.

Pursuant to the terms of all of the NEOs' outstanding restricted stock award agreements, all unvested restricted stock would immediately vest upon death or disability.

***Retirement***

Pursuant to the provisions of each NEO's respective employment agreement, none of the NEOs would be eligible for a severance payment upon retirement.

Pursuant to the terms of all of the NEOs' outstanding restricted stock award agreements, there would be no accelerated vesting of any unvested equity awards.

***Potential Payments***

The table on the following page displays the amounts that would have been payable to the NEOs for various service termination or CIC scenarios on December 31, 2025. The amounts that would actually be payable to the NEOs, if employment termination or a CIC were to occur in the future, would be different than those set forth in the table below, which are calculated under the assumption that the event occurred on December 31, 2025 and based on the closing price of Kforce's common stock on the last trading day of the year. We note that such payments are contingent upon various factors in place at the time of the occurrence of the assumed event, including, but not limited to: each NEO's current salary rate; annual incentive awards and equity LTI; the amount and type of unvested equity and other incentive awards held by the NEO; the trading price of Kforce's common stock; the cost of providing employee benefits; the NEO's elections of employee benefits; the NEO's age and/or years of service with Kforce; the date of termination; the circumstances of the termination; and the NEO's historical salary, annual cash incentives and equity LTI.

41 Kforce 2026 Proxy Statement

------

<u>[**Table of Contents**](#ibde21b2946834ef1acfb04b1aa73fd7c_16)</u>

**POTENTIAL PAYMENTS UPON TERMINATION OR CHANGE IN CONTROL TABLE**

***At Fiscal Year Ended December 31, 2025***

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Name** | **Retirement** | **Termination By Employer Without Cause or By Employee For Good Reason** | **Following CIC - Termination By Employer Without Cause or By Employee For Good Reason** | **CIC - No Termination** | **Death** | **Disability** |
| **Joseph J. Liberatore** | | | | | | |
| &nbsp;&nbsp;Severance payment <sup>(</sup><sup>1</sup><sup>)</sup> | $— | $3272813 | $18086837 | $— | $— | $— |
| &nbsp;&nbsp;Equity-based compensation <sup>(2)</sup> |  |  | 6685306 | 6685306 | 6685306 | 6685306 |
| &nbsp;&nbsp;Continuation of base salary <sup>(3)</sup> |  |  |  |  | 2567962 | 2567962 |
| &nbsp;&nbsp;Continuation of health benefits <sup>(4)</sup> |  |  | 26205 |  | 26205 | 26205 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | $— | $3272813 | $24798348 | $6685306 | $9279473 | $9279473 |
| **David M. Kelly** |  |  |  |  |  |  |
| &nbsp;&nbsp;Severance payment <sup>(</sup><sup>1</sup><sup>)</sup> | $— | $1236450 | $4763904 | $— | $— | $— |
| &nbsp;&nbsp;Equity-based compensation <sup>(2)</sup> |  |  | 2555105 | 2555105 | 2555105 | 2555105 |
| &nbsp;&nbsp;Continuation of base salary <sup>(3)</sup> |  |  |  |  | 632383 | 1233368 |
| &nbsp;&nbsp;Continuation of health benefits <sup>(</sup><sup>4</sup><sup>)</sup>  |  |  | 18160 |  | 9185 | 18160 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | $— | $1236450 | $7337169 | $2555105 | $3196673 | $3806633 |
| **Jeffrey B. Hackman** |  |  |  |  |  |  |
| &nbsp;&nbsp;Severance payment <sup>(</sup><sup>1</sup><sup>)</sup> | $— | $765050 | $1147575 | $— | $— | $— |
| &nbsp;&nbsp;Equity-based compensation <sup>(2)</sup> |  |  | 1822672 | 1822672 | 1822672 | 1822672 |
| &nbsp;&nbsp;Continuation of base salary <sup>(3)</sup> |  |  |  |  |  |  |
| &nbsp;&nbsp;Continuation of health benefits <sup>(</sup><sup>4</sup><sup>)</sup>  |  |  | 9468 |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | $— | $765050 | $2979715 | $1822672 | $1822672 | $1822672 |
| **Andrew G. Thomas** |  |  |  |  |  |  |
| &nbsp;&nbsp;Severance payment <sup>(</sup><sup>1</sup><sup>)</sup> | $— | $860013 | $2653008 | $— | $— | $— |
| &nbsp;&nbsp;Equity-based compensation <sup>(2)</sup> |  |  | 1304144 | 1304144 | 1304144 | 1304144 |
| &nbsp;&nbsp;Continuation of base salary <sup>(3)</sup> |  |  |  |  | 413481 | 806433 |
| &nbsp;&nbsp;Continuation of health benefits <sup>(4)</sup> |  |  | 8692 |  | 4397 | 8692 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | $— | $860013 | $3965844 | $1304144 | $1722022 | $2119269 |

---

<sup>(1)</sup> According to the terms of his employment agreement, if any payment or distribution by Kforce to Mr. Liberatore is determined to be subject to the excise tax imposed under Section 4999 of the Code, Mr. Liberatore would be entitled to receive from Kforce a payment in an amount sufficient to place him in the same after-tax financial position that he would have been if he had not incurred any excise tax. The severance amount in the event of a termination following CIC for Mr. Liberatore includes $4.5 million of excise tax gross up. The employment agreements with Messrs. Kelly, Hackman and Thomas do not contain excise tax gross-up provisions and, thus, no amounts were included in the tables above with respect thereto.

<sup>(2)</sup> The amounts represent the unvested restricted stock shares on December 31, 2025, multiplied by $30.92, which was the closing stock price on December 31, 2025.

<sup>(3)</sup> For purposes of the Disability scenario, we have used 2.99 years for Mr. Liberatore and 2.00 years for Messrs. Kelly and Thomas as these are deemed to be the most probable outcomes if a disability occurred on December 31, 2025. The annual payment amounts have been discounted at a rate of 5.1%. Mr. Hackman would not receive any additional salary or benefits upon disability and, thus, no amounts were included in the tables above with respect thereto.

<sup>(4)</sup> These amounts represent the value of Kforce's portion of the healthcare benefits provided to each respective NEO consistent with those benefits received as of December 31, 2025. The annual benefit amounts have been discounted at a rate of 2.3%.

42 Kforce 2026 Proxy Statement

------

<u>[**Table of Contents**](#ibde21b2946834ef1acfb04b1aa73fd7c_16)</u>

***<u>2026 NEO Compensation Changes</u>***

The Committee continually monitors and reviews the effectiveness of the NEO compensation framework relative to its stated compensation philosophies and the Firm's initiatives and makes any necessary adjustments. The 2026 framework continues to target total annual NEO compensation at the market median for median performance and emphasizes the use of variable performance-based compensation over fixed compensation to effectively motivate our NEOs to drive operational performance. The primary components of the structure continue to include salary, annual incentive compensation and equity LTI compensation.

As part of the Committee's annual benchmarking of compensation against the market median, which is conducted in collaboration with its independent compensation consultant (Pay Governance), and in consideration of market-leading compensation plan practices, the Committee approved an aggregate increase in compensation (at Target) for all NEOs of $1.1 million with 95% of this increase being in performance-based compensation (annual incentive and LTI).

**CEO PAY RATIO**

Under the applicable SEC rules, we calculated the ratio of our CEO's total annual compensation to the median of the total annual compensation of our employees using a reasonable estimate. As of December 31, 2025, Kforce employed approximately 1,600 associates and 7,800 consultants on assignment providing staffing services and solutions to our clients. The majority of the consultants are employed directly by Kforce with the remainder consisting of independent contractors. To determine our median employee, we compiled a list of all employees from our payroll records, including all full-time, part-time, temporary and seasonal employees who were employed as of December 31, 2025, which included our consultants that were directly employed by Kforce as of that date, but did not include the independent contractors. We examined all wages as reportable on Form W-2 for 2025 for these individuals, excluding our CEO. We annualized the compensation for any full-time and part-time employees that were not employed by us for the entire 2025 fiscal year, except for our consultants as they are considered temporary per our interpretation of the SEC guidelines, therefore we did not annualize their compensation. As such, our employee population includes a significant number of individuals that do not reflect a full year of compensation due to the short-term nature of their assignments.

Mr. Liberatore had $5,415,821 in total annual compensation for 2025, as reflected in the SCT included in this Proxy Statement. Our median employee had total annual compensation of $67,590 for 2025, which was calculated on the same basis as Mr. Liberatore's compensation for the purposes of the SCT. As a result, we estimate Mr. Liberatore's total compensation for 2025 was approximately 80 times that of our median employee. Given the different methodologies that various companies use to determine an estimate of their CEO pay ratio, and given the uniqueness of our temporary employee population, we do not believe that this estimated ratio should be used as a basis for comparison with other companies.

43 Kforce 2026 Proxy Statement

------

<u>[**Table of Contents**](#ibde21b2946834ef1acfb04b1aa73fd7c_16)</u>

**PAY VERSUS PERFORMANCE**

This section provides information regarding the relationship between executive compensation and our financial performance in accordance with Item 402(v) of Regulation S-K. The table below summarizes compensation values both previously reported in our SCT and the adjustments to derive to the Compensation Actually Paid (CAP). Note that for our NEOs other than our principal executive officer (the PEO), the compensation figures are reported as an average.

---

| | | | | | | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Pay Versus Performance Table** | **Pay Versus Performance Table** | **Pay Versus Performance Table** | **Pay Versus Performance Table** | **Pay Versus Performance Table** | **Pay Versus Performance Table** | **Pay Versus Performance Table** | **Pay Versus Performance Table** | **Pay Versus Performance Table** |  |  |  |  |  |  |  |  |  |
| **Fiscal Year** | **SCT**<br>**Total for PEO** <sup>(</sup><sup>1</sup><sup>)</sup><br>**($)** | **Compensation Actually Paid to PEO** <sup>(</sup><sup>1</sup><sup>)</sup> <sup>(4)</sup><br>**($)** | **Average SCT**<br> **Total for non-PEO NEOs** <sup>(2)</sup><br>**($)** | **Average Compensation Actually Paid to non-PEO NEOs** <sup>(2)</sup> <sup>(4)</sup><br>**($)** | **Value of Initial Fixed $100 Investment Based on** | **Value of Initial Fixed $100 Investment Based on** | <br>**Net Income** <br>**(in millions)**<br>**($)** | **Revenue <br>(in millions)<br>($)** |  |  |  |  |  |  |  |  |  |
| **Fiscal Year** | **SCT**<br>**Total for PEO** <sup>(</sup><sup>1</sup><sup>)</sup><br>**($)** | **Compensation Actually Paid to PEO** <sup>(</sup><sup>1</sup><sup>)</sup> <sup>(4)</sup><br>**($)** | **Average SCT**<br> **Total for non-PEO NEOs** <sup>(2)</sup><br>**($)** | **Average Compensation Actually Paid to non-PEO NEOs** <sup>(2)</sup> <sup>(4)</sup><br>**($)** | **TSR<br>($)** | **Performance Peer Group** <br>**TSR** <sup>(3)</sup><br>**($)** | <br>**Net Income** <br>**(in millions)**<br>**($)** | **Revenue <br>(in millions)<br>($)** | | | | | | | | | |
| **Fiscal Year** | **SCT**<br>**Total for PEO** <sup>(</sup><sup>1</sup><sup>)</sup><br>**($)** | **Compensation Actually Paid to PEO** <sup>(</sup><sup>1</sup><sup>)</sup> <sup>(4)</sup><br>**($)** | **Average SCT**<br> **Total for non-PEO NEOs** <sup>(2)</sup><br>**($)** | **Average Compensation Actually Paid to non-PEO NEOs** <sup>(2)</sup> <sup>(4)</sup><br>**($)** | **TSR<br>($)** | **Performance Peer Group** <br>**TSR** <sup>(3)</sup><br>**($)** | <br>**Net Income** <br>**(in millions)**<br>**($)** | **Revenue <br>(in millions)<br>($)** | **2025** | $5415821 | $3821212 | $2140043 | $1875727 | $77 | $71 | $35 | $1329 |
| **Fiscal Year** | **SCT**<br>**Total for PEO** <sup>(</sup><sup>1</sup><sup>)</sup><br>**($)** | **Compensation Actually Paid to PEO** <sup>(</sup><sup>1</sup><sup>)</sup> <sup>(4)</sup><br>**($)** | **Average SCT**<br> **Total for non-PEO NEOs** <sup>(2)</sup><br>**($)** | **Average Compensation Actually Paid to non-PEO NEOs** <sup>(2)</sup> <sup>(4)</sup><br>**($)** | **TSR<br>($)** | **Performance Peer Group** <br>**TSR** <sup>(3)</sup><br>**($)** | <br>**Net Income** <br>**(in millions)**<br>**($)** | **Revenue <br>(in millions)<br>($)** | **2024** | $4205824 | $5731169 | $1542541 | $2087310 | $159 | $107 | $50 | $1405 |
| **2023** | $4571826 | $9383427 | $1366246 | $2771680 | $185 | $128 | $61 | $1532 |  |  |  |  |  |  |  |  |  |
| **2022** | $5564913 | $2066802 | $1982332 | $754954 | $146 | $115 | $75 | $1711 |  |  |  |  |  |  |  |  |  |
| **2021** | $6329950 | $11686235 | $3629803 | $6925993 | $197 | $144 | $75 | $1580 |  |  |  |  |  |  |  |  |  |

---

<sup>(1)</sup> Mr. Liberatore, President and CEO, is reflected in the table as the PEO for 2025, 2024, 2023 and 2022. Mr. Dunkel, current Chairman of the Board, was the CEO until he retired effective December 30, 2021, and is reflected as the PEO for 2021.

<sup>(2)</sup> Reflects average compensation amounts reported in the SCT for the following non-PEO NEOs for the fiscal years noted below:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• 2025, 2024, 2023 and 2022: Messrs. Kelly, Hackman and Thomas.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• 2021: Messrs. Liberatore, Kelly and Thomas.

<sup>(3)</sup> The amounts reflect the TSR for our Performance Peer Group for all years presented.

<sup>(4)</sup> For the unvested stock awards included in CAP for both the PEO and non-PEO NEOs, we used the closing stock price on the last trading day of each fiscal year, less the closing stock price on the last trading day in the immediately preceding fiscal year to obtain the incremental value of the unvested stock awards. The closing stock price of $30.92 and $56.70 was used for December 31, 2025 and December 31, 2024, respectively. For the vested awards included in CAP for both the PEO and non-PEO NEOs, we used the closing stock price on the vesting date, less the closing stock price on the last trading day of the fiscal year.

The following tables reconciles the amount disclosed in our SCT to the amount disclosed for CAP for the PEO and non-PEO NEOs:

**<u>PEO Reconciliation:</u>**

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Year** | **SCT Total** | **<u>Deductions</u>**<br>**from SCT table** <sup>(1)</sup> | **<u>Additions</u>** <br>**to SCT Table** <sup>(2)</sup> | **CAP** |
| **2025** | $5415821 | $(3461758) | $1867149 | $3821212 |
| **2024** | $4205824 | $(2937074) | $4462419 | $5731169 |
| **2023** | $4571826 | $(3259326) | $8070927 | $9383427 |
| **2022** | $5564913 | $(2992559) | $(505552) | $2066802 |
| **2021** | $6329950 | $(3529950) | $8886235 | $11686235 |

---

**<u>Average non-PEO NEOs Reconciliation:</u>**

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Year** | **SCT Total** | **<u>Deductions</u>**<br>**from SCT table** <sup>(1)</sup> | **<u>Additions</u>** <br>**to SCT Table** <sup>(2)</sup> | **CAP** |
| **2025** | $2140043 | $(1175235) | $910919 | $1875727 |
| **2024** | $1542541 | $(944674) | $1489443 | $2087310 |
| **2023** | $1366246 | $(758779) | $2164213 | $2771680 |
| **2022** | $1982332 | $(756924) | $(470454) | $754954 |
| **2021** | $3629803 | $(2161178) | $5457368 | $6925993 |

---

<sup>(1)</sup> Represents the grant date fair value of equity-based awards granted each year, and the value of dividends on unvested equity-based awards.

<sup>(2)</sup> Reflects the impact of fluctuations in Kforce's stock price on vested and unvested equity awards pursuant to the SEC's methodology for determining CAP for each year shown.

44 Kforce 2026 Proxy Statement

------

<u>[**Table of Contents**](#ibde21b2946834ef1acfb04b1aa73fd7c_16)</u>

The following table provides the equity values included in the PEO and non-PEO NEO reconciliation tables above:

**<u>PEO Equity Component of CAP:</u>**

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Year** | **Fair Value of Current Year Equity Awards at End of Year** | **Change in Fair Value of Prior Years' Awards That Remain Unvested at End of Year** | **Change in Fair Value of Prior Years' Awards That Vested During Year** | **Equity Value <br>included in CAP** |
| **2025** | $3217504 | $(2891330) | $1540975 | $1867149 |
| **2024** | $2699997 | $(1159674) | $2922096 | $4462419 |
| **2023** | $3034998 | $1312870 | $3723059 | $8070927 |
| **2022** | $2800004 | $(2106837) | $(1198719) | $(505552) |
| **2021** | $3200009 | $2608988 | $2903017 | $8712014 |

---

**<u>Average Non-PEO NEO's Equity Component of CAP:</u>**

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Year** | **Fair Value of Current Year Equity Awards at End of Year** | **Change in Fair Value of Prior Years' Awards That Remain Unvested at End of Year** | **Change in Fair Value of Prior Years' Awards That Vested During Year** | **Equity Value <br>included in CAP** |
| **2025** | $1113759 | $(650515) | $447675 | $910919 |
| **2024** | $888659 | $(238580) | $839364 | $1489443 |
| **2023** | $700845 | $293613 | $1169755 | $2164213 |
| **2022** | $688117 | $(630923) | $(527556) | $(470362) |
| **2021** | $2064996 | $2002501 | $1389871 | $5457368 |

---

**Relationships between CAP and Company Performance Measures**

The graphs below show the relationship of "compensation actually paid" to our CEO and non-PEO NEOs in 2025, 2024, 2023, 2022 and 2021 to (1) TSR of both Kforce Inc. and our Performance Peer Group, (2) net income and (3) revenue (our company selected measure).

CAP, as required under SEC rules, reflects adjusted values to unvested and vested equity awards during the years shown in the table based on year-end stock prices and various accounting valuation assumptions, but does not reflect actual amounts paid out for those awards. Due to the sensitivity of CAP to stock price changes, the timing of the grants and the changes in stock price thereafter significantly influence the CAP each year.

In the "Compensation Discussion and Analysis" section of this Proxy Statement and in the proxy statements covering fiscal years 2024, 2023, 2022 and 2021 as filed with the SEC, we provide greater detail on the elements of our executive compensation program and our "pay-for-performance" compensation philosophy. We believe the Firm's executive compensation program appropriately rewards our PEO and the non-PEO NEOs for Company and individual performance, promotes retention of our senior leadership team, and supports long-term value creation for our shareholders.

45 Kforce 2026 Proxy Statement

------

<u>[**Table of Contents**](#ibde21b2946834ef1acfb04b1aa73fd7c_16)</u>

![3667](kfrc-20260313_g55.jpg)

![3669](kfrc-20260313_g56.jpg)

46 Kforce 2026 Proxy Statement

------

<u>[**Table of Contents**](#ibde21b2946834ef1acfb04b1aa73fd7c_16)</u>

![3671](kfrc-20260313_g57.jpg)

The three items listed below represent the most important financial performance metrics used to determine compensation for our NEOs as further described in our 2025 NEO Compensation within the CD&A sections titled "Annual Incentive Compensation" and "Equity Long-Term Incentive".

---

| | | |
|:---|:---|:---|
| **Most Important Performance Measures** | **Most Important Performance Measures** | **Most Important Performance Measures** |
| **Revenue (and implied revenue growth)** | **Adjusted Diluted EPS (and implied EPS growth)** | **Three-Year Relative TSR** |

---

47 Kforce 2026 Proxy Statement

------

<u>[**Table of Contents**](#ibde21b2946834ef1acfb04b1aa73fd7c_16)</u>

**PROPOSAL 3. ADVISORY VOTE ON EXECUTIVE COMPENSATION**

The Dodd-Frank Act requires that we provide our shareholders with the opportunity to vote to approve, on a non-binding advisory basis, the compensation of our NEOs, as disclosed in this Proxy Statement.

As described in the CD&A above, Kforce's executive compensation program is designed to attract, motivate and retain our NEOs who are able to maximize shareholder value in an industry where we believe people represent the true assets of Kforce. Our Board believes that executive compensation levels are commensurate with Kforce's performance and shareholder return, promote a pay-for-performance philosophy and are strongly aligned with the interests of our shareholders.

We are asking our shareholders to indicate their support for our executive compensation. This proposal, commonly known as a Say On Pay proposal, is not intended to address any specific item of compensation, but rather the overall compensation of our NEOs and the philosophy, policies and practices described in this Proxy Statement in accordance with the SEC's compensation disclosure rules.

This advisory vote on executive compensation is not binding, however, the Board and Compensation Committee value the opinions expressed by our shareholders and will consider the outcome of the vote when making future decisions on our executive compensation.

Accordingly, we ask our shareholders to vote on the following resolution at the Annual Meeting:

RESOLVED, that the compensation paid to Kforce's Named Executive Officers, as disclosed pursuant to Item 402 of Regulation S-K, including the Compensation Discussion and Analysis, compensation tables and narrative discussion, is hereby APPROVED.

**VOTE REQUIRED**

Approval of this proposal requires the affirmative vote of a majority of the shares entitled to vote on the matter. An abstention is considered as present and entitled to vote and will have the effect of a vote against the proposal. A broker non-vote is considered not entitled to vote and will not affect the voting.

**THE BOARD UNANIMOUSLY RECOMMENDS AN ADVISORY VOTE FOR PROPOSAL 3.**<br>

48 Kforce 2026 Proxy Statement

------

<u>[**Table of Contents**](#ibde21b2946834ef1acfb04b1aa73fd7c_16)</u>

**PROPOSAL 4. APPROVAL OF THE KFORCE INC. 2026 STOCK INCENTIVE PLAN**

Since the completion of its Initial Public Offering in August 1995, Kforce has had a series of key employee equity incentive plans, with the most recent being the Kforce Inc. 2025 Stock Incentive Plan (the 2025 SIP). These plans were designed to provide an additional incentive to and for the retention of executives, employees and directors that we believe are key to the success of Kforce, especially given that we consider our people to be the true assets of Kforce. The Board believes these plans have been effective in providing such incentive and retention benefits. The Board also believes that for Kforce to continue to attract and retain outstanding individuals, it must continue to have incentive plans of these types in place. We have been operating in an uncertain macroeconomic environment for more than three years. While we believe we are fully prepared for the various possibilities that may lie ahead, depending on performance and fluctuations in Kforce's stock price, the remaining shares available for grant under the 2025 SIP may be limited and may not satisfy Kforce's needs over the next few years.

**CURRENT AWARDS OUTSTANDING**

Set forth below is certain information related to our 2025 SIP as of the Record Date (February 20, 2026) (in thousands):

---

| | |
|:---|:---|
| **Award Type** | **Shares Outstanding** |
| Restricted stock outstanding (unvested) | 1086 |
| Stock options outstanding |  |
| Shares remaining for grant under the 2025 SIP (1) | 602 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)This is the number of full value shares available for issuance under the 2025 SIP.

For additional information regarding stock-based awards previously granted, refer to Note 14, *Stock-Based Compensation*, to Kforce's Consolidated Financial Statements in our Annual Report on Form 10-K for the year ended December 31, 2025.

---

| | | | |
|:---|:---|:---|:---|
| **What We Do** | **What We Do** | **What We Don't Do** | **What We Don't Do** |
| ![Checkmark in a box.jpg](kfrc-20260313_g22.jpg) | Require Minimum Levels of Share Ownership | ![x.jpg](kfrc-20260313_g46.jpg) | Pay Out Cash Dividends on Unvested Awards |
| ![Checkmark in a box.jpg](kfrc-20260313_g22.jpg) | Maintain a Significant Clawback Policy  | ![x.jpg](kfrc-20260313_g46.jpg) | Allow Repricing or Cash Buyouts of Previous Equity-Based LTI Grants |
| ![Checkmark in a box.jpg](kfrc-20260313_g22.jpg) | Minimum Vesting Period of One Year for All Award Types | ![x.jpg](kfrc-20260313_g46.jpg) | Allow Hedging or Pledging or Other Related Activities |
| ![Checkmark in a box.jpg](kfrc-20260313_g22.jpg) | Minimum Holding Period of One Year After Exercise for Options and SARs | ![x.jpg](kfrc-20260313_g46.jpg) | Allow Liberal Share Recycling |

---

**SUMMARY OF PROPOSAL**

The potential insufficiency of the remaining shares available for grant under the 2025 SIP would result in a critical element of our overall compensation structure either not being available or being significantly limited. Therefore, the Board believes it is in the best interests of Kforce and its shareholders to adopt a new 2026 Stock Incentive Plan (the 2026 SIP). Accordingly, on March 6, 2026, the Board adopted the 2026 SIP, subject to shareholder approval. Therefore, the 2026 SIP will become effective only upon shareholder approval.

If the 2026 SIP is approved, the aggregate number of shares of common stock that may be subject to awards under the 2026 SIP (the Share Reserve) will be: (1) 1,211,000 shares (or approximately 445,000 full value shares), plus (2) any shares of common stock that, as of the date this plan is approved by the shareholders of the Firm, are reserved and available for grant or issuance under the 2025 SIP, and are not issued or subject to outstanding grants (the 2025 SIP Reserved Shares). Upon the approval of the 2026 SIP by the shareholders of the Firm, no additional grants shall be made under the 2025 SIP. As of the date of the adoption of the 2026 SIP by the Board, the number of 2025 SIP Reserved Shares is approximately 1,637,000 (or approximately 602,000 full value shares).

Therefore, as of the date of the adoption of the 2026 SIP by the Board, the Share Reserve is 2,848,000 (1,211,000 new shares + 1,637,000 2025 SIP Reserved Shares) shares. The full value shares equivalent is approximately 1,047,000 (approximately 445,000 new shares + approximately 602,000 2025 SIP Reserved Shares), both of these being subject to adjustment to reflect the grant, termination, cancellation, or forfeiture of outstanding awards under the 2025 SIP after the date of adoption of the 2026 SIP by the Board and prior to the approval by our shareholders. Each option or SAR granted shall reduce the Share Reserve by one share; and each full value share shall reduce the Share Reserve by 2.72 Shares. Depending on fluctuations in our stock price, the aggregate number of shares of common stock available under the 2026 SIP can be expected to last approximately three years.

49 Kforce 2026 Proxy Statement

------

<u>[**Table of Contents**](#ibde21b2946834ef1acfb04b1aa73fd7c_16)</u>

The potential dilutive effect of restricted stock outstanding (unvested) of approximately 1,086,000 (as of February 20, 2026) and the number of full value shares available for issuance under the 2026 SIP, if approved, of approximately 1,047,000 (approximately 445,000 new full value shares subject to approval of the 2026 SIP plus approximately 602,000 that are available under the 2025 SIP) is 11.7% on a basic and fully diluted basis.

**DESCRIPTION OF THE 2026 SIP, SUBJECT TO SHAREHOLDER APPROVAL**

The following summary of the 2026 SIP is qualified in its entirety by the terms of the 2026 SIP as set forth in Appendix A.

<u>Purposes</u>. The purposes of the 2026 SIP are to attract and retain highly qualified individuals for and in positions of substantial responsibility, to provide additional incentive to the Firm's employees and consultants in contributing to the success and progress of the Firm, and to align participants' interests directly to those of the Firm's shareholders through increased stock ownership.

<u>Awards.</u> The 2026 SIP provides for awards of incentive stock options, nonqualified stock options, stock awards (including restricted stock and restricted stock units), SARs, and other stock-based awards. The Board may adopt sub-plans applicable to particular foreign subsidiaries. With limited exceptions, the rules of such sub-plans may take precedence over other provisions of the 2026 SIP.

<u>Stock Subject to the 2026 SIP.</u> The aggregate number of shares of common stock that may be subject to awards under the 2026 SIP, subject to adjustment upon a change in capitalization, is 2,848,000 which includes shares that are reserved and available for grant and issuance under the 2025 SIP, and are not issued or subject to outstanding grants under the 2025 SIP. If any portion of an award under the 2026 SIP or the 2025 SIP, for any reason, expires, is terminated, is canceled or is forfeited, the shares allocable to the expired, terminated, canceled, or forfeited portion of the award will become available for future awards under the 2026 SIP at a rate of 2.72 shares for each expired, terminated, canceled, or forfeited share. However, the following shares are not available for issuance under the 2026 SIP: shares tendered or withheld as payment for option or SAR exercises, shares tendered by grantees or withheld by the Firm to cover tax withholding requirements for any type of award and shares that have been repurchased by the Firm using stock option exercise proceeds. Each option or SAR granted under the 2026 SIP will reduce the number of shares available for future awards by one share, and each full value award share will reduce the available shares by 2.72 shares. Such shares may be authorized, but unissued, or reacquired shares of common stock.

<u>Administration.</u> The 2026 SIP will be administered by the Committee. Subject to the other provisions of the 2026 SIP, the Committee has the power to determine the terms of each award granted, including the type of award, the exercise price of options, the number of shares subject to the award and the exercisability, vesting or settlement thereof.

<u>Eligibility.</u> The 2026 SIP provides that the Committee may grant awards to associates of the Firm and its subsidiaries, and to consultants, including non-employee directors. The Committee may grant incentive stock options only to employees. There are currently approximately 1,600 associates, 7,800 consultants and eight non-employee directors who are eligible to receive grants of awards under the 2026 SIP. A grantee who has received a grant of an award may, if he or she is otherwise eligible, receive additional award grants. The Committee selects the grantees and determines the number of shares of common stock to be subject to each award.

<u>Maximum Awards for Non-Employee Directors.</u> The 2026 SIP includes annual limits on the value of awards that may be granted to non-employee directors. A non-employee director may not receive options and SARs with an aggregate grant date fair value of more than $220,000 during any calendar year, and may not receive stock awards and other stock-based awards with an aggregate grant date fair value of more than $400,000 in any calendar year.

<u>Maximum Term and General Terms and Conditions of Awards.</u> With respect to any grantee who owns stock possessing ten percent or more of the voting power of all classes of stock of the Firm, the maximum term of any incentive stock option granted to such grantee must not exceed five years. The term of all other awards granted under the 2026 SIP, other than incentive stock options, may not exceed 15 years, except that permissible deferrals of awards may extend beyond 15 years. Each award granted under the 2026 SIP is evidenced by a written or electronic agreement between the grantee and Firm.

50 Kforce 2026 Proxy Statement

------

<u>[**Table of Contents**](#ibde21b2946834ef1acfb04b1aa73fd7c_16)</u>

An award agreement may set forth the manner in which the grantee's death or termination of continuous status as an employee or consultant and related events will affect the award. However, in the absence of an explicit provision in the applicable award agreement, the 2026 SIP provides the default manner in which the grantee's termination will affect the grantee's awards. The default provisions in the 2026 SIP provide that upon a grantee's termination of continuous status as an employee or consultant for any reason, all of the grantee's outstanding unvested awards will be forfeited. If the grantee's continuous status as an employee or consultant is terminated for cause, all of the grantee's unexercised options and SARs will be forfeited. In the event of the grantee's death or termination of continuous status as an employee or consultant as a result of disability, the vested portions of the grantee's outstanding options and SARs may be exercised within 90 days following the grantee's death or termination, whichever is applicable. In the event of termination of the grantee's continuous status as an employee or consultant for a reason other than death, disability, or cause, the vested portions of the grantee's outstanding options and SARs may be exercised within 30 days following the grantee's termination. Except as described below, an award granted under the 2026 SIP is not transferable by the grantee, other than by will or the laws of descent and distribution, and is exercisable during the grantee's lifetime only by the grantee. In the event of the grantee's death, an option or SAR may be exercised by a person who acquires the right to exercise the award by bequest or inheritance. To the extent and in the manner permitted by applicable law and the Committee, a grantee may transfer an award to certain family members and other individuals and entities, but a transfer to a third party for value is not permitted.

<u>Minimum Vesting Requirement.</u> Except with respect to a maximum of five percent of the shares subject to the 2026 SIP, and except for a provision in the 2026 SIP or an individual award agreement or an employment agreement with the grantee for an acceleration of vesting in the event of the death or disability of the grantee or a change in control, no award will provide for vesting that is any more rapid than vesting on the one year anniversary of the date of grant or, with respect to a performance-based award, a performance period that is less than twelve months.

<u>Options.</u> The Committee will not grant to any employee in any calendar year options to purchase more than 500,000 shares of common stock, and will not grant to any consultant (excluding non-employee directors, who are subject to the annual limits on the value of options and SARs described above) in any calendar year options to purchase more than 100,000 shares. Each option granted under the 2026 SIP is subject to the following terms and conditions (the award agreement may contain other terms and conditions not inconsistent with the 2026 SIP, as determined by the Committee).

*Exercise Price*. The Committee determines the exercise price of options to purchase shares of common stock at the time the options are granted. As a general rule, the exercise price of an option must be no less than 100 percent (110 percent for an incentive stock option granted to a grantee who owns stock possessing ten percent or more of the voting power of all classes of stock of the Firm) of the fair market value of the common stock on the date the option is granted. The closing market price per share of the common stock as of the Record Date was $28.54 per share. The 2026 SIP provides exceptions for certain options granted in connection with an acquisition by the Firm of another corporation.

*Exercise of the Option.* Each award agreement specifies the term and vesting of the option. The vesting provisions are determined by the Committee, subject to the minimum vesting requirement described above. An option is exercised by giving written or electronic notice of exercise to the Firm, specifying the number of full shares of common stock to be purchased and by tendering full payment of the purchase price to the Firm.

*Form of Consideration*. The award agreement specifies the option exercise procedures. Except as otherwise determined by the Committee in the award agreement, the acceptable form of consideration when exercising an option generally may consist of any combination of cash, personal check, wire transfer, other shares of Firm's common stock, or net exercise.

*Value Limitation.* If the aggregate fair market value of all shares of common stock subject to a grantee's incentive stock option which are exercisable for the first time during any calendar year exceeds $100,000, the excess shares will be treated as subject to nonqualified options. For this purpose, fair market value is determined as of the grant date.

*Holding Requirement*. Each grantee who is an NEO will be required to hold the shares of Common Stock acquired upon exercise of an option for a minimum period of one year following the date of exercise.

51 Kforce 2026 Proxy Statement

------

<u>[**Table of Contents**](#ibde21b2946834ef1acfb04b1aa73fd7c_16)</u>

<u>Stock Appreciation Rights.</u> The exercise of a SAR will entitle the grantee to receive the excess of the fair market value of a share of common stock on the date of exercise over the base price for each share with respect to which the SAR is exercised. The base price of a SAR must be no less than 100 percent of the fair market value of the common stock on the date the SAR is granted. The closing market price per share of the common stock as of the Record Date was $28.54 per share. The terms of the vesting of a SAR are determined by the Committee, subject to the minimum vesting requirement described above. During any calendar year, the Committee will not grant to any employee SARs covering more than 500,000 shares, and will not grant to any consultant (excluding non-employee directors, who are subject to the annual limits on the aggregate value of options and SARs described above) SARs covering more than 100,000 shares. Payment upon exercise of a SAR may be in cash, shares of common stock or a combination of cash and shares, as determined by the Committee. SARs may be exercised by the delivery to the Firm of a written or electronic notice of exercise. Each grantee who is an NEO will be required to hold the shares of Common Stock acquired upon exercise of a SAR for a minimum period of one year following the date of exercise.

<u>Stock Awards</u>. A stock award may be made in shares of common stock or in units representing rights to receive shares. During any calendar year, no stock awards covering more than 500,000 shares of common stock may be granted to any employee, and no stock awards covering more than 100,000 shares may be granted to any consultant (excluding non-employee directors, who are subject to the annual limits on the aggregate value of options and other stock-based awards described above). Subject to the minimum vesting requirement described above, the award agreement will set forth any vesting, forfeiture, settlement, or payment conditions applicable to the stock award. Conditions for effectiveness or vesting may be time-based, performance-based, or both time-based and performance-based. A stock award made in shares may be designated as an award of restricted stock, and a stock award denominated in units may be designated as an award of restricted stock units or RSUs. An award of restricted stock generally entitles the grantee to voting rights, and may entitle the grantee to dividend and other ownership rights, during the period in which the award is subject to forfeiture conditions. Although an award of RSUs generally will not provide any shareholder rights to the grantee until such time, if any, as the underlying shares are actually issued to the grantee, the Committee may provide in a restricted stock unit award agreement for the payment of dividend equivalents. However, the grantee will not receive payment of any dividends or dividend equivalents unless and until the stock award has become vested.

<u>Other Stock-Based Awards and Cash-Based Awards.</u> The Committee may grant other stock-based awards in such amounts, on such terms and conditions, and for such consideration, including no consideration or such minimum consideration as may be required by applicable law, as the Committee determines in its discretion. Other stock-based awards may be denominated in cash, in shares of common stock or other securities, in units, in securities or debentures convertible into common stock, or in any combination of the foregoing, and may be paid in cash, in shares of common stock or other securities, or in any combination of the foregoing, all as determined in the discretion of the Committee. Subject to the minimum vesting requirement described above, the terms and conditions of any other stock-based award may include, without limitation, terms and conditions relating to dividend and voting rights, as well as time-based and/or performance-based, or other condition(s) on the effectiveness or vesting of the award. However, the grantee will not receive payment of any dividends or dividend equivalents unless and until the award has become vested. During any calendar year, no other stock-based awards covering more than 500,000 shares of common stock may be granted to any employee, and no other stock-based awards covering more than 100,000 shares may be granted to any consultant (excluding non-employee directors, who are subject to the annual limits on the aggregate value of stock awards and other stock-based awards described above). The maximum amount that a grantee may earn by satisfaction of performance goals during any calendar year under other stock-based awards that are denominated in cash or any medium other than shares or units representing rights to receive shares is $7,500,000. For purposes of the limitation stated in the immediately preceding sentence, the calendar year in which the applicable performance goal(s) is satisfied is the calendar year in which the limitation applies, without regard to the duration of the performance period or any additional time-based vesting conditions or other terms or conditions relating to the payment of the other stock-based award.

<u>Performance-Based Awards.</u> The Committee may grant options, SARs, stock awards and/or other stock-based awards with respect to which the amount, grant, vesting, or settlement is contingent upon the achievement of specific performance goals. The Committee will determine the performance goal(s), the performance period, and the performance measure(s) that will be applied with respect to each such award at the time of grant.

52 Kforce 2026 Proxy Statement

------

<u>[**Table of Contents**](#ibde21b2946834ef1acfb04b1aa73fd7c_16)</u>

The Committee will establish the performance goal or goals for the applicable performance period based upon the performance measure selected by the Committee to apply to each award and a formula or matrix prescribing the extent to which such award will be granted and/or vested based upon the level of achievement of such performance goal or goals. The Committee may establish different performance goals for different grantees and different awards. The performance goals with respect to such performance measurement criteria may be established at such levels and in such terms as the Committee may determine, in its discretion, including in absolute terms, as a goal relative to performance in prior periods, or as a goal compared to the performance of one or more comparable companies or an index covering multiple companies. The performance goals may be established in terms of Firm-wide objectives or objectives that are related to the performance of the individual grantee or the subsidiary, division, department, or function within the Firm or subsidiary in which the Grantee is employed, or any other manner that the Committee determines appropriate in its discretion. Performance goals need not be based on audited financial results.

Notwithstanding the achievement of any performance goal and any contrary provision of the 2026 SIP, the Committee may, in its discretion, reduce the amount of compensation otherwise to be paid or earned in connection with an award. The Committee may determine performance before payment of bonuses, capital charges, non-recurring income or expense, items of an unusual nature or of a type that indicates infrequency of occurrence, or other financial and general and administrative expenses for the performance period, and may measure the attainment of the performance goal by appropriately adjusting the evaluation of performance goal performance to exclude the effect of any changes in accounting principles affecting the Firm's or a business unit's reported results. The Committee may establish additional rules and procedures relating to the Committee's ability to adjust aspects of a performance-based award, including the ability to increase or decrease the amount of compensation payable under the award, and the Committee's certification or other determination of the extent to which performance goals have or have not been achieved.

<u>Adjustment upon Changes in Capitalization.</u> In the event of changes in the common stock by reason of any stock splits, reverse stock splits, stock dividends, or other change in the capital structure of the Firm or extraordinary dividend, spinoff, or similar event affecting the value of common stock, an appropriate adjustment will be made by the Board in the number of shares of common stock subject to the 2026 SIP, the number of shares subject to any award outstanding under the 2026 SIP, the exercise price of any such outstanding award, any share-based performance condition, and the annual per-person limitations on awards. The determination of the Board, as to which adjustments will be made, will be conclusive.

<u>Change in Control.</u> In the event of a change in control of the Firm, then the following provisions apply:

*Vesting.* In the event of a change in control of the Firm, the Board may accelerate the vesting of any outstanding award that is not fully vested on the date of the change in control.

*Dissolution or Liquidation.* In the event of a proposed dissolution or liquidation of the Firm, all outstanding awards will terminate immediately before the consummation of such proposed action. The Board may, in the exercise of its discretion in such instances, declare that any option or SAR will terminate as of a date fixed by the Board and give each grantee the right to exercise his option or SAR as to all or any part of the shares covered by such award, including shares as to which the award would not otherwise be exercisable.

*Merger or Asset Sale.* In the event of a merger of the Firm with or into another corporation, the sale of substantially all of the assets of the Firm or the acquisition by any person, other than the Firm or other named persons expressly excluded in the 2026 SIP, of 50 percent or more of the Firm's then outstanding securities, each award will be assumed or an equivalent award will be substituted by the successor corporation; provided, however, if such successor or purchaser refuses to assume the then outstanding awards, the Board may accelerate the vesting of any outstanding award that is not fully vested on the date of the change in control.

<u>Restriction on Repricing.</u> The 2026 SIP expressly prohibits any modification or amendment of an option or SAR that constitutes a repricing under the NYSE listing rules, unless the Firm's shareholders approve the modification or amendment. For this purpose, a repricing is generally defined as lowering the exercise or base price of an option or SAR after it is granted, any other action that is treated as a repricing under generally accepted accounting principles, or granting a new award or cash in exchange for the cancellation of an option or SAR with an exercise price or base price that exceeds the current fair market value of the underlying stock, unless the cancellation and exchange occurs in connection with a merger, acquisition, spin-off or other similar corporate transaction. The definition of repricing also includes any other action that has the same effect as one of these prohibited actions. Adjustments to the exercise price or number of shares subject to an option or SAR to reflect the effects of a stock split or other extraordinary corporate transaction will not constitute a repricing.

53 Kforce 2026 Proxy Statement

------

<u>[**Table of Contents**](#ibde21b2946834ef1acfb04b1aa73fd7c_16)</u>

<u>Amendment and Termination of the 2026 SIP.</u> The Board may at any time amend, alter, suspend or terminate the 2026 SIP. The Firm will obtain shareholder approval of any amendment to the 2026 SIP in such a manner and to such a degree as is necessary and desirable to comply with any applicable law or regulation, including the requirements of any exchange on which the common stock is listed or quoted. Under these laws and regulations, however, shareholder approval will not necessarily be required for all amendments which might increase the cost of the 2026 SIP or broaden eligibility. Unless terminated earlier by the Board, the 2026 SIP will terminate on April 22, 2036. Any awards outstanding under the 2026 SIP at the time of its termination will remain outstanding until they expire by their terms.

<u>Tax Consequences.</u> The federal income tax consequences of participation in the 2026 SIP are complex and subject to change. The following discussion is only a summary of the general tax rules applicable to the 2026 SIP.

*Options*. Options granted under the 2026 SIP may be either incentive stock options or non-qualified stock options. Options that are designated as incentive stock options are intended to qualify as such under Section 422 of the Code. With respect to incentive stock options, neither the grant nor the exercise of the option will subject the employee to taxable income, other than under the Alternative Minimum Tax (Section 56(b)(3) of the Code), which is not discussed in detail in this summary. There is no required tax withholding in connection with the exercise of incentive stock options. Upon the ultimate disposition of the stock obtained on an exercise of an incentive stock option, the employee's entire gain will be taxed at the rates applicable to long-term capital gains, provided the employee has satisfied the prescribed holding periods relating to incentive stock options and the underlying stock. This treatment will apply to the entire amount of gain recognized on the sale of the stock, including the portion of gain that reflects the spread on the date of exercise between the fair market value of the stock at the time of grant and the fair market value of the stock at the time of exercise.

The Firm does not receive a compensation deduction for tax purposes with respect to incentive stock options. However, if the employee disposes of the stock purchased on exercise of the incentive stock option prior to the expiration of the applicable holding periods required by Section 422 of the Code, the Firm will be entitled to a deduction equal to the employee's realization of ordinary income by virtue of the employee's disqualifying disposition.

Non-qualified stock options granted under the 2026 SIP will not qualify for any special tax benefits to the option holder. An option holder generally will not recognize any taxable income at the time he or she is granted a non-qualified option. However, upon its exercise, the option holder will recognize ordinary income for federal tax purposes measured by the excess of the fair market value of the shares at the time of exercise over the exercise price. The income realized by the option holder will be subject to income and other employee withholding taxes.

The option holder's basis for determination of gain or loss upon the subsequent disposition of shares acquired upon the exercise of a non-qualified stock option will be the amount paid for such shares plus any ordinary income recognized as a result of the exercise of such option. Upon disposition of any shares acquired pursuant to the exercise of a non-qualified stock option, the difference between the sale price and the option holder's basis in the shares will be treated as a capital gain or loss and generally will be characterized as long-term capital gain or loss if the shares have been held for more than one year at the time of their disposition.

In general, there will be no federal income tax deduction allowed to the Firm upon the grant or termination of a nonqualified stock option or a sale or disposition of the shares acquired upon the exercise of a nonqualified stock option. However, upon the exercise of a nonqualified stock option by a holder, the Firm will be entitled to a deduction for federal income tax purposes equal to the amount of ordinary income that an option holder is required to recognize as a result of the exercise, provided that the deduction is not otherwise disallowed under the Code.

*Stock Awards and Stock Appreciation Rights.* With respect to stock awards and SARs that may be settled either in cash or in shares that are either transferable or not subject to a substantial risk of forfeiture, the grantee will realize ordinary taxable income, subject to tax withholding, equal to the amount of the cash or the fair market value of the shares received. The Firm will be entitled to a deduction in the same amount and at the same time as the compensation income is received by the grantee. With respect to restricted stock award shares that are both nontransferable and subject to a substantial risk of forfeiture, the award recipient will realize ordinary taxable income equal to the fair market value of the shares at the first time the shares are either transferable or not subject to a substantial risk of forfeiture. The Firm will be entitled to a deduction in the same amount and at the same time as the ordinary taxable income realized by the grantee.

Some awards, such as restricted stock unit awards, may be considered to be deferred compensation subject to special federal income tax rules under Section 409A of the Code. Failure to satisfy the applicable requirements under Section 409A of the Code for such awards would result in the acceleration of income and additional income tax liability to the grantee, including certain penalties. The 2026 SIP and awards under the 2026 SIP are intended to be designed and administered so that any awards that are considered to be deferred compensation will not result in negative tax consequences to the grantees under Section 409A of the Code.

54 Kforce 2026 Proxy Statement

------

<u>[**Table of Contents**](#ibde21b2946834ef1acfb04b1aa73fd7c_16)</u>

All of the above-described deductions are subject to the limitations on deductibility described in Section 162(m) of the Code. Therefore, there can be no assurance that compensation attributable to 2026 SIP awards will be fully deductible under all circumstances. In addition, as a result of the provisions of Section 280G of the Code, compensation paid to certain employees resulting from vesting of awards in connection with a change in control of the Firm also may not be deductible.

The foregoing is only a summary of the effect of federal income taxation upon the award recipient and the Firm with respect to the grant and exercise of awards under the 2026 SIP, does not purport to be complete and does not discuss the tax consequences of the recipient's death or the income tax laws of any municipality, state or foreign country in which a recipient may reside.

<u>New Plan Benefits.</u> All awards under the 2026 SIP are made at the discretion of the Committee. Therefore, the benefits and amounts that will be received or allocated under the 2026 SIP in the future are not determinable at this time.

**RECOMMENDATION OF THE BOARD**

The Board believes that the proposed 2026 SIP is necessary to ensure that a sufficient number of shares will be available to provide incentive and retention benefits. If our shareholders do not approve the 2026 SIP, we will experience a shortfall of shares available for issuance that we believe may adversely affect our ability to attract, retain and reward NEOs and other key employees who contribute to our long-term success. If the 2026 SIP is approved by our shareholders, we intend to file, pursuant to the Securities Act of 1933, as amended, a registration statement on Form S-8 to register the additional shares available for issuance under the 2026 SIP as soon as reasonably practicable.

**VOTE REQUIRED**

Approval of this proposal requires the affirmative vote of a majority of the shares entitled to vote on the matter. An abstention is considered as present and entitled to vote and will have the effect of a vote against the proposal. A broker non-vote is considered not entitled to vote and will not affect the voting.

**THE BOARD UNANIMOUSLY RECOMMENDS A VOTE FOR PROPOSAL 4.**<br>

55 Kforce 2026 Proxy Statement

------

<u>[**Table of Contents**](#ibde21b2946834ef1acfb04b1aa73fd7c_16)</u>

**OTHER MATTERS**

**SECURITIES AUTHORIZED FOR ISSUANCE UNDER EQUITY COMPENSATION PLANS**

The following table provides information about our common stock that may be issued under all of our existing equity compensation plans as of December 31, 2025:

---

| | | | |
|:---|:---|:---|:---|
| **Plan Category** | **Number of Securities to be Issued Upon Exercise of Outstanding Options, Warrants and Rights<br>(a)** | **Weighted-Average Exercise Price of Outstanding Options, Warrants and Rights<br>(b)** | **Number of Securities Remaining Available for Future Issuance Under Equity Compensation Plans (Excluding Securities Reflected in Column (a)) <br>(c)** |
| Equity compensation plans approved by shareholders <sup>(1)</sup> | N/A | N/A | 1620592 |
| Equity compensation plans not approved by shareholders | N/A | N/A |  |

---

<sup>(1)</sup> On April 23, 2025, Kforce shareholders approved the 2025 SIP. The 2025 SIP allows for the issuance of stock options, stock appreciation rights, stock awards (including restricted stock awards (RSAs) and restricted stock units (RSUs)) and other stock-based awards. As of the effective date of the 2025 SIP, no additional awards may be granted pursuant to any previously approved stock incentive plan; however, awards outstanding as of the effective date continue to vest in accordance with their original terms. As of December 31, 2025, the number of outstanding issued and unvested shares under the 2025 SIP, and prior stock incentive plans approved by shareholders, were approximately 2,987,000.

**STOCK OWNERSHIP INFORMATION**

**DELINQUENT SECTION 16(a) REPORTS**

Section 16(a) of the Exchange Act requires Kforce directors, executive officers and persons holding more than 10 percent of our common stock to file reports of ownership and changes in ownership of our common stock with the SEC.

Based solely on our review of copies of reports and written representations from the reporting persons, we believe that all directors, executive officers and persons holding more than 10 percent of our common stock timely met their reporting obligations with the exception of a one-day delay in filing a Form 4 for Mr. Dunkel in May 2025.

56 Kforce 2026 Proxy Statement

------

<u>[**Table of Contents**](#ibde21b2946834ef1acfb04b1aa73fd7c_16)</u>

**SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT**

**OWNERS OF MORE THAN 5%**

The following table contains information about the number of shares of our common stock held as of the most recent practicable date (such date for each such owner is listed below in the applicable footnote) by persons we know to be the beneficial owners of more than five percent of our outstanding common stock. The percentage ownership is based on the number of shares of our common stock outstanding as of the Record Date.

---

| | | |
|:---|:---|:---|
| **Name and Address of Beneficial Owner** | **Beneficially Owned Shares of Common Stock** | **Percent of Class** |
| Kayne Anderson Rudnick Investment Management, LLC <sup>(1)</sup> <br>2000 Avenue of the Stars, Suite 1110, Los Angeles, CA 90067 | 1980243 | 10.9% |
| The Vanguard Group <sup>(2)</sup> <br>&nbsp;&nbsp;&nbsp;&nbsp; 100 Vanguard Blvd, Malvern, Pennsylvania 19355 | 1245945 | 6.8% |
| BlackRock, Inc. <sup>(3)</sup> <br>&nbsp;&nbsp;&nbsp;&nbsp; 55 East 52nd Street, New York, New York 10055 | 1383617 | 7.6% |

---

<sup>(1)</sup> Based on Amendment No. 2 to Schedule 13G filed February 13, 2026 in which Kayne Anderson Rudnick Investment Management, LLC reported that as of December 31, 2025, it had shared dispositive power over 389,052 of the shares and sole dispositive power over 1,591,191 shares.

<sup>(2)</sup> Based on Amendment No. 15 to Schedule 13G filed January 30, 2026 in which The Vanguard Group reported that, as of December 31, 2025, it had shared dispositive power over 137,294 shares and sole dispositive power over 1,108,651 shares.

<sup>(3)</sup> Based on Amendment No. 18 to Schedule 13G filed April 24, 2025 in which BlackRock, Inc. reported that, as of March 31, 2025, it had sole dispositive power over all 1,383,617 shares.

**DIRECTORS AND NAMED EXECUTIVE OFFICERS**

The following table shows the amount of Kforce common shares beneficially owned as of the Record Date by: (1) our NEOs; (2) our directors; and (3) all of our directors and executive officers as a group. The percentage ownership is based on the number of shares of our common stock outstanding as of the Record Date.

---

| | | | |
|:---|:---|:---|:---|
| **Name of Individual or Identity of Group** | **Beneficially Owned Shares of Common Stock** <sup>(</sup><sup>1</sup><sup>)</sup> | **Restricted Stock Units** <sup>(</sup><sup>1</sup><sup>)</sup> | **Percent of Class** |
| **Joseph J. Liberatore** | 335527 |  | 1.8% |
| **David M. Kelly** | 136779 |  | \* |
| **Jeffrey B. Hackman** | 116799 |  | \* |
| **Andrew G. Thomas** | 117231 |  | \* |
| **Derrick D. Brooks** | 2111 | 10324 | \* |
| **Catherine H. Cloudman** | 9172 | 3304 | \* |
| **David L. Dunkel** | 521329 | 7535 | 2.9% |
| **Ann E. Dunwoody** | 23080 | 5625 | \* |
| **Mark F. Furlong** | 26355 |  | \* |
| **Randall A. Mehl** | 4504 | 24609 | \* |
| **Elaine D. Rosen** | 13836 | 36620 | \* |
| **N. John Simmons** | 17252 |  | \* |
| **All directors and executive officers as a group** | 1323975 | 88017 | 7.3% |

---

*\*Less than 1% of the outstanding common shares*

<sup>(1)</sup> Amounts in the Beneficially Owned Shares of Common Stock column do not include shares to be received upon settlement of deferred restricted stock units more than 60 days after the Record Date; therefore these shares are reflected in the Restricted Stock Units column of this table. The deferred restricted stock units have no voting rights and are not included in the Percent of Class column calculation.

57 Kforce 2026 Proxy Statement

------

<u>[**Table of Contents**](#ibde21b2946834ef1acfb04b1aa73fd7c_16)</u>

**GENERAL INFORMATION**

***Why have I received this proxy statement and how does Kforce's Board recommend I vote on the proposals?***

We sent you these materials because the Board of Kforce Inc. is soliciting your vote at the Firm's 2026 Annual Meeting of Shareholders and the Board recommends that you vote your shares as follows:

• **FOR** election of the director nominees named in this Proxy Statement (Proposal 1);

• **FOR** ratification of Deloitte & Touche LLP as the Firm's independent registered public accountant for 2026 (Proposal 2);

• **FOR** the advisory vote on executive compensation (Proposal 3); and

• **FOR** the Kforce Inc. 2026 Stock Incentive Plan (Proposal 4).

***Will any other Business be conducted at the Annual Meeting?***

We do not know of any other business to be considered at the Annual Meeting. If any other business is properly presented at the Annual Meeting, the persons named on your proxy card will have authority to vote on such matters at their discretion.

 ***Do I have appraisal rights if I dissent from voting on a matter at the Annual Meeting?***

There are no statutory or contractual rights of appraisal or similar remedies available to those shareholders who dissent from any matter to be acted on at the Annual Meeting.

***Who is entitled to vote?***

Each share of Kforce common stock has one vote on each matter. Only shareholders of record as of the close of business on the Record Date (February 20, 2026) are entitled to vote at the Annual Meeting. As of the Record Date, 18,227,637 shares of common stock were outstanding.

***How do I vote?***

If your shares are registered directly in your name with Kforce's transfer agent, Computershare Trust Company, N.A. (Computershare), then you are the shareholder of record with respect to those shares and you may vote your shares by any one of the following methods:

---

| | | | |
|:---|:---|:---|:---|
| ![eps10-orange-street-view-or-person-in-circle-line-icon-or-logo-isolated-on-white-background-human-location-symbol-in-a-simple-flat-trendy-modern-style-for-your-website-design-and-mobile-app-v.jpg](kfrc-20260313_g58.jpg) | ***In Person***<br>at the Annual Meeting upon presentation of valid photo identification and proof of stock ownership as of the Record Date | ![phone-icon-telephone-icon-symbol-for-app-and-messenger-free-vector.jpg](kfrc-20260313_g59.jpg) | ***Phone***<br>by calling toll free 1-800-652-VOTE (8683) |
| ![image (1).jpg](kfrc-20260313_g60.jpg) | ***Scan the QR Code***<br>to vote with your mobile device or visit <br>http://www.investorvote.com/KFRC | ![blue-mail-icon-or-email-vector-45402883.jpg](kfrc-20260313_g61.jpg) | ***Mail***<br>complete, sign and date the enclosed proxy card and return it promptly in the enclosed postage paid envelope |

---

***Please see your proxy card for more information and voting deadlines.***

If your shares are held through a bank, broker or other nominee then you are considered the "beneficial owner" of shares held in "street name" and your bank, broker or nominee is the shareholder of record, however, as the beneficial owner you have the right to direct your bank, broker or other nominee to vote your shares. If you hold your shares in street name then please refer to the instructions provided by your bank, broker or nominee when voting your shares. Please note, if you hold your shares in street name you must obtain a legal proxy in your name from your bank, broker or other nominee to vote in person at the Annual Meeting.

***Can I change my vote?***

You may change your vote at any time before the Annual Meeting by using the internet or telephone methods described above, in which case only your latest submission will be counted. You may also change your vote by signing and returning a new proxy card with a later date, attending the Annual Meeting and voting in person, or sending written notice of revocation before the Annual Meeting to our Corporate Secretary at the Firm's principal executive offices located at 1150 Assembly Drive, Suite 500, Tampa, Florida 33607.

***What is the quorum requirement for the Annual Meeting?***

The presence at the meeting, in person or by proxy, of a majority of the shares entitled to vote will constitute a quorum. Broker non-votes (described below) and abstentions are counted for purposes of establishing a quorum but will not be counted for purposes of determining whether a proposal has been approved.

58 Kforce 2026 Proxy Statement

------

<u>[**Table of Contents**](#ibde21b2946834ef1acfb04b1aa73fd7c_16)</u>

***How are my shares voted if I submit a proxy but do not specify how I want to vote?***

If you are the shareholder of record and you submit a valid proxy without specifying how you want to vote, then the person(s) designated as proxy holders will vote your shares as recommended by the Board on all matters presented in this Proxy Statement and at their discretion on all other matters properly presented. If you are the beneficial owner of shares held in street name and do not provide your bank, broker or nominee with specific voting instructions then the organization that holds your shares may generally vote in their discretion on routine matters, but cannot vote on non-routine matters. If the organization that holds your shares does not receive instructions from you on how to vote your shares in a non-routine matter, that organization will inform the inspector of election that it does not have the authority to vote on this matter with respect to your shares. This is generally referred to as a broker non-vote.

***Which proposals are considered routine or non-routine?***

Ratification of Deloitte & Touche LLP as the Firm's independent registered public accountant for 2026 (Proposal 2) is considered a routine matter under applicable rules and each of the other proposals are considered non-routine. Therefore, if your shares are held in street name by your broker or other nominee and you do not provide instructions on how to vote your shares then your broker or nominee will permitted to vote its shares only with regards to Proposal 2 and will not be permitted to vote on the other matters.

***Assuming that a quorum is present at the Annual Meeting, what is the required vote for the proposals to pass?***

Refer to the respective proposal for a description of the vote required for it to pass.

***Who will count the vote?***

A representative of Computershare, an independent tabulator, will count the vote and act as the inspector of elections.

***Who is paying the costs of this proxy solicitation?***

Kforce will pay the costs of soliciting these proxies on behalf of the Board. We have engaged Georgeson LLC to assist in the solicitation of proxies and we anticipate that the costs associated with this engagement will be approximately $14,000 plus out-of-pocket expenses. We will also pay brokerage houses and other custodians, nominees and fiduciaries for their reasonable out-of-pocket expenses for forwarding proxy and solicitation materials to our shareholders and obtaining beneficial owners' voting instructions. In addition to mailing proxy solicitation material, our directors and employees, without additional compensation, may solicit proxies in person, by phone or by electronic communication.

***How can I find the results of the Annual Meeting?***

Preliminary results will be announced at the Annual Meeting. Final results will be published in a Current Report on Form 8-K within four business days following the Annual Meeting.

59 Kforce 2026 Proxy Statement

------

<u>[**Table of Contents**](#ibde21b2946834ef1acfb04b1aa73fd7c_16)</u>

**SHAREHOLDER COMMUNICATIONS, PROPOSALS AND OTHER MATTERS**

We are committed to engaging with our shareholders and taking their feedback into consideration. Our shareholders and other interested parties are invited to communicate with our directors by writing to the attention of our Corporate Secretary at Kforce Inc., 1150 Assembly Drive, Suite 500, Tampa, Florida 33607, or email corporatesecretary@kforce.com. Such communications will be delivered directly to Kforce's Board Chairman and Lead Independent Director.

All shareholder proposals to be considered for inclusion in next year's proxy statement pursuant to Rule 14a-8 of the Securities Exchange Act of 1934, as amended, (the Exchange Act), must be submitted in writing to the Corporate Secretary at 1150 Assembly Drive, Suite 500, Tampa, Florida 33607 no later than November 13, 2026. The Board will review any proposal from eligible shareholders that it receives by that date and will determine whether any such proposal will be included in our proxy materials for our Annual Meeting of Shareholders in 2027. The proxy solicited by the Board for the next Annual Meeting will confer discretionary authority to vote on any shareholder proposal presented at that meeting, unless we are provided with written notice of such proposal by January 27, 2027.

Pursuant to the Firm's Articles of Incorporation, proposals submitted other than pursuant to Rule 14(a)-8 or director nominations must be delivered to the Corporate Secretary no later than 60 days before the date of the meeting; however, if we give less than 70 days' notice of the date of the scheduled annual meeting is given, notice must be delivered not later than the close of business on the tenth day following the date on which notice of the annual meeting was given. The Nomination Committee will consider nominees for the Board that are proposed by our shareholders. The same identifying and evaluating procedures apply to all candidates for director nomination, including candidates submitted by shareholders. Any shareholder who wishes to recommend a prospective nominee for the Board for the Nomination Committee's consideration may do so by giving the candidate's name and qualifications in writing to the Firm's Corporate Secretary at 1150 Assembly Drive, Suite 500, Tampa, Florida 33607. In addition to satisfying the foregoing requirements under Kforce's bylaws, to comply with the universal proxy rules, shareholders who intend to solicit proxies in support of director nominees other than Kforce's nominees, must solicit 67% of the voting power and provide notice that sets forth the information required by Rule 14a-19 under the Exchange Act no later than February 21, 2027.

The material referred to in this proxy statement under the captions "Compensation Committee Report," and "Audit Committee Report" shall not be deemed soliciting material or otherwise deemed filed, or subject to the liabilities of Section 18 of the Exchange Act, and shall not be deemed to be incorporated by any general statement of incorporation by reference in any filings made under the Securities Act of 1933, as amended, (the Securities Act) or the Exchange Act.

Shareholders who share an address may receive only one copy of this Proxy Statement, and the accompanying Annual Report, unless we have received contrary instructions from a shareholder at that address. Shareholders sharing an address who would like to receive a separate copy of these materials now, or in the future, may do so by mailing a request to the Firm's Corporate Secretary at 1150 Assembly Drive, Suite 500, Tampa, Florida 33607 or by calling Kforce Investor Relations at (813) 552-5000.

60 Kforce 2026 Proxy Statement

------

<u>[**Table of Contents**](#ibde21b2946834ef1acfb04b1aa73fd7c_16)</u>

**APPENDIX A** 

**KFORCE INC. 2026 STOCK INCENTIVE PLAN**

**1. Purposes of the Plan.** The purposes of this Kforce Inc. 2026 Stock Incentive Plan are to attract and retain highly qualified individuals for and in positions of substantial responsibility, to provide additional incentive to our Employees and Consultants in contributing to the success and progress of the Firm, and to align participants' interests directly to those of Kforce's shareholders through increased stock ownership. Awards granted under the Plan may be Incentive Stock Options, Nonqualified Stock Options, Stock Appreciation Rights, Stock Awards, and Other Stock-Based Awards, any of which may be performance-based, as determined by the Committee.

**2. Definitions.** As used herein, the following definitions shall apply, unless otherwise provided in the Grantee's employment agreement:

"*Applicable Law*" means the legal requirements relating to the administration of the Plan under applicable federal, state, local and foreign corporate, tax and securities laws, and the rules and requirements of any stock exchange or quotation system on which the Common Stock is listed or quoted, all as amended through the applicable date. The term "Applicable Law" includes laws and regulations that are not mandatory but compliance with which confers benefits on the Firm or Grantees (e.g., Code Sections 409A, and 422, and Exchange Act Rule 16b-3), where such compliance (or exemption, as applicable) is intended under the Plan.

"*Award*" means an Option, Stock Appreciation Right, Stock Award, or Other Stock-Based Award granted under the Plan, any of which may be performance-based.

"*Award Agreement*" means the agreement, notice and/or terms or conditions by which an Award is evidenced, documented in such form (including by electronic communication) as may be approved by the Committee.

"*Board*" means the Board of Directors of the Firm.

"*Base Price*" means the price to be used as the basis for determining the Spread upon the exercise of a Stock Appreciation Right.

"*Cause*" means the happening of any of the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ the Grantee is convicted by a court of competent jurisdiction or enter a guilty plea or a plea of nolo contendere for any felony; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ the Grantee breaches any provisions of this Plan or his/her employment agreement and the breach results in material injury to the Firm or its acquiring or surviving entity; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ the Grantee engages in misconduct, a policy violation, dishonesty or fraud concerning the Firm or its acquiring or surviving entity's business or affairs and this misconduct, policy violation, dishonesty or fraud results in material injury to the Firm or its acquiring or surviving entity.

"*Change in Control*" means the happening of any of the following, unless otherwise provided in an Award Agreement:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)the acquisition by any person or entity, including a "group" as defined in Section 13(d)(3) of the Exchange Act (a "Person") of beneficial ownership of fifty percent (50%) or more of the combined voting power of the then-outstanding voting securities of the Firm that may be cast for the election of directors; provided, however, that for purposes of this clause (i), the following acquisitions shall not constitute a Change in Control: (A) any acquisition directly from the Firm or one of its affiliates, (B) any acquisition by the Firm or one of its affiliates, (C) any acquisition by any executive benefit plan (or related trust) sponsored or maintained by the Firm or one of its affiliates, (D) any acquisition by any corporation pursuant to a transaction that complies with clauses (A), (B) and (C) of clause (iii) of this section, or (E) any acquisition by David L. Dunkel or his family members; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)individuals who, as of the date of this Plan, constitute the Board (the "Incumbent Board") cease for any reason to constitute at least a majority of the Board; provided, however, that any individual becoming a director subsequent to the date of this Plan whose election, or nomination for election by shareholders, was approved by a vote of at least a majority of the directors then comprising the Incumbent Board shall be considered as though such individual were a member of the Incumbent Board, but excluding, for this purpose, any such individual whose initial assumption of office occurs as a result of an actual or threatened election contest with respect to the election or removal of directors or other actual or threatened solicitation of proxies or consents by or on behalf of a person other than the Board; or

61 Kforce 2026 Proxy Statement

------

<u>[**Table of Contents**](#ibde21b2946834ef1acfb04b1aa73fd7c_16)</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)consummation of a reorganization, merger or consolidation or sale or other disposition of all or substantially all of the assets of the Firm (a "Business Combination"), in each case, unless, following such Business Combination, (A) all or substantially all of the Persons who were the beneficial owners, respectively, of the Firm's outstanding Common Stock and outstanding voting securities immediately prior to such Business Combination beneficially own, directly or indirectly, more than 50% of, respectively, the then outstanding shares of Common Stock and the combined voting power of the then outstanding voting securities entitled to vote generally in the election of directors, as the case may be, of the corporation resulting from such Business Combination (including, without limitation, a corporation that as a result of such transaction owns the Firm or all or substantially all of the Firm's assets either directly or through one or more subsidiaries) in substantially the same proportions as their ownership, immediately prior to such Business Combination of the Firm's Common Stock and voting securities, as the case may be, (B) no person (excluding any corporation resulting from such Business Combination or any Executive benefit plan (or related trust) of the Firm or such corporation resulting from such Business Combination) beneficially owns, directly or indirectly, twenty-five percent or more of, respectively, the then outstanding shares of Common Stock of the corporation resulting from such Business Combination or the combined voting power of the then outstanding voting securities of such corporation except to the extent that such ownership existed prior to the Business Combination and (C) at least a majority of the members of the board of directors of the corporation resulting from such Business Combination were members of the Incumbent Board at the time of the execution of the initial agreement, or of the action of the Board, providing for such Business Combination; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv)approval by shareholders of a complete liquidation or dissolution of the Firm.

"*Code*" means the Internal Revenue Code of 1986, as amended. References to any provision of the Code or regulation include regulations, proposed regulations and applicable guidance thereunder.

"*Committee*" means the Compensation Committee of the Board.

"*Common Stock*" means the Common Stock, $0.01 par value, of the Firm.

"*Consultant*" means any person, including an advisor, engaged by the Firm or a Parent or Subsidiary to render services and who is compensated for such services, including without limitation non-Employee Directors who are compensated by the Firm for their services as non-Employee Directors. In addition, as used herein, "consulting relationship" shall be deemed to include service by a non-Employee Director as such.

"*Continuous Status as an Employee or Consultant*" means that the employment or consulting relationship is in good standing and not interrupted or terminated by the Firm, any Parent or Subsidiary. Continuous Status as an Employee or Consultant shall not be considered interrupted in the case of (i) any leave of absence approved in writing by the Board, an Officer, or a person designated in writing by the Board or an Officer as authorized to approve a leave of absence, including sick leave, military leave, or any other personal leave; provided, however, that for purposes of Incentive Stock Options, any such leave may not exceed 90 days, unless reemployment upon the expiration of such leave is guaranteed by contract (including certain Firm policies) or statute, or (ii) transfers between locations of the Firm or between the Firm, a Parent, a Subsidiary or successor of the Firm; or (iii) a change in the status of the Grantee from Employee to Consultant or from Consultant to Employee (subject to Section 21 and other applicable requirements of Code Section 409A).

"*Covered Stock*" means the Common Stock subject to an Award.

"*Date of Grant*" means the date on which the Committee makes the determination granting the Award, or such other later date as is determined by the Committee on which the grant of the Award shall become effective, including the date of the satisfaction of one, or more than one, objective employment, performance, or other grant condition that the Committee requires to be timely satisfied before the grant of a Stock Award or Other Stock-Based Award will be effective, consistent with the requirements of Applicable Law. Notice of the determination shall be provided to each Grantee within a reasonable time after the Date of Grant.

"*Date of Termination*" means the date on which a Grantee's Continuous Status as an Employee or Consultant terminates unless otherwise specified in an Award Agreement (subject to Section 21 and other applicable requirements of Code Section 409A).

"*Director*" means a member of the Board.

"*Disability*" means, unless otherwise provided in an Award Agreement, total and permanent disability as defined in Section 22(e)(3) of the Code.

"*Dividend Equivalent*" means a right to receive value equal to the amount of cash dividends and value of other distributions that would have been payable on Covered Stock during a period of time had such Covered Stock been issued to the Grantee during such period of time.

62 Kforce 2026 Proxy Statement

------

<u>[**Table of Contents**](#ibde21b2946834ef1acfb04b1aa73fd7c_16)</u>

"*Employee*" means any person, including Officers and Directors, employed by the Firm or any Parent or Subsidiary of the Firm. Neither service as a Director nor payment of a director's fee by the Firm shall be sufficient to constitute "employment" by the Firm.

"*Exchange Act*" means the Securities Exchange Act of 1934, as amended.

"*Fair Market Value*" means, as of any date, the value of Common Stock determined as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)If the Common Stock is listed on any established stock exchange or a national market system, including, but without limitation to, the New York Stock Exchange ("NYSE"), the Fair Market Value of a Share of Common Stock shall be the closing sales price for such stock (or the closing bid, if no sales were reported) as quoted on such system or exchange (or the exchange with the greatest volume of trading in Common Stock) on the day of determination.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)If the Common Stock is quoted not listed on an established national securities exchange but is regularly quoted by a recognized securities dealer, and closing selling prices are not reported, the Fair Market Value of a Share of Common Stock shall be the mean between the high bid and low asked prices for the Common Stock on the day of determination, as reported by such quotation service or such other source as the Committee deems reliable;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)In the absence of an established market for the Common Stock, the Fair Market Value shall be determined by the Committee on a reasonable basis using a method that complies with Code Section 409A.

"*Firm*" means Kforce Inc., a Florida corporation.

"*Grantee*" means an individual who has been granted an Award.

"*Incentive Stock Option*" means an Option intended to qualify as an incentive stock option within the meaning of Section 422 of the Code and the regulations promulgated thereunder.

*"Named Executive Officer" or "NEO"* means, as of any date of determination, a "named executive officer" (as such term is defined under Item 402(a)(3) of Regulation S-K) of the Firm listed in the Firm's most recently filed proxy statement for its annual meeting of shareholders.

"*Nonqualified Stock Option*" means an Option not intended to qualify as an Incentive Stock Option.

"*Officer*" means a person who is an officer of the Firm within the meaning of Section 16 of the Exchange Act and the rules and regulations promulgated thereunder.

"*Option*" means a stock option granted under the Plan, which may be an Incentive Stock Option or a Nonqualified Stock Option.

"*Other Stock-Based Award*" means an Award granted under Section 9 of the Plan.

"*Parent*" means a corporation, whether now or hereafter existing, in an unbroken chain of corporations ending with the Firm if each of the corporations other than the Firm holds at least 50 percent of the voting shares of one of the other corporations in such chain.

"*Performance-Based Award*" means an Award with respect to which the amount, awarding, vesting, or settlement is contingent on the achievement of specific Performance Goals during a Performance Period, determined using one or more specific Performance Measures, all as specified in the related Award Agreement. Performance-Based Awards may be granted in the form of Stock Options, SARs, Restricted Stock, Restricted Stock Units, and/or Other Stock-Based Awards.

"*Performance Goal(s)*" mean, with respect to a Performance-Based Award, one or more targets, goals or levels of attainment selected by the Committee and required to be achieved in terms of the specified Performance Measure during the specified Performance Period.

"*Performance Measure*" means, with respect to a Performance-Based Award, one or more of the criteria selected by the Committee for the purpose of establishing, and measuring attainment of, Performance Goals for a Performance Period in respect of such Award, as provided in the applicable Award Agreement. For purposes of clarity, the Committee may establish Performance Measures that are measured on an absolute or relative basis and are related to the performance of the Firm, a Subsidiary, the Grantee, the division, department, or function within the Firm or Subsidiary in which the Grantee is employed, a region, a product-line, or any other manner that it determines appropriate in its discretion.

"*Performance Period*" means, with respect to a Performance-Based Award, the one or more periods of time, which may be of varying and overlapping durations, as the Committee may select during which the attainment of one or more Performance Goals will be measured.

"*Plan*" means this Kforce Inc. 2026 Stock Incentive Plan.

"*Rule 16b-3*" means Rule 16b-3 promulgated under the Exchange Act or any successor to Rule 16b-3, as in effect when discretion is being exercised with respect to the Plan.

63 Kforce 2026 Proxy Statement

------

<u>[**Table of Contents**](#ibde21b2946834ef1acfb04b1aa73fd7c_16)</u>

"*Share*" means a share of the Common Stock, as adjusted in accordance with Section 12 of the Plan.

"*Spread*" means, in the case of a Stock Appreciation Right, the amount by which the Fair Market Value per Share on the date when the SAR is exercised exceeds the Base Price specified in the SAR.

"*Stock Appreciation Right*" or "*SAR*" has the meaning set forth in Section 7 of the Plan.

"*Stock Award*" means Restricted Stock or Restricted Stock Units granted to a Grantee under Section 8 of the Plan.

"*Subsidiary*" means a corporation, domestic or foreign, of which not less than 50 percent of the voting shares are held by the Firm or a Subsidiary, whether or not such corporation now exists or is hereafter organized or acquired by the Firm or a Subsidiary.

**3. Stock Subject to the Plan**. Subject to the provisions of Section 12 of the Plan, the aggregate number of Shares of Common Stock that may be subject to awards under this Plan (the "Share Reserve") is (i) 1,211,000 Shares, plus (ii) any Shares of Common Stock that, as of the date this Plan is approved by the shareholders of the Firm, are reserved and available for grant and issuance under the Kforce Inc. 2025 Stock Incentive Plan (the "2025 SIP"), and are not issued or subject to outstanding grants under the 2025 SIP (respectively, the "2025 SIP Reserved Shares"). Upon the approval of this Plan by the shareholders of the Firm, no additional grants shall be made under the 2025 SIP. As of the date of the adoption of this Plan by the Board, the number of 2025 SIP Reserved Shares is 1,637,000 Shares. Therefore, as of the date of the adoption of this Plan by the Board, the Share Reserve is 2,848,000 subject to adjustment to reflect the grant, termination, cancellation, or forfeiture of outstanding awards under the 2025 SIP after the date of adoption of this Plan by the Board and prior to the approval of this Plan by the shareholders of the Firm. In no event shall the number of Shares issued upon the exercise of Incentive Stock Options exceed the Share Reserve. Each Option or SAR granted shall reduce the Share Reserve by one Share; and each full value share (Stock Award) shall reduce the Share Reserve by 2.72 Shares. Such shares of Common Stock may be authorized, but unissued, or reacquired shares of Common Stock. The Shares issued by the Firm under the Plan may be, at the Firm's option, either (i) evidenced by a certificate registered in the name of the Grantee, or (ii) credited to a book-entry account for the benefit of the Grantee maintained by the Firm's stock transfer agent or its designee.

If any portion of an Award granted under the Plan for any reason expires, is terminated, is canceled or is forfeited (including those forfeited as a result of not being earned pursuant to the Award's performance criteria), then (i) with respect to Options and SARs, the Shares underlying such Award shall be restored to the Share Reserve on a one-for-one basis and shall become available for future Awards under the Plan (unless the Plan has terminated); and (B) with respect to each Award other than an Option or SAR, the Shares underlying such Award shall be restored to the Share Reserve at a rate of 2.72 Shares for each expired, terminated, canceled, or forfeited Share and shall become available for future Awards under the Plan (unless the Plan has terminated). If any portion of an outstanding award that was granted under the 2025 SIP or any other prior plan maintained by the Firm for any reason expires, is terminated, is canceled or is forfeited on or after the date on which the shareholders of the Firm approve this Plan, then (i) with respect to options and stock appreciation rights, the Shares underlying such award shall be added to the Share Reserve on a one-for-one basis and shall become available for future Awards under the Plan (unless the Plan has terminated); and (B) with respect to each award other than an option or stock appreciation right, the Shares underlying such award shall be added to the Share Reserve at a rate of 2.72 Shares for each expired, terminated, canceled, or forfeited Share and shall become available for future Awards under the Plan (unless the Plan has terminated). With respect to an Option and SAR, if the payment upon exercise of an Option or SAR is in the form of Shares, the Shares subject to the Option or SAR shall be counted against the Share Reserve as one Share for every Share subject to the Option or SAR, regardless of the number of Shares used to settle the Option or SAR upon exercise. In the event that (i) any Option or SAR granted under the Plan or any other plan maintained by the Firm is exercised through the tendering of Shares by the Grantee or by the withholding of Shares by the Firm, or (ii) withholding tax liabilities arising from any Option or SAR or Stock Award of any other Awards are satisfied by the tendering of Shares by the Grantee or by the withholding of Shares by the Firm, or (iii) Shares are repurchased by the Firm using Option exercise proceeds, then the Shares so tendered or withheld or repurchased will not again be available for issuance under the Plan.

**4. Administration of the Plan.** 

(a)*Procedure*.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)*Administration by Committee*. The Plan shall be administered by the Committee.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)*Rule 16b-3*. To the extent the Committee considers it desirable for transactions relating to Awards to be eligible to qualify for an exemption under Rule 16b-3, the transactions contemplated under the Plan shall be structured to satisfy the requirements for exemption under Rule 16b-3.

(b)*Powers of the Committee*. Subject to the provisions of the Plan, and subject to the specific duties delegated by the Board to the Committee, the Committee shall have the authority, in its discretion:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)to determine the Fair Market Value of the Common Stock;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)to select the Employees and Consultants to whom Awards will be granted under the Plan;

64 Kforce 2026 Proxy Statement

------

<u>[**Table of Contents**](#ibde21b2946834ef1acfb04b1aa73fd7c_16)</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)to determine whether, when, to what extent and in what types and amounts Awards are granted under the Plan;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv)to determine the number of shares of Common Stock to be covered by each Award granted under the Plan;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v)to determine the forms of Award Agreements, which need not be the same for each grant or for each Grantee, and which may be delivered electronically, for use under the Plan;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vi)to determine the terms and conditions, not inconsistent with the terms of the Plan (including the minimum vesting provision in Sections 5(c) of the Plan and the holding requirements applicable to certain Options and SARs in Section 6(f)(ii) and 7(e) of the Plan), of any Award granted under the Plan. Such terms and conditions, which need not be the same for each Award or for each Grantee, include, but are not limited to, the exercise price, the time or times when Options and SARs may be exercised (which may be based on performance criteria), the extent to which vesting is suspended during a leave of absence, any vesting acceleration or waiver of forfeiture restrictions, and any restriction or limitation regarding any Award or the shares of Common Stock relating thereto, based in each case on such factors as the Committee shall determine;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vii)to construe and interpret the terms of the Plan and Awards;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(viii)to prescribe, amend and rescind rules and regulations relating to the Plan, including, without limiting the generality of the foregoing, rules and regulations relating to the operation and administration of the Plan to accommodate the specific requirements of local and foreign laws and procedures;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;i.to modify or amend each Award (subject to Section 14 of the Plan). However, the Administrator's authority to modify or amend an Award is expressly limited in accordance with Section 303A.08 of the NYSE Listed Company Manual Section 303A.08 of the NYSE Listed Company Manual. Therefore, any modification or amendment of an Option or SAR that would be treated as a "repricing" under Section 303A.08 of the NYSE Listed Company Manual shall not be effective without the approval of the shareholders of the Firm. For purposes of this Section 4(b)(ix) of the Plan, "repricing" means any of the following or any other action that has the same effect:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)lowering the exercise price of an Option or SAR after it is granted;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)any other action that is treated as a repricing under generally accepted accounting principles; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)canceling an Option or SAR at a time when its exercise price exceeds the Fair Market Value of the underlying Shares, in exchange for another Award or cash, unless the cancellation and exchange occurs in connection with a merger, acquisition, spin-off, or other similar corporate transaction;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(x)to authorize any person to execute on behalf of the Firm any instrument required to effect the grant of an Award previously granted by the Committee;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(xi)to determine the terms and restrictions applicable to Awards;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(xii)to make such adjustments or modifications to Awards granted to Grantees who are Employees of foreign Subsidiaries as are advisable to fulfill the purposes of the Plan or to comply with Applicable Law;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(xiii)to delegate its duties and responsibilities under the Plan with respect to sub-plans applicable to foreign Subsidiaries, except its duties and responsibilities with respect to Employees who are also Officers or Directors subject to Section 16(b) of the Exchange Act;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(xiv)to correct any defect or supply any omission, or reconcile any inconsistency in the Plan, or in any Award Agreement, in the manner and to the extent it shall deem necessary or expedient to make the Plan and/or Award Agreement fully effective;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(xv)to provide any notice, agreement or other communication required or permitted by the Plan in either written or electronic form;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(xvi)subject to the minimum vesting provision in Sections 5(c) of the Plan, to determine the vesting period during which each Award shall be subject to a risk of forfeiture upon a voluntary termination of employment or service, or termination in other specified circumstances, and the terms upon which such risk will end (i.e., "vesting" will occur), at a stated date or dates or on an accelerated basis in specified circumstances; and

&nbsp;&nbsp;&nbsp;&nbsp;(xvii)to make all other determinations deemed necessary or advisable for administering the Plan.

(d)*Effect of Administrator's Decision*. The Committee's decisions, determinations and interpretations shall be final and binding on all Grantees and any other holders of Awards.

**5. Eligibility and General Conditions of Awards.** 

(a)*Eligibility*. Awards other than Incentive Stock Options may be granted to Employees and Consultants. Incentive Stock Options may be granted only to Employees. If otherwise eligible, an Employee or Consultant who has been granted an

65 Kforce 2026 Proxy Statement

------

<u>[**Table of Contents**](#ibde21b2946834ef1acfb04b1aa73fd7c_16)</u>

Award may be granted additional Awards. Modifications to outstanding Awards may be made without regard to whether the Grantee is then currently eligible for a new Award.

(b)*Maximum Term; Deferral*. Subject to the following provision, the term during which an Award may be outstanding shall not extend more than 15 years after the Date of Grant and shall be subject to earlier termination as specified elsewhere in the Plan or Award Agreement. The Committee may permit or require a Grantee to defer receipt of the payment of cash or the delivery of Shares that would otherwise be due by virtue of the grant of or the lapse or waiver of restrictions with respect to Awards other than Options and SARs. If any such deferral is required or permitted, the Committee shall establish such rules and procedures for such deferral, including rules and procedures implemented pursuant to Section 21 of the Plan for compliance with Code Section 409A. Any deferral of a cash payment or of the delivery of Shares that is permitted or required by the Committee may, if so permitted or required by the Committee, extend more than 15 years after the Date of Grant of the Award to which the deferral relates.

(c)*Minimum Vesting*. Except with respect to a maximum of five percent of the Share Reserve, as may be adjusted pursuant to Section 12 of the Plan, and except for the death or Disability of the grantee, or a Change in Control, no Award shall provide for vesting that is any more rapid than vesting on the one year anniversary of the Date of Grant or, with respect to a Performance-Based Award, a Performance Period that is less than twelve months. Treatment of Awards in cases of death, Disability, and Change in Control may be specifically addressed in the Plan or an individual Award Agreement or an employment agreement with the Grantee.

(d)*Award Agreement*. To the extent not set forth in the Plan, the terms and conditions of each Award, which need not be the same for each Award or for each Grantee, shall be set forth in an Award Agreement. The Committee, in its discretion, may require as a condition to any Award Agreement's effectiveness that the Award Agreement be executed by the Grantee, including by electronic signature or other electronic indication of acceptance, and that the Grantee agree to such further terms and conditions as specified in the Award Agreement.

(e)*Maximum Awards to Non-Employee Directors.* Notwithstanding any provision to the contrary in the Plan, the following limitations shall apply to Awards granted to non-Employee Directors under the Plan: (i) the maximum number of Shares subject to Options and SARs granted under the Plan to any non-Employee Director during any calendar year shall not exceed $220,000 in total value (the "Non-Employee Director Option/SAR Limit"), and (ii) the maximum number of Shares subject to Stock Awards and Other Stock-Based Awards granted under the Plan to any non-Employee Director during any calendar year shall not exceed $400,000 in total value, excluding for this purpose the value of any dividends or Dividend Equivalents paid pursuant to any Stock Awards and Other Stock-Based Awards granted in a previous year (the "Non-Employee Director Full Value Award Limit"). For purposes of the Non-Employee Director Option/SAR Limit and the Non-Employee Director Full Value Award Limit, the value of any Award shall be its Fair Market Value on the Date of Grant for the Firm's financial reporting purposes.

(f)*Termination of Employment or Consulting Relationship*. In the event that a Grantee's Continuous Status as an Employee or Consultant terminates (other than upon the Grantee's death or Disability), then, unless otherwise provided by the Committee in the Award Agreement or an employment agreement with the Grantee, and subject to Section 12 of the Plan:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)Subject to Section 5(f)(ii) below, the Grantee may exercise his or her unexercised Option or SAR within 30 days of the Date of Termination and only to the extent that the Grantee was entitled to exercise it at the Date of Termination (but in no event later than the expiration of the term of such Option or SAR as set forth in the Award Agreement). If, at the Date of Termination, the Grantee is not entitled to exercise his or her entire Option or SAR, the Shares covered by the unexercisable portion of the Option or SAR shall revert to the Plan and increase the Share Reserve. If, after the Date of Termination, the Grantee does not exercise his or her Option or SAR within 30 days, the Option or SAR shall terminate, and the Shares covered by such Option or SAR shall revert to the Plan and increase the Share Reserve. If a Grantee exercises his or her unexercised Option or SAR subsequent to the Date of Termination, the Grantee is not permitted to utilize Shares to cover the exercise cost of the Option or SAR or to cover their minimum payroll tax withholding obligations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)in the event that a Grantee's Continuous Status as an Employee or Consultant terminates for Cause, all of his or her unexercised Options or SARs shall terminate immediately upon the Date of Termination and the Shares covered by such Option or SAR shall revert to the Plan and increase the Share Reserve;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)the Grantee's Stock Awards and Other Stock-Based Awards, to the extent forfeitable immediately before the Date of Termination, shall thereupon automatically be forfeited;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv)the Grantee's Stock Awards and Other Stock-Based Awards that were not forfeitable immediately before the Date of Termination shall promptly be settled in accordance with the terms of the applicable Award Agreement; and

66 Kforce 2026 Proxy Statement

------

<u>[**Table of Contents**](#ibde21b2946834ef1acfb04b1aa73fd7c_16)</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v)any Stock Awards and Other Stock-Based Awards subject to performance criteria with respect to which the Performance Period has not ended as of the Date of Termination shall terminate immediately upon the Date of Termination.

(g)*Disability of Grantee*. In the event that a Grantee's Continuous Status as an Employee or Consultant terminates as a result of the Grantee's Disability, then, unless otherwise provided by the Committee in the Award Agreement or an employment agreement with the Grantee:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)the Grantee may exercise his or her unexercised Option or SAR at any time within 90 days from the Date of Termination, but only to the extent that the Grantee was entitled to exercise the Option or SAR at the Date of Termination (but in no event later than the expiration of the term of the Option or SAR as set forth in the Award Agreement). If, at the Date of Termination, the Grantee is not entitled to exercise his or her entire Option or SAR, the Shares covered by the unexercisable portion of the Option or SAR shall revert to the Plan and increase the Share Reserve. If, after the Date of Termination, the Grantee does not exercise his or her Option or SAR within the time specified herein, the Option or SAR shall terminate, and the Shares covered by such Option or SAR shall revert to the Plan and increase the Share Reserve.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)the Grantee's Stock Awards and Other Stock-Based Awards, to the extent forfeitable immediately before the Date of Termination, shall thereupon automatically be forfeited;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)the Grantee's Stock Awards and Other Stock-Based Awards that were not forfeitable immediately before the Date of Termination shall promptly be settled in accordance with the terms of the applicable Award Agreement; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv)any Stock Awards and Other Stock-Based Awards subject to performance criteria with respect to which the Performance Period has not ended as of the Date of Termination shall terminate immediately upon the Date of Termination.

(h)*Death of Grantee*. In the event of the death of a Grantee, then, unless otherwise provided by the Committee in the Award Agreement or an employment agreement with the Grantee,

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)the Grantee's unexercised Option or SAR may be exercised at any time within 90 days following the date of death (but in no event later than the expiration of the term of such Option or SAR as set forth in the Award Agreement), by the Grantee's estate or by a person who acquired the right to exercise the Option or SAR by bequest or inheritance, but only to the extent that the Grantee was entitled to exercise the Option or SAR at the date of death. If, on the date of death, the Grantee was not entitled to exercise his or her entire Option or SAR, the Shares covered by the unexercisable portion of the Option or SAR shall immediately revert to the Plan and increase the Share Reserve. If, after death, the Grantee's estate or a person who acquired the right to exercise the Option or SAR by bequest or inheritance does not exercise the Option or SAR within the time specified herein, the Option or SAR shall terminate, and the Shares covered by such Option or SAR shall revert to the Plan and increase the Share Reserve.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)the Grantee's Stock Awards and Other Stock-Based Awards, to the extent forfeitable immediately before the date of death, shall thereupon automatically be forfeited;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)the Grantee's Stock Awards and Other Stock-Based Awards that were not forfeitable immediately before the date of death shall promptly be settled in accordance with the terms of the applicable Award Agreement; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv)any Stock Awards and Other Stock-Based Awards subject to performance criteria with respect to which the Performance Period has not ended as of the date of death shall terminate immediately upon the date of death.

(i)*Nontransferability of Awards*.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)Except as provided in Section 5(i)(iii) below, each Award, and each right under any Award, shall be exercisable only by the Grantee during the Grantee's lifetime, or, if permissible under Applicable Law, by the Grantee's guardian or legal representative.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)Except as provided in Section 5(i)(iii) below, no Award (prior to the time, if applicable, Shares are issued in respect of such Award), and no right under any Award, may be assigned, alienated, pledged, attached, sold or otherwise transferred or encumbered by a Grantee otherwise than by will or by the laws of descent and distribution (or in the case of Restricted Stock Awards, to the Firm) and any such purported assignment, alienation, pledge, attachment, sale, transfer or encumbrance shall be void and unenforceable against the Firm or any Subsidiary; provided, that the designation of a beneficiary shall not constitute an assignment, alienation, pledge, attachment, sale, transfer or encumbrance.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)To the extent and in the manner permitted by Applicable Law, and to the extent and in the manner permitted by the Committee, and subject to such terms and conditions as may be prescribed by the Committee, a Grantee may transfer an Award to:

67 Kforce 2026 Proxy Statement

------

<u>[**Table of Contents**](#ibde21b2946834ef1acfb04b1aa73fd7c_16)</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.a child, stepchild, grandchild, parent, stepparent, grandparent, spouse, former spouse, sibling, niece, nephew, mother-in-law, father-in-law, son-in-law, daughter-in-law, brother-in-law, or sister-in-law of the Grantee (including adoptive relationships);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.any person sharing the employee's household (other than a tenant or employee);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.a trust in which persons described in (a) and (b) have more than 50 percent of the beneficial interest;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.a foundation in which persons described in (a) or (b) or the Grantee control the management of assets; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.any other entity in which the persons described in (a) or (b) or the Grantee own more than 50 percent of the voting interests;

provided such transfer is not for value. The following shall not be considered transfers for value: a transfer under a domestic relations order in settlement of marital property rights, and a transfer to an entity in which more than 50 percent of the voting interests are owned by persons described in (a) above or the Grantee, in exchange for an interest in such entity.

**6. Stock Options.** Subject to the terms of the Plan, including without limitation the minimum vesting provision in Section 5(c) of the Plan, the Committee may grant Options to Employees or Consultants from time to time upon such terms and conditions as the Committee may determine in accordance with the following provisions:

(a)*Limitations*.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)Options granted under the Plan may be Incentive Stock Options, Nonqualified Stock Options, or a combination of the foregoing. Each Award shall specify whether (or the extent to which) the Option is an Incentive Stock Option or a Nonqualified Stock Option. Notwithstanding any such designation, to the extent that the aggregate Fair Market Value of the Shares as of the Date of Grant with respect to which Options designated as Incentive Stock Options are exercisable for the first time by the Grantee during any calendar year (under the Plan and any other employee stock option plan of the Firm or any Parent or Subsidiary) exceeds $100,000, such Options shall be treated as Nonqualified Stock Options.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)No Employee shall be granted, in any calendar year, Options to purchase more than 500,000 Shares, and no Consultant (other than a non-Employee Director, who is subject to the Non-Employee Director Option/SAR Limit in Section 5(e) of the Plan) shall be granted, in any calendar year, Options to purchase more than 100,000 Shares. The limitation described in this Section 6(a)(ii) shall be adjusted proportionately in connection with any change in the Firm's capitalization as described in Section 12 of the Plan. If an Option is canceled in the same calendar year in which it was granted (other than in connection with a transaction described in Section 12 of the Plan), the canceled Option will be counted against the limitation described in this Section 6(a)(ii).

(b)*Term of Option*. The term of each Option shall be stated in the Award Agreement. The term of a Nonqualified Stock Option shall be 15 years from the Date of Grant or such shorter term as may be provided in the Award Agreement. The term of an Incentive Stock Option shall not exceed 10 years from the Date of Grant or such shorter term as may be provided in the Award Agreement; in the case of an Incentive Stock Option granted to a Grantee who on the Date of Grant owns stock representing more than 10 percent of the voting power of all classes of stock of the Firm or any Parent or Subsidiary, the term of the Incentive Stock Option shall be 5 years from the Date of Grant or such shorter term as may be provided in the Award Agreement.

(c)Option Exercise Price. The per share exercise price for the Shares to be issued pursuant to exercise of an Option shall be determined by the Committee and, except as otherwise provided in this Section 6(c), shall be no less than 100 percent of the Fair Market Value per Share on the Date of Grant.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.In the case of an Incentive Stock Option granted to an Employee who on the Date of Grant owns stock representing more than 10 percent of the voting power of all classes of stock of the Firm or any Parent or Subsidiary, the per Share exercise price shall be no less than 110 percent of the Fair Market Value per Share on the Date of Grant.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Any Option that is (1) granted to a Grantee in connection with the acquisition ("Acquisition"), however effected, by the Firm of another corporation or entity ("Acquired Entity") or the assets thereof, (2) associated with an option to purchase shares of stock or other equity interest of the Acquired Entity or an affiliate thereof ("Acquired Entity Option") held by such Grantee immediately prior to such Acquisition, and (3) intended to preserve for the Grantee the economic value of all or a portion of such Acquired Entity Option, may be granted with such exercise price as the Committee determines to be necessary to achieve such preservation of economic value.

a.*Waiting Period and Exercise Dates*. At the time an Option is granted, the Committee shall fix the period within which the Option may be exercised and shall determine any conditions that must be satisfied before the Option may be exercised. An Option shall be exercisable only to the extent that it is vested according to the terms of the Award Agreement.

68 Kforce 2026 Proxy Statement

------

<u>[**Table of Contents**](#ibde21b2946834ef1acfb04b1aa73fd7c_16)</u>

b.*Form of Consideration*. The Committee shall determine the acceptable form of consideration for exercising an Option, including the method of payment. In the case of an Incentive Stock Option, the Committee shall determine the acceptable form of consideration at the time of Award. The acceptable form of consideration may consist of any combination of cash, personal check, wire transfer or, subject to the approval of the Committee:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)net exercise, in which case the Firm will not require payment of the Option exercise price from the Grantee but will reduce the number of Shares issued upon the exercise by the number of whole Shares that has an aggregate Fair Market Value that is equal to the aggregate Option exercise price for the portion of the Option exercised;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)pursuant to procedures approved by the Committee, (A) through the sale of the Shares acquired on exercise of the Option through a broker-dealer to whom the Grantee has submitted an irrevocable notice of exercise and irrevocable instructions to deliver promptly to the Firm the amount of sale or loan proceeds sufficient to pay the exercise price, together with, if requested by the Firm, the amount of federal, state, local or foreign withholding taxes payable by the Grantee by reason of such exercise, or (B) through simultaneous sale through a broker of Shares acquired upon exercise; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) such other consideration and method of payment for the issuance of Shares to the extent permitted by Applicable Law.

c.*Exercise of Option*.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)*Procedure for Exercise; Rights as a Shareholder*.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.Any Option granted hereunder shall be exercisable according to the terms of the Plan and at such times and under such conditions as determined by the Committee and set forth in the Award Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.An Option may not be exercised for a fraction of a Share.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.An Option shall be deemed exercised when the Firm receives:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;i.written or electronic notice of exercise (in accordance with the Award Agreement and any action taken by the Committee pursuant to Section 4(b) of the Plan) from the person entitled to exercise the Option, and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ii.full payment for the Shares with respect to which the Option is exercised. Full payment may consist of any consideration and method of payment authorized by the Committee and permitted by the Award Agreement and the Plan.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;iii.Shares issued upon exercise of an Option shall be issued in the name of the Grantee or, if requested by the Grantee, in the name of the Grantee and his or her spouse (or other permitted transferee). Until the stock certificate evidencing such Shares is issued or delivery is otherwise effected by the Firm (as evidenced by the appropriate entry on the books of the Firm or of a duly authorized transfer agent of the Firm), no right to vote or receive dividends or any other rights as a shareholder shall exist with respect to such Shares, notwithstanding the exercise of the Option. The Firm shall issue (or cause to be issued) such stock certificate, or provide a commercially reasonable alternative means of delivery, promptly after the Option is exercised. No adjustment will be made for a dividend or other right for which the record date is prior to the date the stock certificate is issued or delivery is otherwise effected by the Firm, except as provided in Section 12 of the Plan.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;iv.Exercising an Option in any manner shall decrease the number of Shares thereafter available, both for purposes of the Plan and for sale under the Option, by the number of Shares as to which the Option is exercised.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)*Holding Requirement.* As a condition to the grant of an Option to a Grantee who is a Named Executive Officer, the Grantee shall hold the Shares acquired upon exercise of the Option for a minimum period of one year following the date of exercise.

**7. Stock Appreciation Rights.** Subject to the terms of the Plan, including without limitation the minimum vesting provision in Section 5(c) of the Plan, the Committee may grant Stock Appreciation Rights to Employees or Consultants from time to time upon such terms and conditions as the Committee may determine in accordance with the following provisions. A SAR shall be exercisable only to the extent that it is vested according to the terms of the Award Agreement. A SAR is the right of the Grantee to receive from the Firm an amount in Shares equal to the Spread at the time of the exercise of such right. The term of each SAR shall be stated in the Award Agreement; provided, however, that the term shall be 15 years from the Date of Grant or such shorter term as may be provided in the Award Agreement.

(a)*Base Price*. The Base Price shall be equal to or greater than the Fair Market Value on the Date of Grant.

69 Kforce 2026 Proxy Statement

------

<u>[**Table of Contents**](#ibde21b2946834ef1acfb04b1aa73fd7c_16)</u>

(b)*Exercise of SARs*. SARs shall be exercised by the delivery of a written or electronic notice of exercise to the Firm (in accordance with the Award Agreement and any action taken by the Committee pursuant to Section 4(b) of the Plan or otherwise), setting forth the number of Shares with respect to which the SAR is to be exercised.

(c)*Payment of SAR Benefit*. Upon exercise of a SAR, the Grantee shall be entitled to receive payment in the form of Shares from the Firm in an amount determined by multiplying:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)the Spread; by

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)the number of Shares with respect to which the SAR is exercised; provided, that the Committee may provide in the Award Agreement that the benefit payable on exercise of a SAR shall not exceed such limit (which may be expressed as a percentage of the Fair Market Value of a Share on the Date of Grant or as a fixed value limit or otherwise) as the Committee shall specify. The payment upon exercise of a SAR shall be in Shares that have an aggregate Fair Market Value (as of the date of exercise of the SAR) equal to the amount of the payment.

Until the stock certificate evidencing such Shares is issued or delivery is otherwise effected by the Firm (as evidenced by the appropriate entry on the books of the Firm or of a duly authorized transfer agent of the Firm), no right to vote or receive dividends or any other rights as a shareholder shall exist with respect to the Covered Stock, notwithstanding the exercise of the SAR. The Firm shall issue (or cause to be issued) such stock certificate, or provide a commercially reasonable alternative means of delivery, promptly after the SAR is exercised. No adjustment will be made for a dividend or other right for which the record date is prior to the date the stock certificate is issued or delivery is otherwise effected by the Firm, except as provided in Section 12 of the Plan.

(d)No Employee shall be granted, in any calendar year, SARs with respect to more than 500,000 Shares, and no Consultant (other than a non-Employee Director, who is subject to the Non-Employee Director Option/SAR Limit in Section 5(e) of the Plan) shall be granted, in any calendar year, SARs to purchase more than 100,000 Shares. The limitation described in this Section 7(d) shall be adjusted proportionately in connection with any change in the Firm's capitalization as described in Section 12 of the Plan. If a SAR is canceled in the same calendar year in which it was granted (other than in connection with a transaction described in Section 12 of the Plan), the canceled SAR will be counted against the limitation described in this Section 7(d).

(e)As a condition to the grant of a SAR to a Grantee who is a Named Executive Officer, the Grantee shall hold the Shares acquired upon exercise of the SAR for a minimum period of one year following the date of exercise.

**8. Stock Awards.** 

(a)*Administrator Action*. Subject to the terms of the Plan, including without limitation the minimum vesting provision in Section 5(c) of the Plan, the Committee, acting in its discretion, may grant Stock Awards to any Employee or Consultant from time to time, in such amount and upon such terms and conditions as shall be determined by the Committee. A Stock Award may be made in Shares or denominated in units representing rights to receive Shares. No Stock Award relating to more than 500,000 Shares may be granted to an Employee in any calendar year, and no Stock Award relating to more than 100,000 Shares may be granted to any Consultant (other than a non-Employee Director, who is subject to the Non-Employee Director Full Value Award Limit in Section 5(e) of the Plan) in any calendar year. Each Stock Award shall be evidenced by an Award Agreement, and each Award Agreement shall set forth the conditions, if any, that will need to be timely satisfied before the Stock Award will be effective, vested and settled, and the conditions, if any, under which the Grantee's interest in the related Shares or units will be forfeited. Any such conditions for effectiveness or nonforfeitability may be based upon the passage of time and continued service by the Grantee, or the achievement of specified performance objectives, or both time-based and performance-based conditions. The Committee, acting in its discretion, may make the grant of a Stock Award to a Grantee subject to the satisfaction of one, or more than one, objective employment, performance, or other grant condition that the Committee deems appropriate under the circumstances for Employees or Consultants generally or for a Grantee in particular, and the related Award Agreement shall set forth each such condition and the deadline for satisfying each such grant condition. Either as an alternative to or in addition to a condition on the effectiveness of the grant of a Stock Award, the Committee may make a Stock Award (if, when, and to the extent that the grant of the Stock Award becomes effective) subject to one, or more than one, objective employment, performance, or other forfeiture condition that the Committee acting in its discretion deems appropriate under the circumstances for Employees or Consultants generally or for a Grantee in particular, and the related Award Agreement shall set forth each such condition and the deadline for satisfying each such forfeiture condition. A Grantee's nonforfeitable interest in the Shares related to a grant of a Stock Award shall depend on the extent to which each such condition is timely satisfied.

(b)*Types of Stock Awards.* A Stock Award made in Shares that are subject to forfeiture conditions and/or other restrictions may be designated as an Award of "Restricted Stock." A Stock Award denominated in units that are subject to forfeiture conditions and/or other restrictions may be designated as an Award of "Restricted Stock Units" or "RSUs." For the

70 Kforce 2026 Proxy Statement

------

<u>[**Table of Contents**](#ibde21b2946834ef1acfb04b1aa73fd7c_16)</u>

avoidance of doubt, the Committee is authorized to grant Shares as a bonus, or to grant Shares or other Awards in lieu of obligations of the Firm or a Subsidiary to pay cash or deliver other property under the Plan or under other plans or compensatory arrangements, subject to such terms as shall be determined by the Committee.

(c)*Dividend Rights*.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)*Restricted Stock Award*. Each Restricted Stock Award Agreement shall state whether the Grantee shall have a right to receive any cash dividends that are paid with respect to his or her Restricted Stock after the date his or her Restricted Stock Award has become effective and before the first day that the Grantee's interest in such stock is forfeited completely or becomes completely vested and nonforfeitable. The Grantee shall not receive any payment of any dividends that are paid with respect to a Share of Restricted Stock unless and not earlier than such time as the Share becomes vested and nonforfeitable, and the Award Agreement shall (subject to Section 21 and other applicable requirements of Code Section 409A) set forth the conditions, if any, under which the Grantee will be eligible to receive payment(s) in the future of the cumulative cash dividends (without interest) payable on the Shares that become vested and nonforfeitable for the period beginning on the effective date of the Award and ending on the vesting date of the Award. If an Award Agreement calls for any such payments to be made, the Firm shall make such payments from the Firm's general assets, and the Grantee shall be no more than a general and unsecured creditor of the Firm with respect to such payments. If a stock dividend is declared on such a Share after the Award is effective but before the Grantee's interest in such Stock has been forfeited or has become nonforfeitable, such stock dividend shall be treated as part of the Award of the related Restricted Stock, and a Grantee's interest in such stock dividend shall be forfeited or shall become vested and nonforfeitable at the same time as the Share with respect to which the stock dividend was paid is forfeited or becomes vested and nonforfeitable. If a dividend is paid other than in cash or stock, the disposition of such dividend shall be made in accordance with such rules as the Committee shall adopt with respect to each such dividend, which shall include a provision that the Grantee shall not receive any payment of any such dividends unless and not earlier than such time as the applicable Share becomes vested and nonforfeitable. For the avoidance of doubt, notwithstanding any provision of an Award Agreement or the absence of any Award Agreement provision relating to dividends, (a) no dividend or distribution declared with respect to a Share of Restricted Stock shall be paid to a Grantee unless and until the Share becomes vested and nonforfeitable, (b) a Grantee shall not have a vested and nonforfeitable right to any dividend or distribution declared with respect to a Share of Restricted Stock unless and until the Share becomes vested and nonforfeitable, and (c) a Grantee's right to any dividend or distribution declared with respect to a Share of Restricted Stock shall be forfeited to the extent that the Grantee's right to the Share is forfeited.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)*RSU Award*. Unless otherwise determined by the Committee, a Grantee shall not have any rights as a shareholder with respect to Shares underlying an Award of RSUs until such time, if any, as the underlying Shares are actually issued to the Grantee. The Committee may provide in an RSU Award Agreement for the payment of Dividend Equivalents to the Grantee at the time of vesting of the RSUs or other payout of the vested RSUs. The Award Agreement shall provide whether such Dividend Equivalents shall be paid in cash or converted into additional shares of Common Stock or RSUs by such formula and at such time and subject to such limitations as may be determined by the Committee. The Grantee shall not receive any payment of any Dividend Equivalent with respect to any RSU unless, and not earlier than such time as, the RSU becomes vested and nonforfeitable. The payment or crediting of Dividend Equivalents shall conform to the applicable requirements of Code Section 409A. For the avoidance of doubt, notwithstanding any provision of an Award Agreement or the absence of any Award Agreement provision relating to Dividend Equivalents, (a) no Dividend Equivalent with respect to any RSU shall be paid to a Grantee unless and until the RSU becomes vested and nonforfeitable, (b) a Grantee shall not have a vested and nonforfeitable right to any Dividend Equivalent with respect to an RSU unless and until the RSU becomes vested and nonforfeitable, and (c) a Grantee's right to any Dividend Equivalent with respect to any RSU shall be forfeited to the extent that the Grantee's right to the RSU is forfeited.

(d)*Voting Rights.* A Grantee shall have the right to vote the Shares related to his or her Restricted Stock grant after the Date of Grant but before his or her interest in such Shares has been forfeited or has become nonforfeitable. A Grantee shall not have the right to vote the Shares related to his or her RSU grant until such time, if any, as the Shares are actually issued to the Grantee.

(e)*Satisfaction of Forfeiture Conditions*. A Share related to a Restricted Stock Award shall cease to be Restricted Stock at such time as a Grantee's interest in such Share becomes nonforfeitable under the Plan, and the certificate representing such Share shall be reissued as soon as practicable thereafter without any further restrictions related to Section 8(c) or Section 8(d) and shall be transferred to the Grantee.

**9. Other Stock-Based Awards.** Subject to the terms of the Plan, including without limitation the minimum vesting provision in Section 5(c) of the Plan, the Committee may grant Other Stock-Based Awards to Employees or Consultants from time to time. Other Stock-Based Awards may be granted in such amounts, on such terms and conditions, including without limitation terms

71 Kforce 2026 Proxy Statement

------

<u>[**Table of Contents**](#ibde21b2946834ef1acfb04b1aa73fd7c_16)</u>

and conditions relating to dividend (including Dividend Equivalent) and voting rights, and for such consideration, including no consideration or such minimum consideration as may be required by Applicable Law, as the Committee determines in its discretion. The Grantee shall not receive any payment of any dividend or Dividend Equivalent with respect to the Award unless, and not earlier than such time as, the portion of the Award to which the dividend or Dividend Equivalent relates becomes vested and nonforfeitable, and the terms of the Award shall (subject to Section 21 and other applicable requirements of Code Section 409A) set forth the conditions, if any, under which the Grantee will be eligible to receive payment(s) of the dividend or Dividend Equivalent following the vesting of the applicable portion of the Award. If the terms of an Other Stock-Based Award calls for any such payments to be made, the Firm shall make such payments from the Firm's general assets, and the Grantee shall be no more than a general and unsecured creditor of the Firm with respect to such payments. For the avoidance of doubt, notwithstanding any provision of an Award Agreement or the absence of any Award Agreement provision relating to dividends or Dividend Equivalents, (a) no dividend or Dividend Equivalent with respect to any Other Stock-Based Award shall be paid to a Grantee unless and until the portion of the Award to which the dividend or Dividend Equivalent relates becomes vested and nonforfeitable, (b) a Grantee shall not have a vested and nonforfeitable right to any dividend or Dividend Equivalent with respect to an Other Stock-Based Award unless and until the portion of the Award to which the dividend or Dividend Equivalent relates becomes vested and nonforfeitable, and (c) a Grantee's right to any dividend or Dividend Equivalent with respect to any Other Stock-Based Award shall be forfeited to the extent that the Grantee's right to the portion of the Award to which the dividend or Dividend Equivalent relates is forfeited. Without limitation, the terms and conditions applicable to an Other Stock-Based Award may include one, or more than one, objective time-based, performance-based, or other grant condition(s) that the Committee requires to be timely satisfied before the grant of the Other Stock-Based Award will be effective, and/or one, or more than one, objective time-based, performance-based, or other condition(s) that the Committee requires to be timely satisfied before the Other Stock-Based Award, or any portion or component of the Other Stock-Based Award, will be vested and nonforfeitable. Other Stock-Based Awards may be denominated in cash, in Shares or other securities, in units representing the rights to receive Shares, in securities or debentures convertible into Shares, or in any combination of the foregoing, and may be paid in Shares or other securities, in cash, or in a combination of Shares or other securities and cash, all as determined in the discretion of the Committee. No more than 500,000 Shares may be granted to an Employee in any calendar year under an Other Stock-Based Award that is denominated in Shares or units representing rights to receive Shares, and no more than 100,000 Shares may be granted to a Consultant (other than a non-Employee Director, who is subject to the Non-Employee Director Full Value Award Limit in Section 5(e) of the Plan) in any calendar year under an Other Stock-Based Award that is denominated in Shares or units representing rights to receive Shares. The maximum amount that a Grantee may earn by satisfaction of performance goals during any calendar year under Other Stock-Based Awards that are denominated in cash or any medium other than Shares or units representing rights to receive Shares is $7,500,000. For purposes of the limitation stated in the immediately preceding sentence, the calendar year in which the applicable performance goal(s) is satisfied is the calendar year in which the limitation applies, without regard to the duration of the Performance Period or any additional time-based vesting conditions or other terms or conditions relating to the payment of the Other Stock-Based Award.

**10. Performance-Based Awards.**

(a)*In General.* The Committee may grant Options, Stock Appreciation Rights, Stock Awards, and Other Stock-Based Awards that are Performance-Based Awards. On the Date of Grant of each Performance-Based Award, the Committee shall establish the Performance Period, the Performance Measure(s), and the Performance Goal(s) in respect of such Performance-Based Awards. Each Performance-Based Award shall provide that, in order for the Award to be granted or earned or for the Grantee to receive all or a portion of the Shares or cash subject to such Performance-Based Award, one or more specific Performance Goals must be attained over a designated Performance Period, with attainment of the Performance Goal(s) determined using specific Performance Measure(s). The Performance Goal(s), Performance Measure(s) and Performance Period shall be established by the Committee in its discretion.

72 Kforce 2026 Proxy Statement

------

<u>[**Table of Contents**](#ibde21b2946834ef1acfb04b1aa73fd7c_16)</u>

(b)*Performance Goals.* If a Stock Award or Other Stock-Based Award is subject to this Section 10, then the effectiveness of the grant of the Award, or the vesting and nonforfeitability of the Award, or both the effectiveness of the grant of the Award and the vesting and nonforfeitability of the Award shall be subject to satisfaction of one, or more than one, objective Performance Goals. The Committee shall, for the Performance Period applicable to the Award, establish the Performance Goal(s) based on the Performance Measure(s) selected by the Committee to apply to each Award and a formula or matrix prescribing the extent to which such Award shall be earned based upon the level of achievement of such Performance Goal(s). The Committee may establish different Performance Goals for different Grantees and different Awards. The Performance Goal(s) with respect to such Performance Measure(s) may be established at such levels and in such terms as the Committee may determine, in its discretion, including in absolute terms, as a goal relative to performance in prior periods, or as a goal compared to the performance of one or more comparable companies or an index covering multiple companies. The performance goals may be established in terms of Firm-wide objectives, objectives that are related to the performance of the individual Grantee or the Subsidiary, division, department, or function within the Firm or Subsidiary in which the Grantee is employed, or any other manner that the Committee determines appropriate in its discretion. Performance goals need not be based on audited financial results.

(c)*Adjustments and Procedure.* The Committee shall retain discretion to decrease the amount of the Award at any time through the date at which the Committee certifies the attainment of the Performance Goal(s), generally referred to as "negative discretion." The Committee may determine performance before payment of bonuses, capital charges, non-recurring income or expense, items of an unusual nature or of a type that indicates infrequency of occurrence, or other financial and general and administrative expenses for the Performance Period, and may measure the attainment of the Performance Goal by appropriately adjusting the evaluation of performance to exclude the effect of any changes in accounting principles affecting the Firm's or a business unit's reported results. The Committee may provide in the applicable Award Agreement additional rules and procedures relating to the Committee's ability to adjust aspects of a Performance-Based Award, the Committee's ability to increase or decrease the amount of compensation provided by a Performance-Based Award, and the Committee's certification or other determination of the extent to which Performance Goals have or have not been attained.

**11. Tax Withholding.** The Firm shall deduct from all cash distributions under the Plan any taxes required to be withheld by federal, state, local or foreign government. Whenever the Firm proposes or is required to issue or transfer Shares under the Plan, the Firm shall have the right to require the recipient to remit to the Firm an amount sufficient to satisfy any federal, state, local and foreign withholding tax requirements prior to the delivery of shares. A Grantee may pay the withholding tax in cash, or a Grantee may elect to have the number of Shares he is to receive reduced by the appropriate number of whole Shares that, when multiplied by the Fair Market Value of the Shares determined as of the Tax Date (defined below), is sufficient to satisfy up to the maximum applicable federal, state, local, and foreign tax withholding obligation arising from exercise, vesting, or payment of an Award as may be permitted under applicable accounting standards that would not result in the Award otherwise classified as an "equity" award under FASB Accounting Standards Codification Topic 718 ("ASC Topic 718") to be classified as a "liability" award under ASC Topic 718 as a result of the withholding of Shares with a Fair Market Value in excess of the minimum statutory tax withholding obligation (a "Withholding Election"). A Grantee may make a Withholding Election only if the Withholding Election is made on or prior to the date on which the amount of tax required to be withheld is determined (the "Tax Date") by executing and delivering to the Firm a properly completed notice of Withholding Election as prescribed by the Committee. The Committee may in its discretion disapprove and give no effect to the Withholding Election.

**12. Adjustments Upon Changes in Capitalization or Change of Control.** 

(a)*Changes in Capitalization*. Subject to any required action by the shareholders of the Firm, the number of Covered Stock, and the number of Shares of Common Stock that have been authorized for issuance under the Plan but as to which no Awards have yet been granted or that have been returned to the Plan upon cancellation or expiration of an Award, and the annual per-person limitations on Awards, as well as the price per share of Covered Stock and share-based performance conditions of Awards, shall be proportionately adjusted for any increase or decrease in the number of issued shares of Common Stock resulting from a stock split, reverse stock split, stock dividend, combination or reclassification of the Common Stock, or any other increase or decrease in the number of issued shares of Common Stock effected without receipt of consideration by the Firm; provided, however, that conversion of any convertible securities of the Firm shall not be deemed to have been "effected without receipt of consideration." Such adjustment shall be made by the Board, whose determination in that respect shall be final, binding and conclusive. Except as expressly provided herein, no issuance by the Firm of shares of stock of any class, or securities convertible into shares of stock of any class, shall affect, and no adjustment by reason thereof shall be made with respect to, the number or price of shares of Covered Stock. No adjustment shall be made pursuant to this Section 12 in a manner that would cause Incentive Stock Options to violate Code Section 422(b) or cause an Award to be subject to adverse tax consequences under Code Section 409A.

73 Kforce 2026 Proxy Statement

------

<u>[**Table of Contents**](#ibde21b2946834ef1acfb04b1aa73fd7c_16)</u>

(b)*Change in Control*. In the event of a Change in Control, then the following provisions shall apply:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)*Vesting*. The Board may, in the exercise of its discretion, accelerate the vesting and nonforfeitability of any Award that is outstanding on the date such Change in Control is determined to have occurred and that is not yet fully vested and nonforfeitable on such date.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)*Dissolution or Liquidation*. In the event of the proposed dissolution or liquidation of the Firm, to the extent that an Award is outstanding, it will terminate immediately prior to the consummation of such proposed action. The Board may, in the exercise of its discretion in such instances, declare that any Option or SAR shall terminate as of a date fixed by the Board and give each Grantee the right to exercise his or her Option or SAR as to all or any part of the Covered Stock, including Shares as to which the Option or SAR would not otherwise be exercisable.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)*Merger or Asset Sale*. Except as otherwise determined by the Board, in its discretion, prior to the occurrence of a merger of the Firm with or into another corporation, or the sale of substantially all of the assets of the Firm, in the event of such a merger or sale each outstanding Option or SAR shall be assumed or an equivalent option or right shall be substituted by the successor corporation or a Parent or Subsidiary of the successor corporation. In the event that the successor corporation or a Parent or Subsidiary of the successor corporation does not agree to assume the Option or SAR or to substitute an equivalent option or right, the Board may, in the exercise of its discretion and in lieu of such assumption or substitution, provide for the Grantee to have the right to exercise the Option or SAR as to all or a portion of the Covered Stock, including Shares as to which it would not otherwise be exercisable. If the Board makes an Option or SAR exercisable in lieu of assumption or substitution in the event of a merger or sale of assets, the Committee shall notify the Grantee that the Option or SAR shall be fully exercisable for a period of 30 days from the date of such notice, and the Option or SAR will terminate upon the expiration of such period. For the purposes of this paragraph, the Option or SAR shall be considered assumed if, following the merger or sale of assets and in a manner consistent with Code Sections 409A and 424, the option or right confers the right to purchase, for each Share of Covered Stock subject to the Option or SAR immediately prior to the merger or sale of assets, the consideration (whether stock, cash, or other securities or property) received in the merger or sale of assets by holders of Common Stock for each Share held on the effective date of the transaction (and if holders were offered a choice of consideration, the type of consideration chosen by the holders of a majority of the outstanding Shares); provided, however, that if such consideration received in the merger or sale of assets was not solely common stock of the successor corporation or its Parent, the Board may, with the consent of the successor corporation and the participant, provide for the consideration to be received upon the exercise of the Option or SAR, for each Share subject to the Option or SAR, to be solely common stock of the successor corporation or its Parent equal in Fair Market Value to the per Share consideration received by holders of Common Stock in the merger or sale of assets.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv)Except as otherwise determined by the Board, in its discretion, prior to the occurrence of a Change in Control other than the dissolution or liquidation of the Firm, a merger of the Firm with or into another corporation, or the sale of substantially all of the assets of the Firm, in the event of such a Change in Control, all outstanding Options and SARs, to the extent they are exercisable and vested, shall be terminated in exchange for a cash payment equal to an amount that does not exceed the Fair Market Value (reduced by the exercise price applicable to such Options or SARs). These cash proceeds shall be paid to the Grantee or, in the event of death of a Grantee prior to payment, to the estate of the Grantee or to a person who acquired the right to exercise the Option or SAR by bequest or inheritance.

**13. Term of Plan.** The Plan shall become effective upon its approval by the shareholders of the Firm. Such shareholder approval shall be obtained in the manner and to the degree required under applicable federal and state law. The Plan shall continue in effect until April 22, 2036, unless terminated earlier under Section 14 of the Plan.

**14. Amendment and Termination of the Plan.** 

(a)*Amendment and Termination*. The Board may at any time amend, alter, suspend or terminate the Plan.

74 Kforce 2026 Proxy Statement

------

<u>[**Table of Contents**](#ibde21b2946834ef1acfb04b1aa73fd7c_16)</u>

(b)*Shareholder Approval*. The Firm shall obtain shareholder approval of any Plan amendment to the extent necessary and desirable to comply with Rule 16b-3 or with Section 422 of the Code (or any successor rule or statute) or other Applicable Law. Such shareholder approval, if required, shall be obtained in such a manner and to such a degree as is required by the Applicable Law. Without the approval of shareholders, no amendment or alteration of the Plan or any outstanding Option or SAR will have the effect of amendment or replacing such an Option or SAR in a transaction that constitutes a "repricing." For this purpose, a repricing means: (1) amending the terms of an Option or SAR after it is granted to lower its exercise price or Base Price; (2) any other action that is treated as a repricing under generally accepted accounting principles ("GAAP"); and (3) repurchasing for cash or canceling an Option or SAR at a time when its strike price is equal to or greater than the Fair Market Value of the underlying Stock, in exchange or substitution for another Option, SAR, Stock Award, Other Stock-Based Award, other equity, or cash or other property. A cancellation and exchange or substitution described in clause (3) of the preceding sentence will be considered a repricing regardless of whether the Option, SAR, Stock Award, Other Stock-Based Award, other equity, or cash or other property is delivered simultaneously with the cancellation, regardless of whether it is treated as a repricing under GAAP, and regardless of whether it is voluntary on the part of the Grantee. Adjustments of Awards under Section 12 will not be deemed repricings, however. The Committee shall have no authority to amend, alter, or modify any Award term after the Award has been granted to the extent that the effect is to waive a term that otherwise at that time would be mandatory for a new Award of the same type under the Plan.

(c)*Effect of Amendment or Termination*. No amendment, alteration, suspension or termination of the Plan shall impair the rights of any Grantee, unless mutually agreed otherwise between the Grantee and the Committee, which agreement must be in writing and signed by the Grantee and the Firm.

**15. Conditions Upon Issuance of Shares.** 

(a)*Legal Compliance*. Shares shall not be issued pursuant to an Award unless the exercise, if applicable, of such Award and the issuance and delivery of such Shares shall comply with all relevant provisions of law, including, without limitation, the Securities Act of 1933, as amended, the Exchange Act, the rules and regulations promulgated thereunder, Applicable Law, and the requirements of any stock exchange or quotation system upon which the Shares may then be listed or quoted, and shall be further subject to the approval of counsel for the Firm with respect to such compliance.

(b)*Investment Representations*. As a condition to the exercise of an Award, the Firm may require the person exercising such Award to represent and warrant at the time of any such exercise that the Shares are being purchased only for investment and without any present intention to sell or distribute such Shares if, in the opinion of counsel for the Firm, such a representation is required.

**16. Liability of Firm.** 

(a)*Inability to Obtain Authority*. The inability of the Firm to obtain authority from any regulatory body having jurisdiction, which authority is deemed by the Firm's counsel to be necessary to the lawful issuance and sale of any Shares hereunder, shall relieve the Firm of any liability in respect of the failure to issue or sell such Shares as to which such requisite authority shall not have been obtained.

(b)*Grants Exceeding Allotted Shares*. If the Covered Stock covered by an Award exceeds, as of the Date of Grant, the number of Shares that may be issued under the Plan without additional shareholder approval, such Award shall be void with respect to such excess Covered Stock, unless shareholder approval of an amendment sufficiently increasing the number of Shares subject to the Plan is timely obtained in accordance with Section 14 of the Plan.

**17. Reservation of Shares.** The Firm, during the term of the Plan, will at all times reserve and keep available such number of Shares as shall be sufficient to satisfy the requirements of the Plan.

**18. Rights of Employees and Consultants.** Neither the Plan nor any Award shall confer upon a Grantee any right with respect to continuing the Grantee's employment or consulting relationship with the Firm, nor shall they interfere in any way with the Grantee's right or the Firm's right to terminate such employment or consulting relationship at any time, with or without cause.

**19. Sub-plans for Foreign Subsidiaries.** The Board may adopt sub-plans applicable to particular foreign Subsidiaries. All Awards granted under such sub-plans shall be treated as grants under the Plan. The rules of such sub-plans may take precedence over other provisions of the Plan, with the exception of Section 3, but unless otherwise superseded by the terms of such sub-plan, the provisions of the Plan shall govern the operation of such sub-plan.

**20. Construction.** The Plan shall be construed under the laws of the State of Florida, to the extent not preempted by federal law, without reference to the principles of conflict of laws.

75 Kforce 2026 Proxy Statement

------

<u>[**Table of Contents**](#ibde21b2946834ef1acfb04b1aa73fd7c_16)</u>

**21. Certain Limitations on Awards to Ensure Compliance with Code Section 409A.** For purposes of this Plan, references to an award term or event (including any authority or right of the Firm or a Grantee) being permitted under Code Section 409A mean, for a "409A Award" (meaning an Award that constitutes a deferral of compensation under Code Section 409A and regulations thereunder), that the term or event would not reasonably be expected to cause the Grantee to be liable for payment of interest or a tax penalty under Code Section 409A and, for a Non-409A Award (meaning all Awards other than 409A Awards), that the term or event would not reasonably be expected to cause the Award to be treated as subject to Code Section 409A. Other provisions of the Plan notwithstanding, the terms of any 409A Award and any Non-409A Award, including any authority of the Firm and rights of the Grantee with respect to the Award, shall be limited to those terms permitted under Code Section 409A, and any terms not permitted under Code Section 409A shall be automatically modified and limited to the extent necessary to conform with Code Section 409A. For this purpose, other provisions of the Plan notwithstanding, the Firm shall have no authority to accelerate distributions relating to 409A Awards in excess of the authority permitted under Code Section 409A, and any distribution subject to Code Section 409A(a)(2)(A)(i) (separation from service) to a specified employee as defined under Code Section 409A(a)(2)(B)(i), shall not occur earlier than the earliest time permitted under Code Section 409A(a)(2)(B)(i). In no event will the Firm or the Committee be liable for all or any portion of any taxes, penalties, interest or other expenses that may be incurred by the Grantee on account of Code Section 409A. The Firm may adopt a specified employee policy that will apply to identify the specified employees for all deferred compensation plans subject to Code Section 409A; otherwise, specified employees will be identified using the default standards contained in the regulations under Code Section 409A.

76 Kforce 2026 Proxy Statement

------

<u>[**Table of Contents**](#ibde21b2946834ef1acfb04b1aa73fd7c_16)</u>

**APPENDIX B**

**RECONCILIATION OF (1) ADJUSTED DILUTED EARNINGS PER SHARE AND (2) EPS FINANCIAL INCENTIVE METRIC ATTAINMENT**

To facilitate a clearer understanding of the items influencing our non-GAAP diluted earnings per share and the EPS financial incentive metric attainment for the year ended December 31, 2025, we have identified and adjusted for several items that impacted our results. These items, which reflect discrete operational, strategic, and/or one-time factors, are presented in the following table to illustrate their individual and combined effect.

The following table outlines the adjustments for the year ended December 31, 2025:

---

| | |
|:---|:---|
| GAAP Diluted Earnings per share | $**1.96** |
| &nbsp;&nbsp;Organizational realignment activities <sup>(1)</sup> | 0.09 |
| &nbsp;&nbsp;Further streamlining our operating costs <sup>(2)</sup> | 0.04 |
| Adjusted Diluted Earnings per share | $**2.09** |
| &nbsp;&nbsp;Federal government disruption (DOGE, U.S. tariffs, U.S. government shutdown) | 0.38 |
| &nbsp;&nbsp;Other (gain on death benefit, retention incentives, and other) | 0.06 |
| EPS financial incentive metric attainment | $**2.53** |

---

<sup>(1)</sup> These items reflect targeted actions taken to refine our organizational structure and improve operational effectiveness.

<sup>(2)</sup> These items include the write-off of certain long-lived assets and coordinated efforts aimed at further streamlining our operating costs.

77 Kforce 2026 Proxy Statement

------

<u>[**Table of Contents**](#ibde21b2946834ef1acfb04b1aa73fd7c_16)</u>

---

| | | |
|:---|:---|:---|
| ![Kforce.jpg](kfrc-20260313_g62.jpg) | | ![2026 Proxy Card Voting.jpg](kfrc-20260313_g63.jpg) |
| | | ![2026 Proxy Card Voting.jpg](kfrc-20260313_g63.jpg) |
| | | ![2026 Proxy Card Voting.jpg](kfrc-20260313_g63.jpg) |
| | | ![2026 Proxy Card Voting.jpg](kfrc-20260313_g63.jpg) |
| | | ![2026 Proxy Card Voting.jpg](kfrc-20260313_g63.jpg) |
| | | ![2026 Proxy Card Voting.jpg](kfrc-20260313_g63.jpg) |
| | | ![2026 Proxy Card Voting.jpg](kfrc-20260313_g63.jpg) |
| | | ![2026 Proxy Card Voting.jpg](kfrc-20260313_g63.jpg) |
| | | ![2026 Proxy Card Voting.jpg](kfrc-20260313_g63.jpg) |
| | | ![2026 Proxy Card Voting.jpg](kfrc-20260313_g63.jpg) |
| | | ![2026 Proxy Card Voting.jpg](kfrc-20260313_g63.jpg) |
| | | ![2026 Proxy Card Voting.jpg](kfrc-20260313_g63.jpg) |
| | | ![2026 Proxy Card Voting.jpg](kfrc-20260313_g63.jpg) |
| Using a <u>black ink</u> pen, mark your votes with an **X** as shown in this example. <br>Please do not write outside the designated areas. | 🗷 | ![2026 Proxy Card Voting.jpg](kfrc-20260313_g63.jpg) |

---

![annualmeetingproxycarda03.jpg](kfrc-20260313_g64.jpg)

▼ IF VOTING BY MAIL, SIGN, DETACH AND RETURN THE BOTTOM PORTION IN THE ENCLOSED ENVELOPE. ▼

---

| | |
|:---|:---|
| **A** | **Proposals — The Board of Directors recommends a vote <u>FOR</u> all nominees listed and <u>FOR</u> Proposals 2, 3 and 4.** |

---

---

| | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| 1. | Election of Directors: | Election of Directors: | Election of Directors: | Election of Directors: | Election of Directors: | Election of Directors: | Election of Directors: | Election of Directors: |  |  |  |  |
|  |  | **For** | **Against** | **Abstain** |  | **For** | **Against** | **Abstain** |  | **For** | **Against** | **Abstain** |
|  | 01 - Derrick D. Brooks (**Class II**) | □ | □ | □ | 02 - Ann E. Dunwoody (**Class II**) | □ | □ | □ | 03 - N. John Simmons (**Class II**) | □ | □ | □ |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | | **For** | **Against** | **Abstain** | | |
| 2. | Ratify the appointment of Deloitte & Touche LLP as Kforce's independent registered public accountants for 2026. | □ | □ | □ | 3. | Advisory vote on Kforce's executive compensation. |
|  |  | **For** | **Against** | **Abstain** |  |  |
| 4. | Approve the Kforce Inc. 2026 Stock Incentive Plan. | □ | □ | □ | 5. | In their discretion, the proxies are authorized to vote upon such other business as may properly come before the Annual Meeting or any adjournments of the Annual Meeting. |

---

---

| | | | |
|:---|:---|:---|:---|
| **B** | **Authorized Signatures — This section must be completed for your vote to be counted. — Date and Sign** | **Authorized Signatures — This section must be completed for your vote to be counted. — Date and Sign** | **Authorized Signatures — This section must be completed for your vote to be counted. — Date and Sign** |
| NOTE: Please date and sign exactly as your name appears on your shares. If signing for estates, trusts, partnerships, corporations or other entities, your title or capacity should be stated. If shares are held jointly, each holder should sign. The signer hereby revokes all proxies heretofore given by the signer to vote at said meeting or any adjournments thereof. | NOTE: Please date and sign exactly as your name appears on your shares. If signing for estates, trusts, partnerships, corporations or other entities, your title or capacity should be stated. If shares are held jointly, each holder should sign. The signer hereby revokes all proxies heretofore given by the signer to vote at said meeting or any adjournments thereof. | NOTE: Please date and sign exactly as your name appears on your shares. If signing for estates, trusts, partnerships, corporations or other entities, your title or capacity should be stated. If shares are held jointly, each holder should sign. The signer hereby revokes all proxies heretofore given by the signer to vote at said meeting or any adjournments thereof. | NOTE: Please date and sign exactly as your name appears on your shares. If signing for estates, trusts, partnerships, corporations or other entities, your title or capacity should be stated. If shares are held jointly, each holder should sign. The signer hereby revokes all proxies heretofore given by the signer to vote at said meeting or any adjournments thereof. |
| Date (mm/dd/yyyy) — Please print date below. | Date (mm/dd/yyyy) — Please print date below. | Signature 1 — Please keep signature within the box. | Signature 2 — Please keep signature within the box. |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;/&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;/ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;/&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;/ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; |  |  |

---

![proxycard3.jpg](kfrc-20260313_g65.jpg)

78 Kforce 2026 Proxy Statement

------

<u>[**Table of Contents**](#ibde21b2946834ef1acfb04b1aa73fd7c_16)</u>

![electronicvoting.jpg](kfrc-20260313_g66.jpg)

▼ IF VOTING BY MAIL, SIGN, DETACH AND RETURN THE BOTTOM PORTION IN THE ENCLOSED ENVELOPE. ▼

![proxykforceincproxycard.jpg](kfrc-20260313_g67.jpg)

**ANNUAL MEETING OF SHAREHOLDERS**

**TO BE HELD APRIL 22, 2026**

**THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS**

The undersigned hereby appoints David M. Kelly and Michael R. Blackman, or either of them, each with full power of substitution and revocation, as the proxy or proxies of the undersigned, to represent the undersigned and vote all shares of the common stock of Kforce Inc. that the undersigned would be entitled to vote if personally present at the Annual Meeting of Shareholders of Kforce Inc., to be held at Kforce's corporate headquarters located at 1150 Assembly Drive, Suite 500, Tampa, Florida 33607, on April 22, 2026 at 8:00 a.m. eastern time, and at any adjournments thereof, upon the matters set forth on the reverse side, and in their discretion, upon all other matters that may properly come before the meeting or any adjournments of the meeting.

The Annual Meeting may be held as scheduled only if a majority of the shares entitled to vote are represented at the meeting in person or by proxy. Accordingly, please complete this proxy, and submit it promptly by mail (using the enclosed envelope), by telephone, or over the Internet.

**The shares of Kforce Inc. common stock covered by this proxy will be voted in accordance with the choices made. When no choice is made, this proxy will be voted FOR all listed nominees for director, FOR the ratification of the appointment of Deloitte & Touche LLP to serve as Kforce's independent registered public accountants for 2026, FOR the advisory approval of Kforce's executive compensation, FOR the approval of the Kforce Inc. 2026 Stock Incentive Plan and as the proxyholders deem advisable on such other matters as may properly come before the meeting.**

Please vote, sign and date on the reverse side and return this proxy card promptly.

---

| | | | |
|:---|:---|:---|:---|
| **C** | **Non-Voting Items** | **Non-Voting Items** | **Non-Voting Items** |
| **Change of Address** — Please print new address below. | **Change of Address** — Please print new address below. | **Meeting Attendance** | |
| | | Mark box to the right if you plan to attend the Annual Meeting. | □ |

---

![Image50.jpg](kfrc-20260313_g65.jpg)